Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    02465060
Previous Study | Return to List | Next Study

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02465060
Recruitment Status : Recruiting
First Posted : June 8, 2015
Last Update Posted : November 11, 2019
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)

Brief Summary:
This phase II MATCH trial studies how well treatment that is directed by genetic testing works in patients with solid tumors or lymphomas that have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic abnormalities (such as mutations, amplifications, or translocations) may benefit more from treatment which targets their tumor's particular genetic abnormality. Identifying these genetic abnormalities first may help doctors plan better treatment for patients with solid tumors, lymphomas, or multiple myeloma.

Condition or disease Intervention/treatment Phase
Advanced Malignant Solid Neoplasm Bladder Carcinoma Breast Carcinoma Cervical Carcinoma Colon Carcinoma Colorectal Carcinoma Endometrial Carcinoma Esophageal Carcinoma Gastric Carcinoma Glioma Head and Neck Carcinoma Kidney Carcinoma Liver and Intrahepatic Bile Duct Carcinoma Lung Carcinoma Lymphoma Malignant Uterine Neoplasm Melanoma Ovarian Carcinoma Pancreatic Carcinoma Plasma Cell Myeloma Prostate Carcinoma Rectal Carcinoma Recurrent Bladder Carcinoma Recurrent Breast Carcinoma Recurrent Cervical Carcinoma Recurrent Colon Carcinoma Recurrent Colorectal Carcinoma Recurrent Esophageal Carcinoma Recurrent Gastric Carcinoma Recurrent Glioma Recurrent Head and Neck Carcinoma Recurrent Liver Carcinoma Recurrent Lung Carcinoma Recurrent Lymphoma Recurrent Malignant Solid Neoplasm Recurrent Melanoma Recurrent Ovarian Carcinoma Recurrent Pancreatic Carcinoma Recurrent Plasma Cell Myeloma Recurrent Prostate Carcinoma Recurrent Rectal Carcinoma Recurrent Skin Carcinoma Recurrent Thyroid Gland Carcinoma Recurrent Uterine Corpus Carcinoma Refractory Lymphoma Refractory Malignant Solid Neoplasm Refractory Plasma Cell Myeloma Skin Carcinoma Thyroid Gland Carcinoma Uterine Corpus Cancer Drug: Adavosertib Drug: Afatinib Drug: Afatinib Dimaleate Drug: Binimetinib Drug: Capivasertib Drug: Copanlisib Drug: Copanlisib Hydrochloride Drug: Crizotinib Other: Cytology Specimen Collection Procedure Drug: Dabrafenib Drug: Dabrafenib Mesylate Drug: Dasatinib Drug: Defactinib Drug: Defactinib Hydrochloride Drug: Erdafitinib Drug: FGFR Inhibitor AZD4547 Drug: Ipatasertib Other: Laboratory Biomarker Analysis Drug: Larotrectinib Drug: Larotrectinib Sulfate Biological: Nivolumab Drug: Osimertinib Drug: Palbociclib Biological: Pertuzumab Drug: PI3K-beta Inhibitor GSK2636771 Drug: Sapanisertib Drug: Sunitinib Malate Drug: Taselisib Drug: Trametinib Biological: Trastuzumab Biological: Trastuzumab Emtansine Drug: Ulixertinib Drug: Vismodegib Phase 2

Detailed Description:

PRIMARY OBJECTIVE:

I. To evaluate the proportion of patients with objective response (OR) to targeted study agent(s) in patients with advanced refractory cancers/lymphomas/multiple myeloma.

SECONDARY OBJECTIVES:

I. To evaluate the proportion of patients alive and progression free at 6 months of treatment with targeted study agent in patients with advanced refractory cancers/lymphomas/multiple myeloma.

II. To evaluate time until death or disease progression. III. To identify potential predictive biomarkers beyond the genomic alteration by which treatment is assigned or resistance mechanisms using additional genomic, ribonucleic acid (RNA), protein and imaging-based assessment platforms.

IV. To assess whether radiomic phenotypes obtained from pre-treatment imaging and changes from pre- through post-therapy imaging can predict objective response and progression free survival and to evaluate the association between pre-treatment radiomic phenotypes and targeted gene mutation patterns of tumor biopsy specimens.

OUTLINE:

STEP 0 (Screening): Patients undergo biopsy along with molecular characterization of the biopsy material for specific, pre-defined mutations, amplifications, or translocations of interest via tumor sequencing and immunohistochemistry. Consenting patients also undergo collection of blood samples for research purposes.

STEPS 1, 3, 5, 7 (Treatment): Patients are assigned to 1 of 37 treatment subprotocols based on molecularly-defined subgroup. (See Arms Section)

STEPS 2, 4, 6 (Screening): Patients experiencing disease progression on the prior Step treatment or who could not tolerate the assigned treatment undergo review of their previous biopsy results to determine if another treatment is available or undergo another biopsy. Patients may have a maximum of 2 screening biopsies and 2 treatments per biopsy.

STEP 8 (Optional Research): Consenting patients undergo end-of-treatment biopsy and collection of blood samples for research purposes.

After completion of study treatment, patients are followed up every 3 months for 2 years and then every 6 months for 1 year.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 6452 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Molecular Analysis for Therapy Choice (MATCH)
Actual Study Start Date : August 12, 2015
Estimated Primary Completion Date : June 30, 2022


Arm Intervention/treatment
Experimental: Subprotocol A (EGFR activating mutation)
Patients with EGFR activating mutation receive afatinib orally (PO) once daily (QD) on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Drug: Afatinib
Given PO
Other Names:
  • BIBW 2992
  • BIBW2992

Drug: Afatinib Dimaleate
Given PO
Other Names:
  • (2E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydrofuran-3-yl)oxy)quinazolin- 6-yl)-4-(dimethylamino)but-2-enamide bis(hydrogen (2Z)-but-2-enedioate)
  • BIBW 2992MA2
  • BIBW2992 MA2
  • Gilotrif

Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Experimental: Subprotocol B (HER2 activating mutation)
Patients with HER2 activating mutation receive afatinib PO QD on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Drug: Afatinib
Given PO
Other Names:
  • BIBW 2992
  • BIBW2992

Drug: Afatinib Dimaleate
Given PO
Other Names:
  • (2E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydrofuran-3-yl)oxy)quinazolin- 6-yl)-4-(dimethylamino)but-2-enamide bis(hydrogen (2Z)-but-2-enedioate)
  • BIBW 2992MA2
  • BIBW2992 MA2
  • Gilotrif

Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Experimental: Subprotocol C1 (MET amplification)
Patients with MET amplification receive crizotinib PO BID on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Drug: Crizotinib
Given PO
Other Names:
  • MET tyrosine kinase inhibitor PF-02341066
  • PF-02341066
  • PF-2341066
  • Xalkori

Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Experimental: Subprotocol C2 (MET exon 14 deletion/mutation)
Patients with MET exon 14 deletion or other mutations that disrupt exon 14 receive crizotinib PO BID on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Drug: Crizotinib
Given PO
Other Names:
  • MET tyrosine kinase inhibitor PF-02341066
  • PF-02341066
  • PF-2341066
  • Xalkori

Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Experimental: Subprotocol E (EGFR T790M or rare activating mutation)
Patients with EGFR T790M or rare activating mutation receive osimertinib PO QD on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Drug: Osimertinib
Given PO
Other Names:
  • AZD-9291
  • AZD9291
  • Mereletinib
  • Tagrisso

Experimental: Subprotocol F (ALK translocation)
Patients with ALK translocation receive crizotinib PO twice daily (BID) on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Drug: Crizotinib
Given PO
Other Names:
  • MET tyrosine kinase inhibitor PF-02341066
  • PF-02341066
  • PF-2341066
  • Xalkori

Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Experimental: Subprotocol G (ROS1 translocation or inversion)
Patients with ROS1 translocation or inversion receive crizotinib PO BID on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Drug: Crizotinib
Given PO
Other Names:
  • MET tyrosine kinase inhibitor PF-02341066
  • PF-02341066
  • PF-2341066
  • Xalkori

Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Experimental: Subprotocol H (BRAF V600E/R/K/D mutation)
Patients with BRAF V600E/R/K/D mutation receive dabrafenib PO BID and trametinib PO QD on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Drug: Dabrafenib
Given PO
Other Names:
  • BRAF Inhibitor GSK2118436
  • GSK-2118436
  • GSK-2118436A
  • GSK2118436

Drug: Dabrafenib Mesylate
Given PO
Other Names:
  • Dabrafenib Methanesulfonate
  • GSK2118436 Methane Sulfonate Salt
  • GSK2118436B
  • Tafinlar

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Drug: Trametinib
Given PO
Other Names:
  • GSK1120212
  • JTP-74057
  • MEK Inhibitor GSK1120212
  • Mekinist

Experimental: Subprotocol I (PIK3CA mutation)
Patients with PIK3CA mutation without RAS mutation or PTEN loss receive taselisib PO QD on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Drug: Taselisib
Given PO
Other Names:
  • GDC-0032
  • RO5537381

Experimental: Subprotocol J (HER2 amplification >= 7 copy numbers)
Patients with HER2 amplification >= 7 copy numbers receive pertuzumab IV over 30-60 minutes and trastuzumab IV over 30 minutes on day 1. Cycles repeat every 3 weeks in the absence of disease progression or unacceptable toxicity.
Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Biological: Pertuzumab
Given IV
Other Names:
  • 2C4
  • 2C4 Antibody
  • MoAb 2C4
  • Monoclonal Antibody 2C4
  • Omnitarg
  • Perjeta
  • rhuMAb2C4
  • RO4368451

Biological: Trastuzumab
Given IV
Other Names:
  • ABP 980
  • ALT02
  • Anti-c-ERB-2
  • Anti-c-erbB2 Monoclonal Antibody
  • Anti-ERB-2
  • Anti-erbB-2
  • Anti-erbB2 Monoclonal Antibody
  • Anti-HER2/c-erbB2 Monoclonal Antibody
  • Anti-p185-HER2
  • c-erb-2 Monoclonal Antibody
  • HER2 Monoclonal Antibody
  • Herceptin
  • Herceptin Biosimilar PF-05280014
  • Herceptin Trastuzumab Biosimilar PF-05280014
  • Herzuma
  • MoAb HER2
  • Monoclonal Antibody c-erb-2
  • Monoclonal Antibody HER2
  • Ogivri
  • Ontruzant
  • PF-05280014
  • rhuMAb HER2
  • RO0452317
  • SB3
  • Trastuzumab Biosimilar ABP 980
  • Trastuzumab Biosimilar ALT02
  • trastuzumab biosimilar EG12014
  • Trastuzumab Biosimilar HLX02
  • Trastuzumab Biosimilar PF-05280014
  • Trastuzumab Biosimilar SB3
  • Trastuzumab-dkst
  • Trastuzumab-dttb
  • Trastuzumab-pkrb
  • Trastuzumab-QYYP
  • Trazimera

Biological: Trastuzumab Emtansine
Given IV
Other Names:
  • Ado Trastuzumab Emtansine
  • ADO-Trastuzumab Emtansine
  • Kadcyla
  • PRO132365
  • RO5304020
  • T-DM1
  • Trastuzumab-DM1
  • Trastuzumab-MCC-DM1
  • Trastuzumab-MCC-DM1 Antibody-Drug Conjugate
  • Trastuzumab-MCC-DM1 Immunoconjugate

Experimental: Subprotocol K1 (FGFR amplification)
Patients with FGFR amplification receive erdafitinib PO QD on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Drug: Erdafitinib
Given PO
Other Names:
  • Balversa
  • JNJ-42756493

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Experimental: Subprotocol K2 (FGFR mutation or fusion)
Patients with FGFR mutation or fusion receive erdafitinib PO QD on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Drug: Erdafitinib
Given PO
Other Names:
  • Balversa
  • JNJ-42756493

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Experimental: Subprotocol L (mTOR mutation)
Patients with mTOR mutation receive sapanisertib PO daily on days 1-28. Cycles repeat every 3 weeks in the absence of disease progression or unacceptable toxicity.
Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Drug: Sapanisertib
Given PO
Other Names:
  • INK-128
  • INK128
  • MLN-0128
  • MLN0128
  • TAK-228

Experimental: Subprotocol M (TSC1 or TSC2 mutation)
Patients with TSC1 or TSC2 mutation receive sapanisertib PO daily on days 1-28. Cycles repeat every 3 weeks in the absence of disease progression or unacceptable toxicity.
Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Drug: Sapanisertib
Given PO
Other Names:
  • INK-128
  • INK128
  • MLN-0128
  • MLN0128
  • TAK-228

Experimental: Subprotocol N (PTEN mutation or deletion and PTEN expression)
Patients with PTEN mutation or deletion and PTEN expression receive PI3K-beta inhibitor GSK2636771 PO QD on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Drug: PI3K-beta Inhibitor GSK2636771
Given PO
Other Name: GSK2636771

Experimental: Subprotocol P (PTEN loss)
Patients with PTEN loss receive PI3K-beta inhibitor GSK2636771 PO QD on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Drug: PI3K-beta Inhibitor GSK2636771
Given PO
Other Name: GSK2636771

Experimental: Subprotocol Q (HER2 amplification)
Patients with HER2 amplification receive trastuzumab emtansine intravenously (IV) over 30-90 minutes on day 1. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity.
Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Biological: Trastuzumab
Given IV
Other Names:
  • ABP 980
  • ALT02
  • Anti-c-ERB-2
  • Anti-c-erbB2 Monoclonal Antibody
  • Anti-ERB-2
  • Anti-erbB-2
  • Anti-erbB2 Monoclonal Antibody
  • Anti-HER2/c-erbB2 Monoclonal Antibody
  • Anti-p185-HER2
  • c-erb-2 Monoclonal Antibody
  • HER2 Monoclonal Antibody
  • Herceptin
  • Herceptin Biosimilar PF-05280014
  • Herceptin Trastuzumab Biosimilar PF-05280014
  • Herzuma
  • MoAb HER2
  • Monoclonal Antibody c-erb-2
  • Monoclonal Antibody HER2
  • Ogivri
  • Ontruzant
  • PF-05280014
  • rhuMAb HER2
  • RO0452317
  • SB3
  • Trastuzumab Biosimilar ABP 980
  • Trastuzumab Biosimilar ALT02
  • trastuzumab biosimilar EG12014
  • Trastuzumab Biosimilar HLX02
  • Trastuzumab Biosimilar PF-05280014
  • Trastuzumab Biosimilar SB3
  • Trastuzumab-dkst
  • Trastuzumab-dttb
  • Trastuzumab-pkrb
  • Trastuzumab-QYYP
  • Trazimera

Biological: Trastuzumab Emtansine
Given IV
Other Names:
  • Ado Trastuzumab Emtansine
  • ADO-Trastuzumab Emtansine
  • Kadcyla
  • PRO132365
  • RO5304020
  • T-DM1
  • Trastuzumab-DM1
  • Trastuzumab-MCC-DM1
  • Trastuzumab-MCC-DM1 Antibody-Drug Conjugate
  • Trastuzumab-MCC-DM1 Immunoconjugate

Experimental: Subprotocol R (BRAF fusion or BRAF non-V600 mutation)
Patients with BRAF fusion or BRAF non-V600 mutation receive trametinib PO QD on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Drug: Trametinib
Given PO
Other Names:
  • GSK1120212
  • JTP-74057
  • MEK Inhibitor GSK1120212
  • Mekinist

Experimental: Subprotocol S1 (NF1 mutation)
Patients with NF1 mutation receive trametinib PO QD on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Drug: Trametinib
Given PO
Other Names:
  • GSK1120212
  • JTP-74057
  • MEK Inhibitor GSK1120212
  • Mekinist

Experimental: Subprotocol S2 (GNAQ or GNA11 mutation)
Patients with GNAQ or GNA11 mutation receive trametinib PO QD on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Drug: Trametinib
Given PO
Other Names:
  • GSK1120212
  • JTP-74057
  • MEK Inhibitor GSK1120212
  • Mekinist

Experimental: Subprotocol T (SMO or PTCH1 mutation)
Patients with SMO or PTCH1 mutation receive vismodegib PO QD on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Drug: Vismodegib
Given PO
Other Names:
  • Erivedge
  • GDC-0449
  • Hedgehog Antagonist GDC-0449

Experimental: Subprotocol U (NF2 inactivating mutation)
Patients with NF2 inactivating mutation receive defactinib PO BID on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Drug: Defactinib
Given PO

Drug: Defactinib Hydrochloride
Given PO
Other Names:
  • PF-04554878
  • VS-6063

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Experimental: Subprotocol V (cKIT exon 9, 11, 13, or 14 mutation)
Patients with cKIT exon 9, 11, 13, or 14 mutation receive sunitinib malate PO QD for 4 weeks. Cycles repeat every 6 weeks in the absence of disease progression or unacceptable toxicity.
Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Drug: Sunitinib Malate
Given PO
Other Names:
  • SU011248
  • SU11248
  • sunitinib
  • Sutent

Experimental: Subprotocol W (FGFR pathway aberrations)
Patients with FGFR1-3 mutation or translocation receive FGFR Inhibitor AZD4547 PO BID on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Drug: FGFR Inhibitor AZD4547
Given PO
Other Name: AZD4547

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Experimental: Subprotocol X (DDR2 S768R, I638F, or L239R mutation)
Patients with DDR2 S768R, I638F, or L239R mutation receive dasatinib PO QD on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Drug: Dasatinib
Given PO
Other Names:
  • BMS-354825
  • Dasatinib Hydrate
  • Dasatinib Monohydrate
  • Sprycel

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Experimental: Subprotocol Y (Akt mutation)
Patients with Akt mutation receive capivasertib PO BID on days 1-4, 8-11, 15-18, and 22-25. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Drug: Capivasertib
Given PO
Other Name: AZD5363

Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Experimental: Subprotocol Z1A (NRAS mutation in codon 12, 13, or 61)
Patients with NRAS mutation in codon 12, 13, or 61 receive binimetinib PO BID on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Drug: Binimetinib
Given PO
Other Names:
  • ARRY-162
  • ARRY-438162
  • MEK162
  • Mektovi

Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Experimental: Subprotocol Z1B (CCND1, 2, or 3 amplification with Rb by IHC)
Patients with CCND1, 2, or 3 amplification that have tumor Rb expression by IHC receive palbociclib PO QD for 21 days. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Drug: Palbociclib
Given PO
Other Names:
  • 6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-8h-pyrido(2,3-d)pyrimidin-7-one
  • Ibrance
  • PD 0332991
  • PD 332991
  • PD 991
  • PD-0332991

Experimental: Subprotocol Z1C (CDK4 or CDK6 amplification and Rb protein)
Patients with CDK4 or CDK6 amplification and tumor Rb protein receive palbociclib PO QD on days 1-21. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Drug: Palbociclib
Given PO
Other Names:
  • 6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-8h-pyrido(2,3-d)pyrimidin-7-one
  • Ibrance
  • PD 0332991
  • PD 332991
  • PD 991
  • PD-0332991

Experimental: Subprotocol Z1D (Loss of MLH1 or MSH2 by IHC)
Patients with mismatch repair deficiency (loss of MLH1 or MSH2 by IHC) receive nivolumab IV over 30 minutes on days 1 and 15 for 4 cycles and then on day 1 every 28 days. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Biological: Nivolumab
Given IV
Other Names:
  • BMS-936558
  • MDX-1106
  • NIVO
  • ONO-4538
  • Opdivo

Experimental: Subprotocol Z1E (NTRK1, NTRK2 or NTRK3 gene fusion)
Patients with NTRK1, NTRK2, or NTRK3 gene fusion receive larotrectinib PO BID on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Drug: Larotrectinib
Given PO
Other Names:
  • ARRY 470
  • LOXO 101
  • LOXO-101

Drug: Larotrectinib Sulfate
Given PO
Other Names:
  • ARRY 470 Sulfate
  • LOXO 101 Sulfate
  • LOXO-101 Sulfate
  • Vitrakvi

Experimental: Subprotocol Z1F (PIK3CA mutation)
Patients with PIK3CA mutation receive copanlisib IV over 1 hour on days 1, 8, and 15. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Drug: Copanlisib
Given IV
Other Names:
  • BAY 80-6946
  • PI3K Inhibitor BAY 80-6946

Drug: Copanlisib Hydrochloride
Given IV
Other Names:
  • 5-Pyrimidinecarboxamide, 2-Amino-N-(2,3-dihydro-7-methoxy-8-(3-(4-morpholinyl)propoxy)imidazo(1,2-C)quinazolin-5-yl)-, Hydrochloride (1:2)
  • Aliqopa
  • BAY 80-6946 Dihydrochloride
  • BAY-80-6946 Dihydrochloride
  • Copanlisib Dihydrochloride

Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Experimental: Subprotocol Z1G (PTEN loss)
Patients with PTEN loss receive copanlisib IV over 1 hour on days 1, 8, and 15. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Drug: Copanlisib
Given IV
Other Names:
  • BAY 80-6946
  • PI3K Inhibitor BAY 80-6946

Drug: Copanlisib Hydrochloride
Given IV
Other Names:
  • 5-Pyrimidinecarboxamide, 2-Amino-N-(2,3-dihydro-7-methoxy-8-(3-(4-morpholinyl)propoxy)imidazo(1,2-C)quinazolin-5-yl)-, Hydrochloride (1:2)
  • Aliqopa
  • BAY 80-6946 Dihydrochloride
  • BAY-80-6946 Dihydrochloride
  • Copanlisib Dihydrochloride

Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Experimental: Subprotocol Z1H (PTEN mutation)
Patients with PTEN mutation receive copanlisib IV over 1 hour on days 1, 8, and 15. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Drug: Copanlisib
Given IV
Other Names:
  • BAY 80-6946
  • PI3K Inhibitor BAY 80-6946

Drug: Copanlisib Hydrochloride
Given IV
Other Names:
  • 5-Pyrimidinecarboxamide, 2-Amino-N-(2,3-dihydro-7-methoxy-8-(3-(4-morpholinyl)propoxy)imidazo(1,2-C)quinazolin-5-yl)-, Hydrochloride (1:2)
  • Aliqopa
  • BAY 80-6946 Dihydrochloride
  • BAY-80-6946 Dihydrochloride
  • Copanlisib Dihydrochloride

Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Experimental: Subprotocol Z1I (BRCA1 or BRCA2 gene mutation)
Patients with BRCA1 or BRCA2 gene mutation receive adavosertib PO QD for 5 days for 2 weeks. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity.
Drug: Adavosertib
Given PO
Other Names:
  • AZD-1775
  • AZD1775
  • MK-1775
  • MK1775

Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Experimental: Subprotocol Z1K (AKT mutation)
Patients receive ipatasertib PO QD. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Drug: Ipatasertib
Given PO
Other Names:
  • GDC-0068
  • RG-7440

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Experimental: Subprotocol Z1L (BRAF fusion, aberration or non-V600 mutation)
Patients with a BRAF non-V600 mutation or BRAF fusion, or another BRAF aberration receive ulixertinib (BVD-523FB) PO BID on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Other: Cytology Specimen Collection Procedure
Optional correlative studies
Other Name: Cytologic Sampling

Other: Laboratory Biomarker Analysis
Undergo molecular analysis

Drug: Ulixertinib
Give PO
Other Names:
  • BVD-523
  • VRT752271




Primary Outcome Measures :
  1. Objective response rate [ Time Frame: Up to 3 years ]
    Defined as the percentage of patients whose tumors have a complete or partial response to treatment. Objective response rate is defined consistent with Response Evaluation Criteria in Solid Tumors version 1.1 criteria for solid tumors, the Cheson (2014) criteria for lymphoma patients, and the Response Assessment in Neuro-Oncology criteria for glioblastoma patients. For each treatment arm, 90% two-sided confidence intervals will be calculated.


Secondary Outcome Measures :
  1. Overall survival, evaluated specifically for each drug (or step) [ Time Frame: From registration onto that step until death, or censored at the date of last contact, assessed up to 3 years ]
    Overall survival will be estimated using the Kaplan-Meier method.

  2. Progression free survival [ Time Frame: From entry onto that step until determination of disease progression or death from any cause, censored at the date of last disease assessment for patients who have not progressed, assessed at 6 months ]
    Progression free survival will be estimated using the Kaplan-Meier method. For each treatment arm, 90% two-sided confidence intervals will be calculated.

  3. Time to progression [ Time Frame: From entry to that step until determination of disease progression or death due to disease, censored at the date of last disease assessment for patients who have not progressed, assessed up to 3 years ]
    Time to progression will be estimated using the Kaplan-Meier method.


Other Outcome Measures:
  1. Potential predictive biomarkers beyond the genomic alteration [ Time Frame: Baseline ]
    Biomarkers measured prior to treatment could be predictive of response or non-response to the agent. Analyses conducted to identify predictive biomarkers will be primarily exploratory and will consist of simple comparisons of biomarkers levels, either using binomial-based tests (for binary biomarkers), t-tests (continuous biomarkers, possibly transformed), or non-parametric tests, as appropriate depending on the distribution of the biomarker values.

  2. Biomarkers that provide clues for mechanisms of acquired resistance [ Time Frame: Up to 3 years ]
    Biomarkers measured at time of progression might provide clues for mechanisms of acquired resistance. Changes in biomarker levels from baseline (prior to receiving the treatment) to progression within patients will be assessed using paired tests appropriate for the type of biomarker measurement (e.g., paired t-tests for normally distributed biomarker values or McNemar tests for paired binary data). It will also be assessed whether patterns of changes in biomarkers are different depending on length of time to progression.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • ELIGIBILITY CRITERIA FOR SCREENING BIOPSY (STEP 0)
  • Women of childbearing potential must have a negative serum pregnancy test within 2 weeks prior to registration; patients that are pregnant or breast feeding are excluded; a female of childbearing potential is any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria:

    • Has not undergone a hysterectomy or bilateral oophorectomy; or
    • Has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)
  • Women of childbearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry, for the duration of study participation, and for 4 months after completion of study; should a woman become pregnant or suspect while she or her partner is participating in this study, she should inform her treating physician immediately
  • Patients must have histologically documented solid tumors or histologically confirmed diagnosis of lymphoma or multiple myeloma requiring therapy and meet one of the following criteria:

    • Patients must have progressed following at least one line of standard systemic therapy and there must not be other approval/standard therapy available that has been shown to prolong overall survival (i.e. in a randomized trial against another standard treatment or by comparison to historical controls); patients who cannot receive other standard therapy that has been shown to prolong overall survival due to medical issues will be eligible, if other eligibility criteria are met; if the patient is currently receiving therapy, the clinician must have assessed that the current therapy is no longer benefitting the patient prior to enrolling on MATCH, regardless of whether it is considered standard OR
    • Patients for whose disease no standard treatment exists that has been shown to prolong overall survival
    • NOTE: No other prior malignancy is allowed except for the following:
    • Adequately treated basal cell or squamous cell skin cancer
    • In situ cervical cancer
    • Adequately treated stage I or II cancer from which the patient is currently in complete remission
    • Any other cancer from which the patient has been disease-free for 5 years
  • Patients must have measurable disease
  • Patients must meet the criteria below and have received results from one of the designated outside laboratories indicating a "rare variant" that is an actionable Mutation of Interest (aMOI) for specific select subprotocols.

    • The following requirements apply:

      • The outside laboratory specifically notified the site that patient may be a potential candidate for MATCH due to a detected "rare variant"; the outside lab reports are NOT sufficient for this purpose

        • NOTE: The content and format of these specific notifications for the Outside Assay process will vary depending on the designated outside lab in question, as they are each responsible for their own outreach efforts; it is strongly recommended that the designated outside laboratory be contacted to confirm the format and receipt of this notification prior to registering any patients to Step 0
      • Patients with an applicable "rare variant" must be able to meet the eligibility criteria for the appropriate subprotocols within 4 weeks following notification of treatment assignment

        • NOTE: The receipt of this notification (and the start of the associated deadline for Step 1 registration) may occur shortly after Step 0 registration, since these patients will not be submitting tissue for screening purposes; however, for certain "rare variant" arms, submission of archival tissue for central immunohistochemistry (IHC) testing may be required
      • Registration to Step 0 must occur after stopping prior systemic anti-cancer therapy; there is no specific duration for which patients must be off treatment prior to registration to Step 0, as long as all eligibility criteria are met
      • There is no particular window of time after notification of potential eligibility from an outside lab in which the patient must be registered to Step 0, but treatment slots will be assigned on a first come, first serve basis to those who do register to Step 0, and are not held for those notified of potential eligibility who do not register to Step 0
      • Patients may have received other non-targeted, immunotherapy or targeted treatment between the prior genetic testing at the outside lab and registration to Step 0; the decision to stop such treatment in favor of participation in MATCH, if no further clinical benefit is expected, is per the treating physician's discretion; documentation of a lack of response to the prior treatment is not required in these cases

        • NOTE: Other potential aMOIs that would be eligibility criteria for "NON RARE" arms, as determined by the designated laboratories, are not applicable for this process in MATCH
        • NOTE: Tumor tissue for the confirmation of "rare variant" by the MATCH assay is to be submitted, preferably from the same time of collection as that evaluated by the designated outside laboratory
  • Patients must have Eastern Cooperative Oncology Group (ECOG) performance status =< 1 and a life expectancy of at least 3 months
  • Patients must be able to swallow tablets or capsules; a patient with any gastrointestinal disease that would impair ability to swallow, retain, or absorb drug is not eligible
  • Patients who are human immunodeficiency virus (HIV)-positive are eligible if:

    • CD4+ cell count greater or equal to 250 cells/mm^3
    • If patient is on antiretroviral therapy, there must be minimal interactions or overlapping toxicity of the antiretroviral therapy with the experimental cancer treatment; for experimental cancer therapeutics with CYP3A/4 interactions, protease inhibitor therapy is disallowed; suggested regimens to replace protease inhibitor therapy include dolutegravir given with tenofovir/emtricitabine; raltegravir given with tenofovir and emtricitabine; once daily combinations that use pharmacologic boosters may not be used
    • No history of non-malignancy acquired immune deficiency syndrome (AIDS)-defining conditions other than historical low CD4+ cell counts
    • Probable long-term survival with HIV if cancer were not present
  • Any prior therapy, radiotherapy (except palliative radiation therapy of 30 gray [Gy] or less), or major surgery must have been completed >= 4 weeks prior to start of treatment; all adverse events due to prior therapy have resolved to a grade 1 or better (except alopecia and lymphopenia) by start of treatment; palliative radiation therapy must have been completed at least 2 weeks prior to start of treatment; the radiotherapy must not be to a lesion that is included as measurable disease

    • NOTE: Prostate cancer patients may continue their luteinizing hormone-releasing hormone (LHRH) agonist
    • NOTE: For patients entering the study via the original screening process, patients may receive non-protocol treatment after biopsy (if clinically indicated) until they receive notification of results; however, lack of response must be documented prior to registration to Step 1; new non-protocol treatment will NOT be permitted as intervening therapy after registration to Step 0; the only intervening treatment permitted is prior therapy that the patient already received prior to Step 0 registration; the decision to stop the intervening non-protocol treatment will be left up to the treating physician if patient has an aMOI; however, patients will need to be off such therapy for at least 4 weeks before receiving any MATCH protocol treatment
    • NOTE: For patients entering the study via a designated outside laboratory, no intervening systemic non-protocol treatment is permitted after Step 0 registration; all other eligibility requirements still apply to these patients, including the washouts for prior therapy noted above in this section, the time restrictions outlined, and the eligibility criteria for the intended subprotocol
  • Patients with brain metastases or primary brain tumors must have completed treatment, surgery or radiation therapy >= 4 weeks prior to start of treatment
  • Patients must have discontinued steroids >= 1 week prior to registration to Step 0 and remain off steroids thereafter, except as permitted; patients with glioblastoma (GBM) must have been on stable dose of steroids, or be off steroids, for one week prior to registration to treatment (Step 1, 3, 5, 7)

    • NOTE: The following steroids are permitted (low dose steroid use is defined as prednisone 10 mg daily or less, or bioequivalent dose of other corticosteroid):

      • Temporary steroid use: e.g. for computed tomography (CT) imaging in setting of contrast allergy
      • Low dose steroid use for appetite
      • Chronic inhaled steroid use
      • Steroid injections for joint disease
      • Stable dose of replacement steroid for adrenal insufficiency or low doses for non-malignant disease
      • Topical steroid
      • Steroids required to manage toxicity related to study treatment, as described in the subprotocols
      • Steroids required as pre- or post-chemotherapy medication for acceptable intervening chemotherapy

        • NOTE: Steroids must be completed alongside last dose of chemotherapy
  • Leukocytes >= 3,000/mcL (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)
  • Absolute neutrophil count >= 1,500/mcL (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)
  • Platelets >= 100,000/mcL (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)
  • NOTE: Patients with documented bone marrow involvement by lymphoma are not required to meet the above hematologic parameters, but must have a platelet count of at least 75,000/mcL and neutrophil count of at least 1,000/mcL
  • Total bilirubin =< 1.5 x institutional upper limit of normal (ULN) (unless documented Gilbert's syndrome, for which bilirubin =< 3 x institutional ULN is permitted) (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)
  • Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT])/alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< 2.5 x institutional ULN (up to 5 times ULN in presence of liver metastases) (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)
  • Creatinine clearance >= 45 mL/min/1.73 m^2 for patients with creatinine levels above institutional normal

    • As defined by the Cockcroft-Gault equation (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)
  • Patients must have an electrocardiogram (ECG) within 8 weeks prior to registration to screening step and must meet the following cardiac criteria:

    • Resting corrected QT interval (QTc) =< 480 msec

      • NOTE: If the first recorded QTc exceeds 480 msec, two additional, consecutive ECGs are required and must result in a mean resting QTc =< 480 msec; it is recommended that there are 10-minute (+/- 5 minutes) breaks between the ECGs
    • The following only need to be assessed if the mean QTc > 480 msec

      • Check potassium and magnesium serum levels
      • Correct any identified hypokalemia and/or hypomagnesemia and may repeat ECG to confirm exclusion of patient due to QTc
      • For patients with heart rate (HR) 60-100 beats per minute (bpm), no manual read of QTc is required
      • For patients with baseline HR < 60 or > 100 bpm, manual read of QT by trained personnel is required, with Fridericia correction applied to determine QTc
      • Patient must not have hypokalemia (value < institutional lower limit of normal)
    • No factors that increase the risk of QTc prolongation or risk of arrhythmic events such as heart failure, congenital long QT syndrome, family history of long QT syndrome or unexplained sudden death under 40 years of age or any concomitant medication known to prolong the QT interval

      • NOTE: Patient must be taken off prohibited medication prior to registration to the screening step (Step 0, 2, 4, 6) and remain off these medications thereafter, unless permitted on a subprotocol for the management of treatment related toxicity; patient must be off the drug for at least 5 half-lives prior to registration to the treatment step (Step 1, 3, 5, 7); the medication half-life can be found in the package insert for Food and Drug Administration (FDA) approved drugs
  • ELIGIBILITY CRITERIA FOR FIRST TREATMENT (STEP 1)
  • If patients have been biopsied or submitted archived tumor tissue obtained within the last 6 months for assessment with the MATCH assays, patients may receive non-protocol treatment after biopsy/tissue submission (if clinically indicated) until they receive notification of results however, lack of response must be documented prior to registration to step 1; new non-protocol treatment will NOT be permitted as intervening therapy after registration to Step 0; for patients entering step 0 with assay results from outside laboratories, no systemic treatment is allowed after step 0 registration; the decision to stop the intervening nonprotocol treatment will be left up to the treating physician if patient has an aMOI; waiting periods as described will apply
  • As MATCH is designed to add additional subprotocols, implement limited expansions of accrual for certain subprotocols, and/or amend existing arm-specific eligibility criteria, some patients entering under the original screening method may be eligible to have their results rerun in MATCHbox, even if they did not match to a treatment initially or did not receive a treatment assignment due to a lack of available assignment slots; patients whose sequence results will be rerun through MATCHbox must also meet the following criteria:

    • Samples must have been collected within 5 months of the activation of the addendum, as there is an additional month needed to get the patients on trial
    • Patient has not had treatment within the 5 months that resulted in a PR or better after the performance of the screening assessment
    • Patient must meet eligibility criteria, including performance status 1 or better and life expectancy of at least 3 months
    • Patients must meet the eligibility requirements with the following exceptions:

      • Patients may have received other non-targeted, immunotherapy or targeted treatment, which could be stopped in favor of returning to MATCH, if no response to the interim treatment has occurred and no further benefit is expected from this interim treatment, per the treating physician's discretion; documentation o

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02465060


  Hide Study Locations
Locations
Layout table for location information
United States, Alabama
University of Alabama at Birmingham Cancer Center Recruiting
Birmingham, Alabama, United States, 35233
Contact: Site Public Contact    205-934-0220    tmyrick@uab.edu   
Principal Investigator: Eddy S. Yang         
Mobile Infirmary Medical Center Recruiting
Mobile, Alabama, United States, 36607
Contact: Site Public Contact    251-435-3942      
Principal Investigator: Furhan Yunus         
University of South Alabama Mitchell Cancer Institute Recruiting
Mobile, Alabama, United States, 36688
Contact: Site Public Contact    251-445-9870    pfrancisco@usouthal.edu   
Principal Investigator: Rodney Rocconi         
United States, Alaska
Anchorage Associates in Radiation Medicine Recruiting
Anchorage, Alaska, United States, 98508
Contact: Site Public Contact    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Alison K. Conlin         
Anchorage Radiation Therapy Center Recruiting
Anchorage, Alaska, United States, 99504
Contact: Site Public Contact    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Alison K. Conlin         
Alaska Breast Care and Surgery LLC Recruiting
Anchorage, Alaska, United States, 99508
Contact: Site Public Contact    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Alison K. Conlin         
Alaska Oncology and Hematology LLC Recruiting
Anchorage, Alaska, United States, 99508
Contact: Site Public Contact    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Alison K. Conlin         
Alaska Regional Hospital Suspended
Anchorage, Alaska, United States, 99508
Alaska Women's Cancer Care Recruiting
Anchorage, Alaska, United States, 99508
Contact: Site Public Contact    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Alison K. Conlin         
Anchorage Oncology Centre Recruiting
Anchorage, Alaska, United States, 99508
Contact: Site Public Contact    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Alison K. Conlin         
Katmai Oncology Group Recruiting
Anchorage, Alaska, United States, 99508
Contact: Site Public Contact    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Alison K. Conlin         
Providence Alaska Medical Center Recruiting
Anchorage, Alaska, United States, 99508
Contact: Site Public Contact    907-212-6871    AKPAMC.OncologyResearchSupport@providence.org   
Principal Investigator: Alison K. Conlin         
Fairbanks Memorial Hospital Recruiting
Fairbanks, Alaska, United States, 99701
Contact: Site Public Contact    907-458-3043    cancerresearch@foundationhealth.org   
Principal Investigator: John A. Keech         
United States, Arizona
CTCA at Western Regional Medical Center Recruiting
Goodyear, Arizona, United States, 85338
Contact: Site Public Contact    623-207-3000      
Principal Investigator: Alan Tan         
Kingman Regional Medical Center Recruiting
Kingman, Arizona, United States, 86401
Contact: Site Public Contact       ecog.rss@jimmy.harvard.edu   
Principal Investigator: John A. Ellerton         
University of Arizona Cancer Center at Saint Joseph's Recruiting
Phoenix, Arizona, United States, 85004
Contact: Site Public Contact    602-406-8222      
Principal Investigator: Jue Wang         
Mayo Clinic Hospital Recruiting
Phoenix, Arizona, United States, 85054
Contact: Site Public Contact    855-776-0015      
Principal Investigator: Alan H. Bryce         
Mayo Clinic in Arizona Recruiting
Scottsdale, Arizona, United States, 85259
Contact: Site Public Contact    855-776-0015      
Principal Investigator: Alan H. Bryce         
United States, Arkansas
Mercy Hospital Fort Smith Recruiting
Fort Smith, Arkansas, United States, 72903
Contact: Site Public Contact    800-378-9373      
Principal Investigator: Jay W. Carlson         
CHI Saint Vincent Cancer Center Hot Springs Recruiting
Hot Springs, Arkansas, United States, 71913
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Recruiting
Jonesboro, Arkansas, United States, 72401
Contact: Site Public Contact    870-936-7067    Dawn.Smith@BMHCC.org   
Principal Investigator: Donald S. Gravenor         
University of Arkansas for Medical Sciences Recruiting
Little Rock, Arkansas, United States, 72205
Contact: Site Public Contact    501-686-8274      
Principal Investigator: Rangaswamy Govindarajan         
United States, California
Kaiser Permanente-Anaheim Recruiting
Anaheim, California, United States, 92806
Contact: Site Public Contact    800-398-3996    clinical.trials@kp.org   
Principal Investigator: Han A. Koh         
Kaiser Permanente-Deer Valley Medical Center Recruiting
Antioch, California, United States, 94531
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
PCR Oncology Recruiting
Arroyo Grande, California, United States, 93420
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Sutter Auburn Faith Hospital Recruiting
Auburn, California, United States, 95602
Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Edmund W. Tai         
Sutter Cancer Centers Radiation Oncology Services-Auburn Recruiting
Auburn, California, United States, 95603
Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Edmund W. Tai         
AIS Cancer Center at San Joaquin Community Hospital Recruiting
Bakersfield, California, United States, 93301
Contact: Site Public Contact    661-323-4673      
Principal Investigator: Primo N. Lara         
Kaiser Permanente-Baldwin Park Recruiting
Baldwin Park, California, United States, 91706
Contact: Site Public Contact    800-398-3996    clinical.trials@kp.org   
Principal Investigator: Han A. Koh         
Kaiser Permanente-Bellflower Recruiting
Bellflower, California, United States, 90706
Contact: Site Public Contact    800-398-3996    clinical.trials@kp.org   
Principal Investigator: Han A. Koh         
Alta Bates Summit Medical Center-Herrick Campus Recruiting
Berkeley, California, United States, 94704
Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Edmund W. Tai         
Providence Saint Joseph Medical Center/Disney Family Cancer Center Recruiting
Burbank, California, United States, 91505
Contact: Site Public Contact    818-847-4793    Najee.Boucher@providence.org   
Principal Investigator: Alison K. Conlin         
Mills-Peninsula Medical Center Recruiting
Burlingame, California, United States, 94010
Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Edmund W. Tai         
Sutter Cancer Centers Radiation Oncology Services-Cameron Park Recruiting
Cameron Park, California, United States, 95682
Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Edmund W. Tai         
Eden Hospital Medical Center Recruiting
Castro Valley, California, United States, 94546
Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Edmund W. Tai         
Community Cancer Institute Recruiting
Clovis, California, United States, 93611
Contact: Site Public Contact    559-387-1827      
Principal Investigator: Li Li         
University Oncology Associates Recruiting
Clovis, California, United States, 93611
Contact: Site Public Contact    559-256-9680      
Principal Investigator: Li Li         
John Muir Medical Center-Concord Campus Active, not recruiting
Concord, California, United States, 94520
City of Hope Corona Recruiting
Corona, California, United States, 92879
Contact: Site Public Contact    800-826-4673    becomingapatient@coh.org   
Principal Investigator: Karen L. Reckamp         
UC Irvine Health Cancer Center-Newport Recruiting
Costa Mesa, California, United States, 92627
Contact: Site Public Contact    877-827-8839      
Principal Investigator: Daniela A. Bota         
Sutter Davis Hospital Recruiting
Davis, California, United States, 95616
Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Edmund W. Tai         
City of Hope Comprehensive Cancer Center Recruiting
Duarte, California, United States, 91010
Contact: Site Public Contact    800-826-4673    becomingapatient@coh.org   
Principal Investigator: Karen L. Reckamp         
Epic Care-Dublin Recruiting
Dublin, California, United States, 94568
Contact: Site Public Contact    925-875-1677      
Principal Investigator: Lisa Bailey         
Kaiser Permanente Dublin Recruiting
Dublin, California, United States, 94568
Contact: Site Public Contact    877-642-4691      
Principal Investigator: Jennifer M. Suga         
Bay Area Breast Surgeons Inc Recruiting
Emeryville, California, United States, 94608
Contact: Site Public Contact    510-835-9900      
Principal Investigator: Lisa Bailey         
Epic Care Partners in Cancer Care Recruiting
Emeryville, California, United States, 94608
Contact: Site Public Contact    510-629-6682      
Principal Investigator: Lisa Bailey         
Kaiser Permanente-Fontana Recruiting
Fontana, California, United States, 92335
Contact: Site Public Contact    800-398-3996    clinical.trials@kp.org   
Principal Investigator: Han A. Koh         
Kaiser Permanente-Fremont Recruiting
Fremont, California, United States, 94538
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Palo Alto Medical Foundation-Fremont Recruiting
Fremont, California, United States, 94538
Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Edmund W. Tai         
Fresno Cancer Center Recruiting
Fresno, California, United States, 93720
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Kaiser Permanente-Fresno Recruiting
Fresno, California, United States, 93720
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Saint Jude Medical Center Recruiting
Fullerton, California, United States, 92835
Contact: Site Public Contact    714-446-5642      
Principal Investigator: William E. Lawler         
Marin Cancer Care Inc Recruiting
Greenbrae, California, United States, 94904
Contact: Site Public Contact    415-925-5000    info@marinspecialtycare.com   
Principal Investigator: Peter D. Eisenberg         
Marin General Hospital Active, not recruiting
Greenbrae, California, United States, 94904
Kaiser Permanente - Harbor City Recruiting
Harbor City, California, United States, 90710
Contact: Site Public Contact    800-398-3996    clinical.trials@kp.org   
Principal Investigator: Han A. Koh         
Kaiser Permanente-Irvine Recruiting
Irvine, California, United States, 92618
Contact: Site Public Contact    800-398-3996    clinical.trials@kp.org   
Principal Investigator: Han A. Koh         
UC San Diego Moores Cancer Center Recruiting
La Jolla, California, United States, 92093
Contact: Site Public Contact    858-822-5354    cancercto@ucsd.edu   
Principal Investigator: Shumei Kato         
Loma Linda University Medical Center Recruiting
Loma Linda, California, United States, 92354
Contact: Site Public Contact    909-558-3375      
Principal Investigator: Gayathri Nagaraj         
Kaiser Permanente Los Angeles Medical Center Recruiting
Los Angeles, California, United States, 90027
Contact: Site Public Contact    800-398-3996    clinical.trials@kp.org   
Principal Investigator: Han A. Koh         
Los Angeles County-USC Medical Center Recruiting
Los Angeles, California, United States, 90033
Contact: Site Public Contact    323-865-0451      
Principal Investigator: Heinz-Josef Lenz         
USC / Norris Comprehensive Cancer Center Recruiting
Los Angeles, California, United States, 90033
Contact: Site Public Contact    323-865-0451      
Principal Investigator: Heinz-Josef Lenz         
Kaiser Permanente-Cadillac Recruiting
Los Angeles, California, United States, 90034
Contact: Site Public Contact    800-398-3996    clinical.trials@kp.org   
Principal Investigator: Han A. Koh         
Cedars Sinai Medical Center Suspended
Los Angeles, California, United States, 90048
Contra Costa Regional Medical Center Recruiting
Martinez, California, United States, 94553-3156
Contact: Site Public Contact    925-957-5400      
Principal Investigator: Lisa Bailey         
Fremont - Rideout Cancer Center Recruiting
Marysville, California, United States, 95901
Contact: Site Public Contact    530-749-4400      
Principal Investigator: Primo N. Lara         
Memorial Medical Center Recruiting
Modesto, California, United States, 95355
Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Edmund W. Tai         
Kaiser Permanente-Modesto Recruiting
Modesto, California, United States, 95356
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Community Hospital of Monterey Peninsula Active, not recruiting
Monterey, California, United States, 93940
Pacific Cancer Care-Monterey Active, not recruiting
Monterey, California, United States, 93940
Palo Alto Medical Foundation-Camino Division Recruiting
Mountain View, California, United States, 94040
Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Edmund W. Tai         
Palo Alto Medical Foundation-Gynecologic Oncology Recruiting
Mountain View, California, United States, 94040
Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Edmund W. Tai         
USC Norris Oncology/Hematology-Newport Beach Recruiting
Newport Beach, California, United States, 92663
Contact: Site Public Contact    323-865-0451      
Principal Investigator: Heinz-Josef Lenz         
Sutter Cancer Research Consortium Suspended
Novato, California, United States, 94945
Alta Bates Summit Medical Center - Summit Campus Recruiting
Oakland, California, United States, 94609
Contact: Site Public Contact    510-204-1414      
Principal Investigator: Lisa Bailey         
Bay Area Tumor Institute Recruiting
Oakland, California, United States, 94609
Contact: Site Public Contact    510-465-2242    lradke@bati.org   
Principal Investigator: Lisa Bailey         
Kaiser Permanente Oakland-Broadway Recruiting
Oakland, California, United States, 94611
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Kaiser Permanente-Oakland Recruiting
Oakland, California, United States, 94611
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Saint Joseph Hospital - Orange Recruiting
Orange, California, United States, 92868
Contact: Site Public Contact    714-734-6220      
Principal Investigator: Timothy E. Byun         
UC Irvine Health/Chao Family Comprehensive Cancer Center Recruiting
Orange, California, United States, 92868
Contact: Site Public Contact    877-827-8839    ucstudy@uci.edu   
Principal Investigator: Daniela A. Bota         
Desert Regional Medical Center Recruiting
Palm Springs, California, United States, 92262
Contact: Site Public Contact    760-416-4730      
Principal Investigator: Coty Ho         
Palo Alto Medical Foundation Health Care Recruiting
Palo Alto, California, United States, 94301
Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Edmund W. Tai         
Stanford Cancer Institute Palo Alto Recruiting
Palo Alto, California, United States, 94304
Contact: Site Public Contact    650-498-7061    ccto-office@stanford.edu   
Principal Investigator: James M. Ford         
VA Palo Alto Health Care System Recruiting
Palo Alto, California, United States, 94304
Contact: Site Public Contact    800-455-0057      
Principal Investigator: Harlan A. Pinto         
Kaiser Permanente - Panorama City Recruiting
Panorama City, California, United States, 91402
Contact: Site Public Contact    800-398-3996    clinical.trials@kp.org   
Principal Investigator: Han A. Koh         
Keck Medical Center of USC Pasadena Recruiting
Pasadena, California, United States, 91105
Contact: Site Public Contact    323-865-0451      
Principal Investigator: Heinz-Josef Lenz         
Kaiser Permanente-Rancho Cordova Cancer Center Recruiting
Rancho Cordova, California, United States, 95670
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Eisenhower Medical Center Active, not recruiting
Rancho Mirage, California, United States, 92270
Kaiser Permanente-Redwood City Recruiting
Redwood City, California, United States, 94063
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Kaiser Permanente-Richmond Recruiting
Richmond, California, United States, 94801
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Kaiser Permanente-Riverside Recruiting
Riverside, California, United States, 92505
Contact: Site Public Contact    800-398-3996    clinical.trials@kp.org   
Principal Investigator: Han A. Koh         
Rohnert Park Cancer Center Recruiting
Rohnert Park, California, United States, 94928
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Kaiser Permanente-Roseville Recruiting
Roseville, California, United States, 95661
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Sutter Cancer Centers Radiation Oncology Services-Roseville Recruiting
Roseville, California, United States, 95661
Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Edmund W. Tai         
Sutter Roseville Medical Center Recruiting
Roseville, California, United States, 95661
Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Edmund W. Tai         
The Permanente Medical Group-Roseville Radiation Oncology Recruiting
Roseville, California, United States, 95678
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Kaiser Permanente Downtown Commons Recruiting
Sacramento, California, United States, 95814
Contact: Site Public Contact    877-642-4691    kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Sutter Medical Center Sacramento Recruiting
Sacramento, California, United States, 95816
Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Edmund W. Tai         
University of California Davis Comprehensive Cancer Center Recruiting
Sacramento, California, United States, 95817
Contact: Site Public Contact    916-734-3089      
Principal Investigator: Primo N. Lara         
Kaiser Permanente-South Sacramento Recruiting
Sacramento, California, United States, 95823
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
South Sacramento Cancer Center Recruiting
Sacramento, California, United States, 95823
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Kaiser Permanente - Sacramento Recruiting
Sacramento, California, United States, 95825
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Saint Helena Hospital Recruiting
Saint Helena, California, United States, 94574
Contact: Site Public Contact    707-967-3698      
Principal Investigator: David J. Tate         
University of California San Diego Recruiting
San Diego, California, United States, 92103
Contact: Site Public Contact    858-822-5354    cancercto@ucsd.edu   
Principal Investigator: Shumei Kato         
Kaiser Permanente-San Diego Mission Recruiting
San Diego, California, United States, 92108
Contact: Site Public Contact    800-398-3996    clinical.trials@kp.org   
Principal Investigator: Han A. Koh         
Kaiser Permanente-San Diego Zion Recruiting
San Diego, California, United States, 92120
Contact: Site Public Contact    800-398-3996    clinical.trials@kp.org   
Principal Investigator: Han A. Koh         
Rady Children's Hospital - San Diego Active, not recruiting
San Diego, California, United States, 92123
Sharp Memorial Hospital Recruiting
San Diego, California, United States, 92123
Contact: Site Public Contact    858-939-5062    cathy.wood@sharp.com   
Principal Investigator: Robert M. Barone         
Naval Medical Center -San Diego Active, not recruiting
San Diego, California, United States, 92134
California Pacific Medical Center-Pacific Campus Recruiting
San Francisco, California, United States, 94115
Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Edmund W. Tai         
Kaiser Permanente-San Francisco Recruiting
San Francisco, California, United States, 94115
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Kaiser Permanente-Santa Teresa-San Jose Recruiting
San Jose, California, United States, 95119
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Kaiser Permanente San Leandro Recruiting
San Leandro, California, United States, 94577
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Kaiser Permanente-San Marcos Recruiting
San Marcos, California, United States, 92078
Contact: Site Public Contact    800-398-3996    clinical.trials@kp.org   
Principal Investigator: Han A. Koh         
Kaiser Permanente-San Rafael Recruiting
San Rafael, California, United States, 94903
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Kaiser San Rafael-Gallinas Recruiting
San Rafael, California, United States, 94903
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Kaiser Permanente Medical Center - Santa Clara Recruiting
Santa Clara, California, United States, 95051
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Palo Alto Medical Foundation-Santa Cruz Recruiting
Santa Cruz, California, United States, 95065
Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Edmund W. Tai         
Kaiser Permanente-Santa Rosa Recruiting
Santa Rosa, California, United States, 95403
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Sutter Pacific Medical Foundation Recruiting
Santa Rosa, California, United States, 95403
Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Edmund W. Tai         
Kaiser Permanente Cancer Treatment Center Recruiting
South San Francisco, California, United States, 94080
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Kaiser Permanente-South San Francisco Recruiting
South San Francisco, California, United States, 94080
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Saint Joseph's Medical Center Recruiting
Stockton, California, United States, 95204
Contact: Site Public Contact    209-461-5257      
Principal Investigator: Chunhui Fang         
Kaiser Permanente-Stockton Recruiting
Stockton, California, United States, 95210
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Palo Alto Medical Foundation-Sunnyvale Recruiting
Sunnyvale, California, United States, 94086
Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Edmund W. Tai         
Gene Upshaw Memorial Tahoe Forest Cancer Center Recruiting
Truckee, California, United States, 96161
Contact: Site Public Contact    530-582-6450      
Principal Investigator: Primo N. Lara         
City of Hope Upland Recruiting
Upland, California, United States, 91786
Contact: Site Public Contact    800-826-4673    becomingapatient@coh.org   
Principal Investigator: Karen L. Reckamp         
Sutter Cancer Centers Radiation Oncology Services-Vacaville Recruiting
Vacaville, California, United States, 95687
Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Edmund W. Tai         
Kaiser Permanente Medical Center-Vacaville Recruiting
Vacaville, California, United States, 95688
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Kaiser Permanente-Vallejo Recruiting
Vallejo, California, United States, 94589
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Sutter Solano Medical Center/Cancer Center Recruiting
Vallejo, California, United States, 94589
Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Edmund W. Tai         
Kaiser Permanente-Walnut Creek Recruiting
Walnut Creek, California, United States, 94596
Contact: Site Public Contact    877-642-4691    Kpoct@kp.org   
Principal Investigator: Jennifer M. Suga         
Epic Care Cyberknife Center Recruiting
Walnut Creek, California, United States, 94597
Contact: Site Public Contact    510-465-8016    somega@bati.org   
Principal Investigator: Lisa Bailey         
John Muir Medical Center-Walnut Creek Active, not recruiting
Walnut Creek, California, United States, 94598
City of Hope West Covina Recruiting
West Covina, California, United States, 91790
Contact: Site Public Contact    800-826-4673    becomingapatient@coh.org   
Principal Investigator: Karen L. Reckamp         
Presbyterian Intercommunity Hospital Recruiting
Whittier, California, United States, 90602
Contact: Site Public Contact    562-698-0811      
Principal Investigator: Dustin E. Stevenson         
Kaiser Permanente-Woodland Hills Recruiting
Woodland Hills, California, United States, 91367
Contact: Site Public Contact    800-398-3996    clinical.trials@kp.org   
Principal Investigator: Han A. Koh         
United States, Colorado
Rocky Mountain Cancer Centers-Aurora Recruiting
Aurora, Colorado, United States, 80012
Contact: Site Public Contact    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
The Medical Center of Aurora Recruiting
Aurora, Colorado, United States, 80012
Contact: Site Public Contact    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
University of Colorado Hospital Recruiting
Aurora, Colorado, United States, 80045
Contact: Site Public Contact    720-848-0650      
Principal Investigator: Christopher H. Lieu         
Boulder Community Hospital Recruiting
Boulder, Colorado, United States, 80301
Contact: Site Public Contact    303-777-2663    jbloomfield@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Rocky Mountain Cancer Centers-Boulder Recruiting
Boulder, Colorado, United States, 80304
Contact: Site Public Contact    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Penrose-Saint Francis Healthcare Recruiting
Colorado Springs, Colorado, United States, 80907
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Rocky Mountain Cancer Centers-Penrose Recruiting
Colorado Springs, Colorado, United States, 80907
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
UCHealth Memorial Hospital Central Recruiting
Colorado Springs, Colorado, United States, 80909
Contact: Site Public Contact    719-365-2406      
Principal Investigator: Christopher H. Lieu         
Memorial Hospital North Recruiting
Colorado Springs, Colorado, United States, 80920
Contact: Site Public Contact    719-364-6700      
Principal Investigator: Christopher H. Lieu         
Cancer Center of Colorado at Sloan's Lake Recruiting
Denver, Colorado, United States, 80204
Contact: Site Public Contact    303-777-2663      
Principal Investigator: Keren Sturtz         
Denver Health Medical Center Suspended
Denver, Colorado, United States, 80204
Kaiser Permanente-Franklin Recruiting
Denver, Colorado, United States, 80205
Contact: Site Public Contact    303-764-5056    josh.b.gordon@nsmtp.kp.org   
Principal Investigator: Alexander Menter         
The Women's Imaging Center Recruiting
Denver, Colorado, United States, 80209
Contact: Site Public Contact    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Porter Adventist Hospital Recruiting
Denver, Colorado, United States, 80210
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Colorado Blood Cancer Institute Recruiting
Denver, Colorado, United States, 80218
Contact: Site Public Contact    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Presbyterian - Saint Lukes Medical Center - Health One Recruiting
Denver, Colorado, United States, 80218
Contact: Site Public Contact    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Rocky Mountain Cancer Centers-Midtown Recruiting
Denver, Colorado, United States, 80218
Contact: Site Public Contact    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
SCL Health Saint Joseph Hospital Recruiting
Denver, Colorado, United States, 80218
Contact: Site Public Contact    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Rocky Mountain Cancer Centers-Rose Recruiting
Denver, Colorado, United States, 80220
Contact: Site Public Contact    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Rose Medical Center Recruiting
Denver, Colorado, United States, 80220
Contact: Site Public Contact    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Mercy Medical Center Recruiting
Durango, Colorado, United States, 81301
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Southwest Oncology PC Recruiting
Durango, Colorado, United States, 81301
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Mountain Blue Cancer Care Center - Swedish Recruiting
Englewood, Colorado, United States, 80113
Contact: Site Public Contact    303-777-2663    WSCR@westernstatesncorp.org   
Principal Investigator: Keren Sturtz         
Swedish Medical Center Recruiting
Englewood, Colorado, United States, 80113
Contact: Site Public Contact    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Poudre Valley Hospital Recruiting
Fort Collins, Colorado, United States, 80524
Contact: Site Public Contact    970-297-6150      
Principal Investigator: Christopher H. Lieu         
Mountain Blue Cancer Care Center Suspended
Golden, Colorado, United States, 80401
National Jewish Health-Western Hematology Oncology Suspended
Golden, Colorado, United States, 80401
Saint Mary's Hospital and Regional Medical Center Recruiting
Grand Junction, Colorado, United States, 81501
Contact: Site Public Contact    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Grand Valley Oncology Active, not recruiting
Grand Junction, Colorado, United States, 81505
North Colorado Medical Center Suspended
Greeley, Colorado, United States, 80631
Rocky Mountain Cancer Centers-Greenwood Village Suspended
Greenwood Village, Colorado, United States, 80111
Good Samaritan Medical Center Recruiting
Lafayette, Colorado, United States, 80026
Contact: Site Public Contact    303-673-1622      
Principal Investigator: Keren Sturtz         
Kaiser Permanente-Rock Creek Recruiting
Lafayette, Colorado, United States, 80026
Contact: Site Public Contact    303-764-5056    josh.b.gordon@nsmtp.kp.org   
Principal Investigator: Alexander Menter         
Rocky Mountain Cancer Centers-Lakewood Suspended
Lakewood, Colorado, United States, 80228
Saint Anthony Hospital Recruiting
Lakewood, Colorado, United States, 80228
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Rocky Mountain Cancer Centers-Littleton Recruiting
Littleton, Colorado, United States, 80120
Contact: Site Public Contact    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Littleton Adventist Hospital Recruiting
Littleton, Colorado, United States, 80122
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Kaiser Permanente-Lone Tree Recruiting
Lone Tree, Colorado, United States, 80124
Contact: Site Public Contact    303-764-5056    josh.b.gordon@nsmtp.kp.org   
Principal Investigator: Alexander Menter         
Rocky Mountain Cancer Centers-Sky Ridge Recruiting
Lone Tree, Colorado, United States, 80124
Contact: Site Public Contact    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Sky Ridge Medical Center Recruiting
Lone Tree, Colorado, United States, 80124
Contact: Site Public Contact    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Longmont United Hospital Recruiting
Longmont, Colorado, United States, 80501
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Rocky Mountain Cancer Centers-Longmont Recruiting
Longmont, Colorado, United States, 80501
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
McKee Medical Center Recruiting
Loveland, Colorado, United States, 80539
Contact: Site Public Contact    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Parker Adventist Hospital Recruiting
Parker, Colorado, United States, 80138
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Rocky Mountain Cancer Centers-Parker Suspended
Parker, Colorado, United States, 80138
Saint Mary Corwin Medical Center Recruiting
Pueblo, Colorado, United States, 81004
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Rocky Mountain Cancer Centers - Pueblo Suspended
Pueblo, Colorado, United States, 81008
National Jewish Health-Northern Hematology Oncology Recruiting
Thornton, Colorado, United States, 80260
Contact: Site Public Contact    303-777-2663    glicht@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Rocky Mountain Cancer Centers-Thornton Suspended
Thornton, Colorado, United States, 80260
SCL Health Lutheran Medical Center Recruiting
Wheat Ridge, Colorado, United States, 80033
Contact: Site Public Contact    303-777-2663    ccrp@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
United States, Connecticut
Smilow Cancer Hospital-Derby Care Center Recruiting
Derby, Connecticut, United States, 06418
Contact: Site Public Contact    203-785-5702    canceranswers@yale.edu   
Principal Investigator: Scott N. Gettinger         
Smilow Cancer Hospital Care Center-Fairfield Recruiting
Fairfield, Connecticut, United States, 06824
Contact: Site Public Contact    203-785-5702    canceranswers@yale.edu   
Principal Investigator: Scott N. Gettinger         
Yale-New Haven Shoreline Medical Center Recruiting
Guilford, Connecticut, United States, 06437
Contact: Site Public Contact    203-785-5702    canceranswers@yale.edu   
Principal Investigator: Scott N. Gettinger         
Smilow Cancer Hospital Care Center at Saint Francis Recruiting
Hartford, Connecticut, United States, 06105
Contact: Site Public Contact    203-785-5702    canceranswers@yale.edu   
Principal Investigator: Scott N. Gettinger         
Smilow Cancer Center/Yale-New Haven Hospital Recruiting
New Haven, Connecticut, United States, 06510
Contact: Site Public Contact    203-785-5702    canceranswers@yale.edu   
Principal Investigator: Scott N. Gettinger         
Yale University Recruiting
New Haven, Connecticut, United States, 06520
Contact: Site Public Contact    203-785-5702    canceranswers@yale.edu   
Principal Investigator: Scott N. Gettinger         
Yale-New Haven Hospital North Haven Medical Center Recruiting
North Haven, Connecticut, United States, 06473
Contact: Site Public Contact    203-785-5702    canceranswers@yale.edu   
Principal Investigator: Scott N. Gettinger         
Eastern Connecticut Hematology and Oncology Associates Recruiting
Norwich, Connecticut, United States, 06360
Contact: Site Public Contact    860-886-8362      
Principal Investigator: Dennis E. Slater         
Smilow Cancer Hospital-Orange Care Center Recruiting
Orange, Connecticut, United States, 06477
Contact: Site Public Contact    203-785-5702    canceranswers@yale.edu   
Principal Investigator: Scott N. Gettinger         
Stamford Hospital/Bennett Cancer Center Active, not recruiting
Stamford, Connecticut, United States, 06904
Smilow Cancer Hospital-Torrington Care Center Recruiting
Torrington, Connecticut, United States, 06790
Contact: Site Public Contact    203-785-5702    canceranswers@yale.edu   
Principal Investigator: Scott N. Gettinger         
Smilow Cancer Hospital Care Center-Trumbull Recruiting
Trumbull, Connecticut, United States, 06611
Contact: Site Public Contact    203-785-5702    canceranswers@yale.edu   
Principal Investigator: Scott N. Gettinger         
Smilow Cancer Hospital-Waterbury Care Center Recruiting
Waterbury, Connecticut, United States, 06708
Contact: Site Public Contact    203-785-5702    canceranswers@yale.edu   
Principal Investigator: Scott N. Gettinger         
Veterans Affairs Connecticut Healthcare System-West Haven Campus Active, not recruiting
West Haven, Connecticut, United States, 06516
United States, Delaware
Beebe Medical Center Recruiting
Lewes, Delaware, United States, 19958
Contact: Site Public Contact    302-645-3770    Dmiskin@Beebehealthcare.org   
Principal Investigator: Gregory A. Masters         
Christiana Gynecologic Oncology LLC Suspended
Newark, Delaware, United States, 19713
Delaware Clinical and Laboratory Physicians PA Recruiting
Newark, Delaware, United States, 19713
Contact: Site Public Contact    302-623-4450    KDempsey@christianacare.org   
Principal Investigator: Gregory A. Masters         
Helen F Graham Cancer Center Recruiting
Newark, Delaware, United States, 19713
Contact: Site Public Contact    302-623-4450    KDempsey@christianacare.org   
Principal Investigator: Gregory A. Masters         
Medical Oncology Hematology Consultants PA Recruiting
Newark, Delaware, United States, 19713
Contact: Site Public Contact    302-623-4450    KDempsey@christianacare.org   
Principal Investigator: Gregory A. Masters         
Christiana Care Health System-Christiana Hospital Recruiting
Newark, Delaware, United States, 19718
Contact: Site Public Contact    302-623-4450    KDempsey@christianacare.org   
Principal Investigator: Gregory A. Masters         
Beebe Health Campus Recruiting
Rehoboth Beach, Delaware, United States, 19971
Contact: Site Public Contact    302-645-3100    Dmiskin@Beebehealthcare.org   
Principal Investigator: Gregory A. Masters         
Nanticoke Memorial Hospital Recruiting
Seaford, Delaware, United States, 19973
Contact: Site Public Contact    302-645-3100    Dmiskin@Beebehealthcare.org   
Principal Investigator: Gregory A. Masters         
Christiana Care Health System-Wilmington Hospital Recruiting
Wilmington, Delaware, United States, 19801
Contact: Site Public Contact    302-623-4450    KDempsey@christianacare.org   
Principal Investigator: Gregory A. Masters         
United States, District of Columbia
MedStar Georgetown University Hospital Recruiting
Washington, District of Columbia, United States, 20007
Contact: Site Public Contact    202-444-2223      
Principal Investigator: Filipa C. Lynce         
MedStar Washington Hospital Center Recruiting
Washington, District of Columbia, United States, 20010
Contact: Site Public Contact    202-877-8839      
Principal Investigator: Filipa C. Lynce         
Sibley Memorial Hospital Recruiting
Washington, District of Columbia, United States, 20016
Contact: Site Public Contact    202-243-2373    jquiver1@jhmi.edu   
Principal Investigator: Michael A. Carducci         
United States, Florida
Mount Sinai Comprehensive Cancer Center at Aventura Recruiting
Aventura, Florida, United States, 33180
Contact: Site Public Contact    305-674-2625    yenrique@msmc.com   
Principal Investigator: Michael A. Schwartz         
UM Sylvester Comprehensive Cancer Center at Coral Gables Recruiting
Coral Gables, Florida, United States, 33146
Contact: Site Public Contact    305-243-2647      
Principal Investigator: Brian M. Slomovitz         
UM Sylvester Comprehensive Cancer Center at Coral Springs Suspended
Coral Springs, Florida, United States, 33065
Broward Health North Recruiting
Deerfield Beach, Florida, United States, 33064
Contact: Site Public Contact    954-941-8300      
Principal Investigator: Israel Wiznitzer         
UM Sylvester Comprehensive Cancer Center at Deerfield Beach Recruiting
Deerfield Beach, Florida, United States, 33442
Contact: Site Public Contact    305-243-2647      
Principal Investigator: Brian M. Slomovitz         
Holy Cross Hospital Recruiting
Fort Lauderdale, Florida, United States, 33308
Contact: Site Public Contact    954-267-7750      
Principal Investigator: Leonard J. Seigel         
Broward Health Medical Center Recruiting
Fort Lauderdale, Florida, United States, 33316
Contact: Site Public Contact    954-355-5346      
Principal Investigator: Israel Wiznitzer         
University of Florida Health Science Center - Gainesville Recruiting
Gainesville, Florida, United States, 32610
Contact: Site Public Contact    352-273-8010    cancer-center@ufl.edu   
Principal Investigator: Thomas J. George         
Memorial Regional Hospital/Joe DiMaggio Children's Hospital Recruiting
Hollywood, Florida, United States, 33021
Contact: Site Public Contact    954-265-1847    OHR@mhs.net   
Principal Investigator: Atif M. Hussein         
UM Sylvester Comprehensive Cancer Center at Hollywood Suspended
Hollywood, Florida, United States, 33021
Mayo Clinic in Florida Recruiting
Jacksonville, Florida, United States, 32224-9980
Contact: Site Public Contact    855-776-0015      
Principal Investigator: Alan H. Bryce         
The Watson Clinic Active, not recruiting
Lakeland, Florida, United States, 33805
Mount Sinai Medical Center Recruiting
Miami Beach, Florida, United States, 33140
Contact: Site Public Contact    305-674-2625    yenrique@msmc.com   
Principal Investigator: Michael A. Schwartz         
University of Miami Miller School of Medicine-Sylvester Cancer Center Recruiting
Miami, Florida, United States, 33136
Contact: Site Public Contact    305-243-2647      
Principal Investigator: Brian M. Slomovitz         
UM Sylvester Comprehensive Cancer Center at Kendall Suspended
Miami, Florida, United States, 33176
Health Central Active, not recruiting
Ocoee, Florida, United States, 34761
UF Cancer Center at Orlando Health Recruiting
Orlando, Florida, United States, 32806
Contact: Site Public Contact    321-841-7246    CancerClinicalTrials@orlandohealth.com   
Principal Investigator: Rebecca L. Moroose         
Memorial Hospital West Recruiting
Pembroke Pines, Florida, United States, 33028
Contact: Site Public Contact    954-265-4325      
Principal Investigator: Atif M. Hussein         
UM Sylvester Comprehensive Cancer Center at Plantation Suspended
Plantation, Florida, United States, 33324
Saint Joseph's Hospital/Children's Hospital-Tampa Active, not recruiting
Tampa, Florida, United States, 33607
Moffitt Cancer Center Active, not recruiting
Tampa, Florida, United States, 33612
Indian River Medical Center Active, not recruiting
Vero Beach, Florida, United States, 32960
United States, Georgia
University Cancer and Blood Center LLC Recruiting
Athens, Georgia, United States, 30607
Contact: Site Public Contact    706-353-5006    research@universitycancer.com   
Principal Investigator: Sharad A. Ghamande         
Emory University Hospital Midtown Recruiting
Atlanta, Georgia, United States, 30308
Contact: Site Public Contact    888-946-7447      
Principal Investigator: Taofeek K. Owonikoko         
Piedmont Hospital Active, not recruiting
Atlanta, Georgia, United States, 30309
Emory University Hospital/Winship Cancer Institute Recruiting
Atlanta, Georgia, United States, 30322
Contact: Site Public Contact    404-778-1868      
Principal Investigator: Taofeek K. Owonikoko         
Emory Saint Joseph's Hospital Recruiting
Atlanta, Georgia, United States, 30342
Contact: Site Public Contact    404-851-7115      
Principal Investigator: Taofeek K. Owonikoko         
Northside Hospital Recruiting
Atlanta, Georgia, United States, 30342
Contact: Site Public Contact    404-303-3355    ClinicalTrials@northside.com   
Principal Investigator: Amelia B. Zelnak         
Augusta University Medical Center Recruiting
Augusta, Georgia, United States, 30912
Contact: Site Public Contact    706-721-2388    ga_cares@augusta.edu   
Principal Investigator: Sharad A. Ghamande         
Northeast Georgia Medical Center Braselton Recruiting
Braselton, Georgia, United States, 30517
Contact: Site Public Contact    770-219-8800    cancerpatient.navigator@nghs.com   
Principal Investigator: Charles H. Nash         
John B Amos Cancer Center Recruiting
Columbus, Georgia, United States, 31904
Contact: Site Public Contact    706-478-7968    cdean@iacthealth.com   
Principal Investigator: Andrew W. Pippas         
Northside Hospital-Forsyth Recruiting
Cumming, Georgia, United States, 30041
Contact: Site Public Contact    404-303-3355    clinicaltrials@northside.com   
Principal Investigator: Amelia B. Zelnak         
Dekalb Medical Center Recruiting
Decatur, Georgia, United States, 30033
Contact: Site Public Contact    404-501-2738    clinicaltrialsoncology@dekalbmedical.org   
Principal Investigator: Sharad A. Ghamande         
Northeast Georgia Medical Center-Gainesville Recruiting
Gainesville, Georgia, United States, 30501
Contact: Site Public Contact    770-219-8800    cancerpatient.navigator@nghs.com   
Principal Investigator: Charles H. Nash         
Central Georgia Gynecologic Oncology Suspended
Macon, Georgia, United States, 31201
Medical Center of Central Georgia Recruiting
Macon, Georgia, United States, 31201
Contact: Site Public Contact    478-633-2152    weatherall.andrew@navicenthealth.org   
Principal Investigator: Bradley T. Sumrall         
Harbin Clinic Medical Oncology and Clinical Research Recruiting
Rome, Georgia, United States, 30165
Contact: Site Public Contact    706-528-9094    Tbrannon@HarbinClinic.com   
Principal Investigator: Dilawar Khan         
Memorial Health University Medical Center Suspended
Savannah, Georgia, United States, 31404
Summit Cancer Care-Memorial Suspended
Savannah, Georgia, United States, 31404
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler Recruiting
Savannah, Georgia, United States, 31405
Contact: Site Public Contact    912-819-5704    underberga@sjchs.org   
Principal Investigator: Howard A. Zaren         
Low Country Cancer Care Associates PC Suspended
Savannah, Georgia, United States, 31405
Summit Cancer Care-Candler Recruiting
Savannah, Georgia, United States, 31405
Contact: Site Public Contact       ecog.rss@jimmy.harvard.edu   
Principal Investigator: Howard A. Zaren         
Lewis Hall Singletary Oncology Center Active, not recruiting
Thomasville, Georgia, United States, 31792
South Georgia Medical Center/Pearlman Cancer Center Recruiting
Valdosta, Georgia, United States, 31602
Contact: Site Public Contact    229-259-4628    maryann.heddon@sgmc.org   
Principal Investigator: Samuel N. Ofori         
United States, Hawaii
Hawaii Cancer Care - Savio Recruiting
'Aiea, Hawaii, United States, 96701
Contact: Site Public Contact    808-539-2273      
Principal Investigator: Jeffrey L. Berenberg         
Hawaii Oncology Inc-Pali Momi Recruiting
'Aiea, Hawaii, United States, 96701
Contact: Site Public Contact    808-487-7447      
Principal Investigator: Jeffrey L. Berenberg         
Pali Momi Medical Center Recruiting
'Aiea, Hawaii, United States, 96701
Contact: Site Public Contact    808-486-6000      
Principal Investigator: Jeffrey L. Berenberg         
The Cancer Center of Hawaii-Pali Momi Recruiting
'Aiea, Hawaii, United States, 96701
Contact: Site Public Contact    808-678-9000      
Principal Investigator: Jeffrey L. Berenberg         
Hawaii Cancer Care Inc-POB II Recruiting
Honolulu, Hawaii, United States, 96813
Contact: Site Public Contact    808-524-6115      
Principal Investigator: Jeffrey L. Berenberg         
Hawaii Oncology Inc-POB I Recruiting
Honolulu, Hawaii, United States, 96813
Contact: Site Public Contact    808-532-0315      
Principal Investigator: Jeffrey L. Berenberg         
Island Urology Recruiting
Honolulu, Hawaii, United States, 96813
Contact: Site Public Contact    808-536-2306    virginia@cc.hawaii.edu   
Principal Investigator: Jeffrey L. Berenberg         
Queen's Medical Center Recruiting
Honolulu, Hawaii, United States, 96813
Contact: Site Public Contact    808-545-8548      
Principal Investigator: Jeffrey L. Berenberg         
Straub Clinic and Hospital Recruiting
Honolulu, Hawaii, United States, 96813
Contact: Site Public Contact    808-522-4333      
Principal Investigator: Jeffrey L. Berenberg         
University of Hawaii Cancer Center Recruiting
Honolulu, Hawaii, United States, 96813
Contact: Site Public Contact    808-586-2979      
Principal Investigator: Jeffrey L. Berenberg         
Hawaii Cancer Care Inc-Liliha Recruiting
Honolulu, Hawaii, United States, 96817
Contact: Site Public Contact    808-536-4888      
Principal Investigator: Jeffrey L. Berenberg         
Hawaii Oncology Inc-Kuakini Recruiting
Honolulu, Hawaii, United States, 96817
Contact: Site Public Contact    808-531-8521      
Principal Investigator: Jeffrey L. Berenberg         
Kuakini Medical Center Recruiting
Honolulu, Hawaii, United States, 96817
Contact: Site Public Contact    808-547-9816      
Principal Investigator: Jeffrey L. Berenberg         
The Cancer Center of Hawaii-Liliha Recruiting
Honolulu, Hawaii, United States, 96817
Contact: Site Public Contact    808-547-6881      
Principal Investigator: Jeffrey L. Berenberg         
Kaiser Permanente Moanalua Medical Center Recruiting
Honolulu, Hawaii, United States, 96819
Contact: Site Public Contact    808-432-5195    shelley.a.clark@kp.org   
Principal Investigator: Jennifer M. Suga         
Kapiolani Medical Center for Women and Children Recruiting
Honolulu, Hawaii, United States, 96826
Contact: Site Public Contact    808-983-6090      
Principal Investigator: Jeffrey L. Berenberg         
Wilcox Memorial Hospital and Kauai Medical Clinic Recruiting
Lihue, Hawaii, United States, 96766
Contact: Site Public Contact    808-535-7960      
Principal Investigator: Jeffrey L. Berenberg         
United States, Idaho
Saint Alphonsus Cancer Care Center-Boise Recruiting
Boise, Idaho, United States, 83706
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: John M. Schallenkamp         
Saint Luke's Mountain States Tumor Institute Recruiting
Boise, Idaho, United States, 83712
Contact: Site Public Contact    208-381-2774    eslinget@slhs.org   
Principal Investigator: Alison K. Conlin         
Saint Alphonsus Cancer Care Center-Caldwell Recruiting
Caldwell, Idaho, United States, 83605
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: John M. Schallenkamp         
Kootenai Medical Center Recruiting
Coeur d'Alene, Idaho, United States, 83814
Contact: Site Public Contact    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: John M. Schallenkamp         
Walter Knox Memorial Hospital Recruiting
Emmett, Idaho, United States, 83617
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: John M. Schallenkamp         
Saint Luke's Mountain States Tumor Institute - Fruitland Recruiting
Fruitland, Idaho, United States, 83619
Contact: Site Public Contact    208-381-8059    hallsc@slhs.org   
Principal Investigator: Alison K. Conlin         
Idaho Urologic Institute-Meridian Recruiting
Meridian, Idaho, United States, 83642
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: John M. Schallenkamp         
Saint Luke's Mountain States Tumor Institute - Meridian Recruiting
Meridian, Idaho, United States, 83642
Contact: Site Public Contact    208-381-8059    hallsc@slhs.org   
Principal Investigator: Alison K. Conlin         
Saint Alphonsus Medical Center-Nampa Recruiting
Nampa, Idaho, United States, 83686
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: John M. Schallenkamp         
Saint Luke's Mountain States Tumor Institute - Nampa Recruiting
Nampa, Idaho, United States, 83686
Contact: Site Public Contact    208-381-8059    hallsc@slhs.org   
Principal Investigator: Alison K. Conlin         
Kootenai Cancer Center Recruiting
Post Falls, Idaho, United States, 83854
Contact: Site Public Contact    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: John M. Schallenkamp         
Kootenai Cancer Clinic Recruiting
Sandpoint, Idaho, United States, 83864
Contact: Site Public Contact    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: John M. Schallenkamp         
Saint Luke's Mountain States Tumor Institute-Twin Falls Recruiting
Twin Falls, Idaho, United States, 83301
Contact: Site Public Contact    208-381-8059    hallsc@slhs.org   
Principal Investigator: Alison K. Conlin         
United States, Illinois
Rush - Copley Medical Center Recruiting
Aurora, Illinois, United States, 60504
Contact: Site Public Contact    630-978-6212    Cancer.Research@rushcopley.com   
Principal Investigator: Vamsi K. Vasireddy         
Saint Joseph Medical Center Active, not recruiting
Bloomington, Illinois, United States, 61701
Illinois CancerCare-Bloomington Recruiting
Bloomington, Illinois, United States, 61704
Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
Illinois CancerCare-Canton Recruiting
Canton, Illinois, United States, 61520
Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
Memorial Hospital of Carbondale Recruiting
Carbondale, Illinois, United States, 62902
Contact: Site Public Contact    618-457-5200    clinical.research@sih.net   
Principal Investigator: Bryan A. Faller         
SIH Cancer Institute Recruiting
Carterville, Illinois, United States, 62918
Contact: Site Public Contact    618-985-3333    clinical.research@sih.net   
Principal Investigator: Bryan A. Faller         
Illinois CancerCare-Carthage Recruiting
Carthage, Illinois, United States, 62321
Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
Centralia Oncology Clinic Recruiting
Centralia, Illinois, United States, 62801
Contact: Site Public Contact    217-876-4740    rhamrick@dmhhs.org   
Principal Investigator: Bryan A. Faller         
Mount Sinai Hospital Medical Center Recruiting
Chicago, Illinois, United States, 60608
Contact: Site Public Contact    773-257-5960    suhi@sinai.org   
Principal Investigator: Pam G. Khosla         
Northwestern University Recruiting
Chicago, Illinois, United States, 60611
Contact: Site Public Contact    312-695-1301    cancer@northwestern.edu   
Principal Investigator: Mark Agulnik         
John H Stroger Jr Hospital of Cook County Recruiting
Chicago, Illinois, United States, 60612
Contact: Site Public Contact    312-864-5204      
Principal Investigator: Thomas E. Lad         
Rush University Medical Center Recruiting
Chicago, Illinois, United States, 60612
Contact: Site Public Contact    312-942-5498    clinical_trials@rush.edu   
Principal Investigator: Timothy M. Kuzel         
University of Illinois Recruiting
Chicago, Illinois, United States, 60612
Contact: Site Public Contact    312-355-3046      
Principal Investigator: Oana C. Danciu         
Swedish Covenant Hospital Recruiting
Chicago, Illinois, United States, 60625
Contact: Site Public Contact    773-878-8200      
Principal Investigator: Elyse A. Lambiase         
University of Chicago Comprehensive Cancer Center Recruiting
Chicago, Illinois, United States, 60637
Contact: Site Public Contact    773-702-8222    cancerclinicaltrials@bsd.uchicago.edu   
Principal Investigator: Daniel V. Catenacci         
Advocate Illinois Masonic Medical Center Recruiting
Chicago, Illinois, United States, 60657
Contact: Site Public Contact    773-296-5360      
Principal Investigator: Mebea Aklilu         
AMG Crystal Lake - Oncology Suspended
Crystal Lake, Illinois, United States, 60014
Carle on Vermilion Recruiting
Danville, Illinois, United States, 61832
Contact: Site Public Contact    800-446-5532    Research@carle.com   
Principal Investigator: Vamsi K. Vasireddy         
Cancer Care Specialists of Illinois - Decatur Recruiting
Decatur, Illinois, United States, 62526
Contact: Site Public Contact    217-876-4740    rhamrick@dmhhs.org   
Principal Investigator: Bryan A. Faller         
Decatur Memorial Hospital Recruiting
Decatur, Illinois, United States, 62526
Contact: Site Public Contact    217-876-4740    rhamrick@dmhhs.org   
Principal Investigator: Bryan A. Faller         
Northwestern Medicine Cancer Center Kishwaukee Recruiting
DeKalb, Illinois, United States, 60115
Contact: Site Public Contact    630-315-1918    claudine.gamster@nm.org   
Principal Investigator: Michael Kahn         
Illinois CancerCare-Dixon Recruiting
Dixon, Illinois, United States, 61021
Contact: Site Public Contact    815-285-7800      
Principal Investigator: Bryan A. Faller         
Carle Physician Group-Effingham Recruiting
Effingham, Illinois, United States, 62401
Contact: Site Public Contact    800-446-5532    Research@carle.com   
Principal Investigator: Vamsi K. Vasireddy         
Crossroads Cancer Center Recruiting
Effingham, Illinois, United States, 62401
Contact: Site Public Contact    217-876-4740    rhamrick@dmhhs.org   
Principal Investigator: Bryan A. Faller         
AMITA Health Alexian Brothers Medical Center Active, not recruiting
Elk Grove Village, Illinois, United States, 60007
Illinois CancerCare-Eureka Recruiting
Eureka, Illinois, United States, 61530
Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
NorthShore University HealthSystem-Evanston Hospital Recruiting
Evanston, Illinois, United States, 60201
Contact: Site Public Contact    847-570-2109      
Principal Investigator: Robert d. Marsh         
Saint Francis Hospital Recruiting
Evanston, Illinois, United States, 60202
Contact: Site Public Contact    847-316-6994      
Principal Investigator: Ira A. Oliff         
Illinois CancerCare-Galesburg Recruiting
Galesburg, Illinois, United States, 61401
Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
Western Illinois Cancer Treatment Center Recruiting
Galesburg, Illinois, United States, 61401
Contact: Site Public Contact    309-344-2831      
Principal Investigator: Bryan A. Faller         
Northwestern Medicine Cancer Center Delnor Recruiting
Geneva, Illinois, United States, 60134
Contact: Site Public Contact    630-315-1918    Claudine.Gamster@CadenceHealth.org   
Principal Investigator: Michael Kahn         
NorthShore University HealthSystem-Glenbrook Hospital Recruiting
Glenview, Illinois, United States, 60026
Contact: Site Public Contact    847-570-2109      
Principal Investigator: Robert d. Marsh         
Ingalls Memorial Hospital Recruiting
Harvey, Illinois, United States, 60426
Contact: Site Public Contact    708-915-4673    clinicaltrials@ingalls.org   
Principal Investigator: Mark F. Kozloff         
NorthShore University HealthSystem-Highland Park Hospital Recruiting
Highland Park, Illinois, United States, 60035
Contact: Site Public Contact    847-570-2109      
Principal Investigator: Robert d. Marsh         
Joliet Oncology-Hematology Associates Limited Recruiting
Joliet, Illinois, United States, 60435
Contact: Site Public Contact    815-730-3098    maureenc@jolietoncology.com   
Principal Investigator: Nafisa D. Burhani         
Presence Saint Mary's Hospital Active, not recruiting
Kankakee, Illinois, United States, 60901
Illinois CancerCare-Kewanee Clinic Recruiting
Kewanee, Illinois, United States, 61443
Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
Northwestern Medicine Lake Forest Hospital Recruiting
Lake Forest, Illinois, United States, 60045
Contact: Site Public Contact       cancertrials@northwestern.edu   
Principal Investigator: Mark Agulnik         
AMG Libertyville - Oncology Suspended
Libertyville, Illinois, United States, 60048
Illinois CancerCare-Macomb Recruiting
Macomb, Illinois, United States, 61455
Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
Carle Physician Group-Mattoon/Charleston Recruiting
Mattoon, Illinois, United States, 61938
Contact: Site Public Contact    800-446-5532    Research@carle.com   
Principal Investigator: Vamsi K. Vasireddy         
Loyola University Medical Center Recruiting
Maywood, Illinois, United States, 60153
Contact: Site Public Contact    708-226-4357      
Principal Investigator: Asha R. Dhanarajan         
Marjorie Weinberg Cancer Center at Loyola-Gottlieb Recruiting
Melrose Park, Illinois, United States, 60160
Contact: Site Public Contact    708-450-4554      
Principal Investigator: Asha R. Dhanarajan         
Trinity Medical Center Suspended
Moline, Illinois, United States, 61265
Good Samaritan Regional Health Center Recruiting
Mount Vernon, Illinois, United States, 62864
Contact: Site Public Contact    618-242-4600      
Principal Investigator: Jay W. Carlson         
UC Comprehensive Cancer Center at Silver Cross Recruiting
New Lenox, Illinois, United States, 60451
Contact: Site Public Contact    773-702-8222    cancerclinicaltrials@bsd.uchicago.edu   
Principal Investigator: Daniel V. Catenacci         
University of Chicago Medicine-Orland Park Recruiting
Orland Park, Illinois, United States, 60462
Contact: Site Public Contact    773-702-8222    cancerclinicaltrials@bsd.uchicago.edu   
Principal Investigator: Daniel V. Catenacci         
Illinois CancerCare-Ottawa Clinic Recruiting
Ottawa, Illinois, United States, 61350
Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
Radiation Oncology of Northern Illinois Suspended
Ottawa, Illinois, United States, 61350
Illinois CancerCare-Pekin Recruiting
Pekin, Illinois, United States, 61554
Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center Recruiting
Pekin, Illinois, United States, 61554
Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
Illinois CancerCare-Peoria Recruiting
Peoria, Illinois, United States, 61615
Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
OSF Saint Francis Radiation Oncology at Peoria Cancer Center Recruiting
Peoria, Illinois, United States, 61615
Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
Methodist Medical Center of Illinois Recruiting
Peoria, Illinois, United States, 61636
Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
OSF Saint Francis Medical Center Recruiting
Peoria, Illinois, United States, 61637
Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
Illinois CancerCare-Peru Recruiting
Peru, Illinois, United States, 61354
Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
Valley Radiation Oncology Recruiting
Peru, Illinois, United States, 61354
Contact: Site Public Contact    815-664-4141      
Principal Investigator: Bryan A. Faller         
Illinois CancerCare-Princeton Recruiting
Princeton, Illinois, United States, 61356
Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com   
Principal Investigator: Bryan A. Faller         
Hematology Oncology Associates of Illinois - Skokie Recruiting
Skokie, Illinois, United States, 60076
Contact: Site Public Contact       info@orchardhr.com   
Principal Investigator: Ira A. Oliff         
North Shore Medical Center Suspended
Skokie, Illinois, United States, 60076
Central Illinois Hematology Oncology Center Active, not recruiting
Springfield, Illinois, United States, 62702
Southern Illinois University School of Medicine Recruiting
Springfield, Illinois, United States, 62702
Contact: Site Public Contact    217-545-7929      
Principal Investigator: Bryan A. Faller         
Springfield Clinic Recruiting
Springfield, Illinois, United States, 62702
Contact: Site Public Contact    800-444-7541      
Principal Investigator: Bryan A. Faller         
Memorial Medical Center Recruiting
Springfield, Illinois, United States, 62781
Contact: Site Public Contact    217-788-3528      
Principal Investigator: Bryan A. Faller         
Cancer Care Specialists of Illinois-Swansea Recruiting
Swansea, Illinois, United States, 62226
Contact: Site Public Contact    217-876-4740    rhamrick@dmhhs.org   
Principal Investigator: Bryan A. Faller         
Southwest Illinois Health Services LLP Recruiting
Swansea, Illinois, United States, 62226
Contact: Site Public Contact    618-236-1000    lynns@thecancercenter.com   
Principal Investigator: Bryan A. Faller         
Carle Cancer Center Recruiting
Urbana, Illinois, United States, 61801
Contact: Site Public Contact    800-446-5532    Research@carle.com   
Principal Investigator: Vamsi K. Vasireddy         
The Carle Foundation Hospital Recruiting
Urbana, Illinois, United States, 61801
Contact: Site Public Contact    800-446-5532    Research@carle.com   
Principal Investigator: Vamsi K. Vasireddy         
Northwestern Medicine Cancer Center Warrenville Recruiting
Warrenville, Illinois, United States, 60555
Contact: Site Public Contact    630-315-1918    Claudine.Gamster@CadenceHealth.org   
Principal Investigator: Michael Kahn         
Rush-Copley Healthcare Center Recruiting
Yorkville, Illinois, United States, 60560
Contact: Site Public Contact    630-978-6212    Cancer.Research@rushcopley.com   
Principal Investigator: Vamsi K. Vasireddy         
Midwestern Regional Medical Center Recruiting
Zion, Illinois, United States, 60099
Contact: Site Public Contact    888-823-5923    ctsucontact@westat.com   
Principal Investigator: Eugene Ahn         
United States, Indiana
Michiana Hematology Oncology PC-Crown Point Active, not recruiting
Crown Point, Indiana, United States, 46307
Michiana Hematology Oncology PC-Elkhart Active, not recruiting
Elkhart, Indiana, United States, 46514
Deaconess Clinic Downtown Recruiting
Evansville, Indiana, United States, 47713
Contact: Site Public Contact    877-654-0311    Research@Deaconess.com   
Principal Investigator: Vamsi K. Vasireddy         
Indiana University/Melvin and Bren Simon Cancer Center Recruiting
Indianapolis, Indiana, United States, 46202
Contact: Site Public Contact    317-278-5632    iutrials@iu.edu   
Principal Investigator: Kathy D. Miller         
Sidney and Lois Eskenazi Hospital Recruiting
Indianapolis, Indiana, United States, 46202
Contact: Site Public Contact    317-278-5632    iutrials@iu.edu   
Principal Investigator: Kathy D. Miller         
Community Cancer Center East Recruiting
Indianapolis, Indiana, United States, 46219
Contact: Site Public Contact    317-497-2823    lcheri@ecommunity.com   
Principal Investigator: Radhika Walling         
Community Cancer Center South Recruiting
Indianapolis, Indiana, United States, 46227
Contact: Site Public Contact    317-497-2823    lcheri@ecommunity.com   
Principal Investigator: Radhika Walling         
Community Cancer Center North Recruiting
Indianapolis, Indiana, United States, 46256
Contact: Site Public Contact    317-497-2823    lcheri@ecommunity.com   
Principal Investigator: Radhika Walling         
Springmill Medical Center Recruiting
Indianapolis, Indiana, United States, 46290
Contact: Site Public Contact    317-278-5632    iutrials@iu.edu   
Principal Investigator: Kathy D. Miller         
Community Howard Regional Health Recruiting
Kokomo, Indiana, United States, 46904
Contact: Site Public Contact    765-453-8571    oncology@communityhoward.org   
Principal Investigator: Radhika Walling         
IU Health Arnett Cancer Care Recruiting
Lafayette, Indiana, United States, 47904
Contact: Site Public Contact    765-838-6871    thimes@iuhealth.org   
Principal Investigator: Bamidele A. Adesunloye         
Franciscan Saint Anthony Health-Michigan City Suspended
Michigan City, Indiana, United States, 46360
Woodland Cancer Care Center Suspended
Michigan City, Indiana, United States, 46360
Memorial Regional Cancer Center Day Road Suspended
Mishawaka, Indiana, United States, 46545
Michiana Hematology Oncology PC-Mishawaka Active, not recruiting
Mishawaka, Indiana, United States, 46545
Chancellor Center for Oncology Recruiting
Newburgh, Indiana, United States, 47630
Contact: Site Public Contact    877-654-0311    Research@Deaconess.com   
Principal Investigator: Vamsi K. Vasireddy         
Michiana Hematology Oncology PC-Plymouth Active, not recruiting
Plymouth, Indiana, United States, 46563
Reid Health Recruiting
Richmond, Indiana, United States, 47374
Contact: Site Public Contact    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Memorial Hospital of South Bend Recruiting
South Bend, Indiana, United States, 46601
Contact: Site Public Contact    800-284-7370      
Principal Investigator: Thomas J. Reid         
Michiana Hematology Oncology PC-Westville Active, not recruiting
Westville, Indiana, United States, 46391
United States, Iowa
Mary Greeley Medical Center Recruiting
Ames, Iowa, United States, 50010
Contact: Site Public Contact    515-956-4132      
Principal Investigator: Debra M. Prow         
McFarland Clinic PC - Ames Recruiting
Ames, Iowa, United States, 50010
Contact: Site Public Contact    515-239-4734    ksoder@mcfarlandclinic.com   
Principal Investigator: Debra M. Prow         
McFarland Clinic PC-Boone Recruiting
Boone, Iowa, United States, 50036
Contact: Site Public Contact    515-956-4132      
Principal Investigator: Debra M. Prow         
Physicians' Clinic of Iowa PC Active, not recruiting
Cedar Rapids, Iowa, United States, 52402
Mercy Hospital Recruiting
Cedar Rapids, Iowa, United States, 52403
Contact: Site Public Contact    319-365-4673      
Principal Investigator: Deborah W. Wilbur         
Oncology Associates at Mercy Medical Center Recruiting
Cedar Rapids, Iowa, United States, 52403
Contact: Site Public Contact    319-363-2690      
Principal Investigator: Deborah W. Wilbur         
Medical Oncology and Hematology Associates-West Des Moines Recruiting
Clive, Iowa, United States, 50325
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Mercy Cancer Center-West Lakes Recruiting
Clive, Iowa, United States, 50325
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Alegent Health Mercy Hospital Recruiting
Council Bluffs, Iowa, United States, 51503
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Greater Regional Medical Center Recruiting
Creston, Iowa, United States, 50801
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Iowa Methodist Medical Center Recruiting
Des Moines, Iowa, United States, 50309
Contact: Site Public Contact    515-241-6727      
Principal Investigator: Robert J. Behrens         
Medical Oncology and Hematology Associates-Des Moines Recruiting
Des Moines, Iowa, United States, 50309
Contact: Site Public Contact    515-282-2921      
Principal Investigator: Robert J. Behrens         
Broadlawns Medical Center Recruiting
Des Moines, Iowa, United States, 50314
Contact: Site Public Contact    515-282-2200      
Principal Investigator: Robert J. Behrens         
Medical Oncology and Hematology Associates-Laurel Recruiting
Des Moines, Iowa, United States, 50314
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Mercy Medical Center - Des Moines Recruiting
Des Moines, Iowa, United States, 50314
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Iowa Lutheran Hospital Recruiting
Des Moines, Iowa, United States, 50316
Contact: Site Public Contact    515-241-8704      
Principal Investigator: Robert J. Behrens         
JCHC McCreery Cancer Center Active, not recruiting
Fairfield, Iowa, United States, 52556
McFarland Clinic PC-Trinity Cancer Center Recruiting
Fort Dodge, Iowa, United States, 50501
Contact: Site Public Contact    515-956-4132      
Principal Investigator: Debra M. Prow         
Trinity Regional Medical Center Recruiting
Fort Dodge, Iowa, United States, 50501
Contact: Site Public Contact    515-574-8302      
Principal Investigator: Robert J. Behrens         
McFarland Clinic PC-Jefferson Recruiting
Jefferson, Iowa, United States, 50129
Contact: Site Public Contact    515-956-4132      
Principal Investigator: Debra M. Prow         
McFarland Clinic PC-Marshalltown Recruiting
Marshalltown, Iowa, United States, 50158
Contact: Site Public Contact    515-956-4132      
Principal Investigator: Debra M. Prow         
Ottumwa Regional Health Center Active, not recruiting
Ottumwa, Iowa, United States, 52501
Siouxland Regional Cancer Center Recruiting
Sioux City, Iowa, United States, 51101
Contact: Site Public Contact    712-252-9326    HoopingarnerT@jencc.com   
Principal Investigator: Donald B. Wender         
Methodist West Hospital Recruiting
West Des Moines, Iowa, United States, 50266-7700
Contact: Site Public Contact    515-343-1000      
Principal Investigator: Robert J. Behrens         
Mercy Medical Center-West Lakes Recruiting
West Des Moines, Iowa, United States, 50266
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
United States, Kansas
Coffeyville Regional Medical Center Recruiting
Coffeyville, Kansas, United States, 67337
Contact: Site Public Contact    620-252-1606      
Principal Investigator: Stephen K. Williamson         
Newman Regional Health Suspended
Emporia, Kansas, United States, 66801
University of Kansas Clinical Research Center Recruiting
Fairway, Kansas, United States, 66205
Contact: Site Public Contact    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Stephen K. Williamson         
Central Care Cancer Center - Garden City Active, not recruiting
Garden City, Kansas, United States, 67846
Saint Catherine Hospital Suspended
Garden City, Kansas, United States, 67846
Central Care Cancer Center - Great Bend Active, not recruiting
Great Bend, Kansas, United States, 67530
Saint Rose Ambulatory and Surgery Center Suspended
Great Bend, Kansas, United States, 67530
Hays Medical Center Recruiting
Hays, Kansas, United States, 67601
Contact: Site Public Contact    785-623-5774      
Principal Investigator: Stephen K. Williamson         
University of Kansas Cancer Center-West Recruiting
Kansas City, Kansas, United States, 66112
Contact: Site Public Contact    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Stephen K. Williamson         
University of Kansas Cancer Center Recruiting
Kansas City, Kansas, United States, 66160
Contact: Site Public Contact    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Stephen K. Williamson         
Kansas Institute of Medicine Cancer and Blood Center Active, not recruiting
Lenexa, Kansas, United States, 66219
Minimally Invasive Surgery Hospital Active, not recruiting
Lenexa, Kansas, United States, 66219
Olathe Medical Center Recruiting
Olathe, Kansas, United States, 66061
Contact: Site Public Contact    913-791-3500    Jeni.wakefield@olathehealth.org   
Principal Investigator: Stephen K. Williamson         
Menorah Medical Center Active, not recruiting
Overland Park, Kansas, United States, 66209
University of Kansas Cancer Center-Overland Park Recruiting
Overland Park, Kansas, United States, 66210
Contact: Site Public Contact    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Stephen K. Williamson         
Saint Luke's South Hospital Recruiting
Overland Park, Kansas, United States, 66213
Contact: Site Public Contact    913-948-5588    aroland@kccop.org   
Principal Investigator: Timothy J. Pluard         
Via Christi Hospital-Pittsburg Recruiting
Pittsburg, Kansas, United States, 66762
Contact: Site Public Contact    620-235-7900      
Principal Investigator: Stephen K. Williamson         
Salina Regional Health Center Recruiting
Salina, Kansas, United States, 67401
Contact: Site Public Contact    785-452-7038    kkavoura@srhc.com   
Principal Investigator: Stephen K. Williamson         
Saint Francis Hospital and Medical Center - Topeka Recruiting
Topeka, Kansas, United States, 66606
Contact: Site Public Contact    785-295-8000      
Principal Investigator: Stephen K. Williamson         
University of Kansas Hospital-Westwood Cancer Center Recruiting
Westwood, Kansas, United States, 66205
Contact: Site Public Contact    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Stephen K. Williamson         
United States, Kentucky
Flaget Memorial Hospital Recruiting
Bardstown, Kentucky, United States, 40004
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Baptist Health Corbin Recruiting
Corbin, Kentucky, United States, 40701
Contact: Site Public Contact    859-523-1934      
Principal Investigator: Amy Schell         
Commonwealth Cancer Center-Corbin Recruiting
Corbin, Kentucky, United States, 40701
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Oncology Hematology Care Inc-Crestview Suspended
Crestview Hills, Kentucky, United States, 41017
Saint Elizabeth Medical Center South Active, not recruiting
Edgewood, Kentucky, United States, 41017
Hardin Memorial Hospital Active, not recruiting
Elizabethtown, Kentucky, United States, 42701
Saint Elizabeth Fort Thomas Active, not recruiting
Fort Thomas, Kentucky, United States, 41075
Baptist Health Lexington Recruiting
Lexington, Kentucky, United States, 40503
Contact: Site Public Contact    859-260-6425      
Principal Investigator: Amy Schell         
Saint Joseph Radiation Oncology Resource Center Recruiting
Lexington, Kentucky, United States, 40504
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Saint Joseph Hospital East Recruiting
Lexington, Kentucky, United States, 40509
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
University of Kentucky/Markey Cancer Center Recruiting
Lexington, Kentucky, United States, 40536
Contact: Site Public Contact    859-257-3379      
Principal Investigator: Susanne M. Arnold         
Saint Joseph London Recruiting
London, Kentucky, United States, 40741
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Jewish Hospital Recruiting
Louisville, Kentucky, United States, 40202
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
The James Graham Brown Cancer Center at University of Louisville Recruiting
Louisville, Kentucky, United States, 40202
Contact: Site Public Contact    502-562-3429      
Principal Investigator: Vivek R. Sharma         
Baptist Health Louisville Recruiting
Louisville, Kentucky, United States, 40207
Contact: Site Public Contact    502-897-8592    Cbcresearch@bhsi.com   
Principal Investigator: Amy Schell         
Saints Mary and Elizabeth Hospital Recruiting
Louisville, Kentucky, United States, 40215
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Jewish Hospital Medical Center Northeast Recruiting
Louisville, Kentucky, United States, 40245
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Baptist Health Madisonville/Merle Mahr Cancer Center Recruiting
Madisonville, Kentucky, United States, 42431
Contact: Site Public Contact    800-733-2312      
Principal Investigator: Amy Schell         
Baptist Health Paducah Recruiting
Paducah, Kentucky, United States, 42003
Contact: Site Public Contact    270-575-2928      
Principal Investigator: Amy Schell         
Jewish Hospital Medical Center South Recruiting
Shepherdsville, Kentucky, United States, 40165
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
United States, Louisiana
LSU Health Baton Rouge-North Clinic Recruiting
Baton Rouge, Louisiana, United States, 70805
Contact: Site Public Contact    225-215-1353    clinicalresearch@marybird.com   
Principal Investigator: David S. Hanson         
Baton Rouge General Medical Center Suspended
Baton Rouge, Louisiana, United States, 70806
Hematology/Oncology Clinic LLP Recruiting
Baton Rouge, Louisiana, United States, 70809
Contact: Site Public Contact    225-767-0822      
Principal Investigator: Hana F. Safah         
Louisiana Hematology Oncology Associates LLC Recruiting
Baton Rouge, Louisiana, United States, 70809
Contact: Site Public Contact    225-215-1353    clinicalresearch@marybird.com   
Principal Investigator: David S. Hanson         
Mary Bird Perkins Cancer Center Recruiting
Baton Rouge, Louisiana, United States, 70809
Contact: Site Public Contact    225-215-1353    clinicalresearch@marybird.com   
Principal Investigator: David S. Hanson         
Ochsner Health Center-Summa Recruiting
Baton Rouge, Louisiana, United States, 70809
Contact: Site Public Contact    225-761-5346    Camille.Beck@Ochsner.org   
Principal Investigator: Marc R. Matrana         
Our Lady of the Lake Physicians Group - Medical Oncology Recruiting
Baton Rouge, Louisiana, United States, 70809
Contact: Site Public Contact    225-215-1353    clinicalresearch@marybird.com   
Principal Investigator: David S. Hanson         
Medical Center of Baton Rouge Recruiting
Baton Rouge, Louisiana, United States, 70816
Contact: Site Public Contact    225-761-5346    Camille.Beck@Ochsner.org   
Principal Investigator: Marc R. Matrana         
Ochsner High Grove Suspended
Baton Rouge, Louisiana, United States, 70836
Mary Bird Perkins Cancer Center - Covington Suspended
Covington, Louisiana, United States, 70433
Northshore Oncology Associates-Covington Recruiting
Covington, Louisiana, United States, 70433
Contact: Site Public Contact    225-215-1353    clinicalresearch@marybird.com   
Principal Investigator: David S. Hanson         
Women's Cancer Care-Covington Recruiting
Covington, Louisiana, United States, 70433
Contact: Site Public Contact    225-215-1353    clinicalresearch@marybird.com   
Principal Investigator: David S. Hanson         
Ochsner Medical Center West Bank Recruiting
Gretna, Louisiana, United States, 70056
Contact: Site Public Contact    504-703-8712    Gregory.Johnstone@ochsner.org   
Principal Investigator: Marc R. Matrana         
Mary Bird Perkins Cancer Center - Houma Suspended
Houma, Louisiana, United States, 70360
Oncology Center of The South Incorporated Suspended
Houma, Louisiana, United States, 70360
Terrebonne General Medical Center Recruiting
Houma, Louisiana, United States, 70360
Contact: Site Public Contact    985-850-6300    ann.hooks@tgmc.com   
Principal Investigator: David S. Hanson         
Ochsner Medical Center Kenner Recruiting
Kenner, Louisiana, United States, 70065
Contact: Site Public Contact    504-464-8314    cris.molina@ochsner.org   
Principal Investigator: Marc R. Matrana         
West Jefferson Medical Center Active, not recruiting
Marrero, Louisiana, United States, 70072
East Jefferson General Hospital Recruiting
Metairie, Louisiana, United States, 70006
Contact: Site Public Contact    504-210-3539    emede1@lsuhsc.edu   
Principal Investigator: Augusto C. Ochoa         
Robert Veith MD LLC Recruiting
Metairie, Louisiana, United States, 70006
Contact: Site Public Contact    504-210-3539    emede1@lsuhsc.edu   
Principal Investigator: Augusto C. Ochoa         
University Health-Conway Active, not recruiting
Monroe, Louisiana, United States, 71202
Louisiana State University Health Science Center Recruiting
New Orleans, Louisiana, United States, 70112
Contact: Site Public Contact    504-210-3539    emede1@lsuhsc.edu   
Principal Investigator: Augusto C. Ochoa         
Tulane University Health Sciences Center Recruiting
New Orleans, Louisiana, United States, 70112
Contact: Site Public Contact    504-988-6121      
Principal Investigator: Hana F. Safah         
University Medical Center New Orleans Recruiting
New Orleans, Louisiana, United States, 70112
Contact: Site Public Contact    504-210-3539    emede1@lsuhsc.edu   
Principal Investigator: Augusto C. Ochoa         
Ochsner Medical Center Jefferson Recruiting
New Orleans, Louisiana, United States, 70121
Contact: Site Public Contact    504-703-8712    Gregory.Johnstone@ochsner.org   
Principal Investigator: Marc R. Matrana         
Louisiana State University Health Sciences Center Shreveport Active, not recruiting
Shreveport, Louisiana, United States, 71103
United States, Maine
Harold Alfond Center for Cancer Care Recruiting
Augusta, Maine, United States, 04330
Contact: Site Public Contact    207-626-4855      
Principal Investigator: Christopher J. Darus         
Eastern Maine Medical Center Recruiting
Bangor, Maine, United States, 04401
Contact: Site Public Contact    207-973-4274      
Principal Investigator: Sarah J. Sinclair         
Waldo County General Hospital Recruiting
Belfast, Maine, United States, 04915
Contact: Site Public Contact    207-338-2500      
Principal Investigator: Christopher J. Darus         
MaineHealth/SMHC Cancer Care and Blood Disorders-Biddeford Recruiting
Biddeford, Maine, United States, 04005
Contact: Site Public Contact       LLemire@mmc.org   
Principal Investigator: Christopher J. Darus         
Lafayette Family Cancer Center-EMMC Recruiting
Brewer, Maine, United States, 04412
Contact: Site Public Contact    800-987-3005      
Principal Investigator: Sarah J. Sinclair         
Stephens Memorial Hospital Recruiting
Norway, Maine, United States, 04268
Contact: Site Public Contact    207-396-8670    OncClinicalResearch@mmc.org   
Principal Investigator: Christopher J. Darus         
Penobscot Bay Medical Center Recruiting
Rockport, Maine, United States, 04856
Contact: Site Public Contact    207-396-8670    ClinicalResearch@mmc.org   
Principal Investigator: Christopher J. Darus         
MaineHealth/SMHC Cancer Care and Blood Disorders-Sanford Recruiting
Sanford, Maine, United States, 04073
Contact: Site Public Contact       LLemire@mmc.org   
Principal Investigator: Christopher J. Darus         
Maine Center for Cancer Medicine-Scarborough Recruiting
Scarborough, Maine, United States, 04074
Contact: Site Public Contact       research@newecs.org   
Principal Investigator: Christian A. Thomas         
Maine Medical Center- Scarborough Campus Recruiting
Scarborough, Maine, United States, 04074
Contact: Site Public Contact    207-396-8090    wrighd@mmc.org   
Principal Investigator: Christopher J. Darus         
Maine Medical Partners - South Portland Recruiting
South Portland, Maine, United States, 04106
Contact: Site Public Contact    207-396-8670    ClinicalResearch@mmc.org   
Principal Investigator: Christopher J. Darus         
United States, Maryland
Anne Arundel Medical Center Recruiting
Annapolis, Maryland, United States, 21401
Contact: Site Public Contact    443-481-1320    kbodenhorn@aahs.org   
Principal Investigator: Carol K. Tweed         
University of Maryland/Greenebaum Cancer Center Recruiting
Baltimore, Maryland, United States, 21201
Contact: Site Public Contact    800-888-8823      
Principal Investigator: Katherine H. Tkaczuk         
Greater Baltimore Medical Center Recruiting
Baltimore, Maryland, United States, 21204
Contact: Site Public Contact    443-849-3706      
Principal Investigator: Mei Tang         
Sinai Hospital of Baltimore Recruiting
Baltimore, Maryland, United States, 21215
Contact: Site Public Contact    410-601-6120    pridgely@lifebridgehealth.org   
Principal Investigator: Marvin J. Feldman         
MedStar Union Memorial Hospital Suspended
Baltimore, Maryland, United States, 21218
MedStar Franklin Square Medical Center/Weinberg Cancer Institute Active, not recruiting
Baltimore, Maryland, United States, 21237
MedStar Good Samaritan Hospital Recruiting
Baltimore, Maryland, United States, 21239
Contact: Site Public Contact    410-261-8151    Barbara.rector@medstar.net   
Principal Investigator: Filipa C. Lynce         
Johns Hopkins University/Sidney Kimmel Cancer Center Recruiting
Baltimore, Maryland, United States, 21287
Contact: Site Public Contact    410-955-8804    jhcccro@jhmi.edu   
Principal Investigator: Michael A. Carducci         
Walter Reed National Military Medical Center Recruiting
Bethesda, Maryland, United States, 20889-5600
Contact: Site Public Contact    301-319-2100      
Principal Investigator: Mary L. Kwok         
National Institutes of Health Clinical Center Recruiting
Bethesda, Maryland, United States, 20892
Contact: Site Public Contact    800-411-1222      
Principal Investigator: A P. Chen         
Western Maryland Regional Medical Center Recruiting
Cumberland, Maryland, United States, 21502
Contact: Site Public Contact    240-964-1400      
Principal Investigator: Qamar U. Zaman         
University of Maryland Shore Medical Center at Easton Recruiting
Easton, Maryland, United States, 21601
Contact: Site Public Contact    410-822-1000    Christina.weisenborn@umm.edu   
Principal Investigator: Mary S. De Shields         
Union Hospital of Cecil County Suspended
Elkton, Maryland, United States, 21921
Frederick Memorial Hospital Recruiting
Frederick, Maryland, United States, 21701
Contact: Site Public Contact    240-566-3584    clinicaltrials@fmh.org   
Principal Investigator: Patrick J. Mansky         
FMH James M Stockman Cancer Institute Recruiting
Frederick, Maryland, United States, 21702
Contact: Site Public Contact    301-668-7043      
Principal Investigator: Patrick J. Mansky         
MedStar Montgomery Medical Center Suspended
Olney, Maryland, United States, 20832
Northwest Hospital Center Recruiting
Randallstown, Maryland, United States, 21133
Contact: Site Public Contact    410-601-4673    cancerinstitute@lifebridgehealth.org   
Principal Investigator: Marvin J. Feldman         
Peninsula Regional Medical Center Active, not recruiting
Salisbury, Maryland, United States, 21801
Holy Cross Hospital Recruiting
Silver Spring, Maryland, United States, 20910
Contact: Site Public Contact    310-754-7552      
Principal Investigator: Cheryl A. Aylesworth         
William E Kahlert Regional Cancer Center/Sinai Hospital Recruiting
Westminster, Maryland, United States, 21157
Contact: Site Public Contact    410-871-6400      
Principal Investigator: Marvin J. Feldman         
United States, Massachusetts
Beverly Hospital Recruiting
Beverly, Massachusetts, United States, 01915
Contact: Site Public Contact    978-922-3000 ext 2405      
Principal Investigator: Corrine L. Zarwan         
Tufts Medical Center Active, not recruiting
Boston, Massachusetts, United States, 02111
Massachusetts General Hospital Cancer Center Recruiting
Boston, Massachusetts, United States, 02114
Contact: Site Public Contact    877-726-5130      
Principal Investigator: Lecia V. Sequist         
Boston Medical Center Recruiting
Boston, Massachusetts, United States, 02118
Contact: Site Public Contact    617-638-8265      
Principal Investigator: Peter C. Everett         
Beth Israel Deaconess Medical Center Recruiting
Boston, Massachusetts, United States, 02215
Contact: Site Public Contact    617-667-9925      
Principal Investigator: Lecia V. Sequist         
Dana-Farber Cancer Institute Recruiting
Boston, Massachusetts, United States, 02215
Contact: Site Public Contact    877-442-3324      
Principal Investigator: Lecia V. Sequist         
Lahey Hospital and Medical Center Recruiting
Burlington, Massachusetts, United States, 01805
Contact: Site Public Contact    781-744-3421    cancerclinicaltrials@lahey.org   
Principal Investigator: Corrine L. Zarwan         
Simonds-Sinon Regional Cancer Center Recruiting
Fitchburg, Massachusetts, United States, 01420
Contact: Site Public Contact    978-343-5670      
Principal Investigator: Jan Cerny         
MetroWest Medical Center-Framingham Union Hospital Active, not recruiting
Framingham, Massachusetts, United States, 01702
Addison Gilbert Hospital Recruiting
Gloucester, Massachusetts, United States, 01930
Contact: Site Public Contact    978-283-4000 ext 559      
Principal Investigator: Corrine L. Zarwan         
Lowell General Hospital Recruiting
Lowell, Massachusetts, United States, 01854
Contact: Site Public Contact    978-788-7084    ghincks@lowellgeneral.org   
Principal Investigator: Murat A. Anamur         
Mercy Medical Center Recruiting
Springfield, Massachusetts, United States, 01104
Contact: Site Public Contact    413-748-9234      
Principal Investigator: Philip J. Stella         
Baystate Medical Center Recruiting
Springfield, Massachusetts, United States, 01199
Contact: Site Public Contact    413-794-3565    tamara.wrenn@baystatehealth.org   
Principal Investigator: John C. McCann         
Winchester Hospital Recruiting
Winchester, Massachusetts, United States, 01890
Contact: Site Public Contact    888-823-5923    ctsucontact@westat.com   
Principal Investigator: Corrine L. Zarwan         
UMass Memorial Medical Center - University Campus Recruiting
Worcester, Massachusetts, United States, 01655
Contact: Site Public Contact    508-856-3216    cancer.research@umassmed.edu   
Principal Investigator: Jan Cerny         
United States, Michigan
Hickman Cancer Center Recruiting
Adrian, Michigan, United States, 49221
Contact: Site Public Contact    517-265-0116      
Principal Investigator: Rex B. Mowat         
Saint Joseph Mercy Hospital Recruiting
Ann Arbor, Michigan, United States, 48106
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
C S Mott Children's Hospital Suspended
Ann Arbor, Michigan, United States, 48109
University of Michigan Comprehensive Cancer Center Recruiting
Ann Arbor, Michigan, United States, 48109
Contact: Site Public Contact    800-865-1125      
Principal Investigator: Ajjai S. Alva         
Bronson Battle Creek Recruiting
Battle Creek, Michigan, United States, 49017
Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
IHA Hematology Oncology Consultants-Brighton Recruiting
Brighton, Michigan, United States, 48114
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Saint Joseph Mercy Brighton Recruiting
Brighton, Michigan, United States, 48114
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Henry Ford Cancer Institute-Downriver Recruiting
Brownstown, Michigan, United States, 48183
Contact: Site Public Contact    313-916-3721    CTOResearch@hfhs.org   
Principal Investigator: Ding Wang         
IHA Hematology Oncology Consultants-Canton Recruiting
Canton, Michigan, United States, 48188
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Saint Joseph Mercy Canton Recruiting
Canton, Michigan, United States, 48188
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Caro Cancer Center Recruiting
Caro, Michigan, United States, 48723
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
IHA Hematology Oncology Consultants-Chelsea Recruiting
Chelsea, Michigan, United States, 48118
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Saint Joseph Mercy Chelsea Recruiting
Chelsea, Michigan, United States, 48118
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Hematology Oncology Consultants-Clarkston Recruiting
Clarkston, Michigan, United States, 48346
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Newland Medical Associates-Clarkston Recruiting
Clarkston, Michigan, United States, 48346
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Henry Ford Macomb Hospital-Clinton Township Recruiting
Clinton Township, Michigan, United States, 48038
Contact: Site Public Contact    313-916-3721    CTOResearch@hfhs.org   
Principal Investigator: Ding Wang         
Beaumont Hospital - Dearborn Recruiting
Dearborn, Michigan, United States, 48124
Contact: Site Public Contact    248-551-7695      
Principal Investigator: Dana Zakalik         
Henry Ford Medical Center-Fairlane Recruiting
Dearborn, Michigan, United States, 48126
Contact: Site Public Contact    313-916-3721    CTOResearch@hfhs.org   
Principal Investigator: Ding Wang         
Wayne State University/Karmanos Cancer Institute Recruiting
Detroit, Michigan, United States, 48201
Contact: Site Public Contact    313-576-9790    ctoadmin@karmanos.org   
Principal Investigator: Anthony F. Shields         
Henry Ford Hospital Recruiting
Detroit, Michigan, United States, 48202
Contact: Site Public Contact    313-916-3721    CTOResearch@hfhs.org   
Principal Investigator: Ding Wang         
Ascension Saint John Hospital Recruiting
Detroit, Michigan, United States, 48236
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Great Lakes Cancer Management Specialists-Doctors Park Recruiting
East China Township, Michigan, United States, 48054
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Michigan State University Clinical Center Active, not recruiting
East Lansing, Michigan, United States, 48824-7016
Green Bay Oncology - Escanaba Recruiting
Escanaba, Michigan, United States, 49829
Contact: Site Public Contact    920-433-8889    Christy.Gilchrist@hshs.org   
Principal Investigator: Brian L. Burnette         
Beaumont Hospital - Farmington Hills Recruiting
Farmington Hills, Michigan, United States, 48336
Contact: Site Public Contact    248-551-7695      
Principal Investigator: Dana Zakalik         
Genesee Cancer and Blood Disease Treatment Center Recruiting
Flint, Michigan, United States, 48503
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Genesee Hematology Oncology PC Recruiting
Flint, Michigan, United States, 48503
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Genesys Hurley Cancer Institute Recruiting
Flint, Michigan, United States, 48503
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Hurley Medical Center Recruiting
Flint, Michigan, United States, 48503
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Helen DeVos Children's Hospital at Spectrum Health Recruiting
Grand Rapids, Michigan, United States, 49503
Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Mercy Health Saint Mary's Recruiting
Grand Rapids, Michigan, United States, 49503
Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Spectrum Health at Butterworth Campus Recruiting
Grand Rapids, Michigan, United States, 49503
Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Academic Hematology Oncology Specialists Recruiting
Grosse Pointe Woods, Michigan, United States, 48236
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Great Lakes Cancer Management Specialists-Van Elslander Cancer Center Recruiting
Grosse Pointe Woods, Michigan, United States, 48236
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Michigan Breast Specialists-Grosse Pointe Woods Recruiting
Grosse Pointe Woods, Michigan, United States, 48236
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
William Beaumont Hospital-Grosse Point Suspended
Grosse Pointe, Michigan, United States, 48230
Allegiance Health Recruiting
Jackson, Michigan, United States, 49201
Contact: Site Public Contact    313-916-3721    CTOResearch@hfhs.org   
Principal Investigator: Ding Wang         
Bronson Methodist Hospital Recruiting
Kalamazoo, Michigan, United States, 49007
Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
West Michigan Cancer Center Recruiting
Kalamazoo, Michigan, United States, 49007
Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Borgess Medical Center Recruiting
Kalamazoo, Michigan, United States, 49048
Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
McLaren-Greater Lansing Active, not recruiting
Lansing, Michigan, United States, 48910
Sparrow Hospital Recruiting
Lansing, Michigan, United States, 48912
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Hope Cancer Clinic Recruiting
Livonia, Michigan, United States, 48154
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Saint Mary Mercy Hospital Recruiting
Livonia, Michigan, United States, 48154
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Great Lakes Cancer Management Specialists-Macomb Medical Campus Recruiting
Macomb, Michigan, United States, 48044
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Michigan Breast Specialists-Macomb Township Recruiting
Macomb, Michigan, United States, 48044
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Saint Mary's Oncology/Hematology Associates of Marlette Recruiting
Marlette, Michigan, United States, 48453
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Mid-Michigan Medical Center - Midland Active, not recruiting
Midland, Michigan, United States, 48670
Monroe Cancer Center Recruiting
Monroe, Michigan, United States, 48162
Contact: Site Public Contact    888-823-5923    ctsucontact@westat.com   
Principal Investigator: Abhijit B. Saste         
Toledo Clinic Cancer Centers-Monroe Recruiting
Monroe, Michigan, United States, 48162
Contact: Site Public Contact    800-444-3561      
Principal Investigator: Rex B. Mowat         
Mercy Health Mercy Campus Recruiting
Muskegon, Michigan, United States, 49444
Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Lakeland Hospital Niles Recruiting
Niles, Michigan, United States, 49120
Contact: Site Public Contact    616-391-1230      
Principal Investigator: Kathleen J. Yost         
Cancer and Hematology Centers of Western Michigan - Norton Shores Recruiting
Norton Shores, Michigan, United States, 49444
Contact: Site Public Contact    616-391-1230    connie.szczepanek@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Ascension Providence Hospitals - Novi Recruiting
Novi, Michigan, United States, 48374
Contact: Site Public Contact    248-849-5332    karen.fife@ascension.org   
Principal Investigator: Robert E. Bloom         
Henry Ford Medical Center-Columbus Recruiting
Novi, Michigan, United States, 48377
Contact: Site Public Contact    313-916-3721    CTOResearch@hfhs.org   
Principal Investigator: Ding Wang         
21st Century Oncology-Pontiac Recruiting
Pontiac, Michigan, United States, 48341
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Hope Cancer Center Recruiting
Pontiac, Michigan, United States, 48341
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Newland Medical Associates-Pontiac Recruiting
Pontiac, Michigan, United States, 48341
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Saint Joseph Mercy Oakland Recruiting
Pontiac, Michigan, United States, 48341
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Huron Medical Center PC Suspended
Port Huron, Michigan, United States, 48060
Lake Huron Medical Center Suspended
Port Huron, Michigan, United States, 48060
Spectrum Health Reed City Hospital Suspended
Reed City, Michigan, United States, 49677
Great Lakes Cancer Management Specialists-Rochester Hills Recruiting
Rochester Hills, Michigan, United States, 48309
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Michigan Cancer Specialists Suspended
Roseville, Michigan, United States, 48066
Oakland Colon and Rectal Association Recruiting
Royal Oak, Michigan, United States, 48067
Contact: Site Public Contact    248-551-7695      
Principal Investigator: Dana Zakalik         
Beaumont Children's Hospital-Royal Oak Suspended
Royal Oak, Michigan, United States, 48073
Cancer Care Associates PC Recruiting
Royal Oak, Michigan, United States, 48073
Contact: Site Public Contact    248-551-7695      
Principal Investigator: Dana Zakalik         
Comprehensive Medical Center PLLC Recruiting
Royal Oak, Michigan, United States, 48073
Contact: Site Public Contact    248-551-7695      
Principal Investigator: Dana Zakalik         
Hematology Oncology Consultants PC Recruiting
Royal Oak, Michigan, United States, 48073
Contact: Site Public Contact    248-551-7695      
Principal Investigator: Dana Zakalik         
Oakland Medical Group Recruiting
Royal Oak, Michigan, United States, 48073
Contact: Site Public Contact    248-551-7695      
Principal Investigator: Dana Zakalik         
William Beaumont Hospital-Royal Oak Recruiting
Royal Oak, Michigan, United States, 48073
Contact: Site Public Contact    248-551-7695      
Principal Investigator: Dana Zakalik         
Ascension Saint Mary's Hospital Recruiting
Saginaw, Michigan, United States, 48601
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Oncology Hematology Associates of Saginaw Valley PC Recruiting
Saginaw, Michigan, United States, 48604
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Lakeland Medical Center Saint Joseph Recruiting
Saint Joseph, Michigan, United States, 49085
Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Marie Yeager Cancer Center Recruiting
Saint Joseph, Michigan, United States, 49085
Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Ascension Providence Hospitals - Southfield Recruiting
Southfield, Michigan, United States, 48075
Contact: Site Public Contact    248-849-5332    karen.fife@ascension.org   
Principal Investigator: Robert E. Bloom         
Bhadresh Nayak MD PC-Sterling Heights Recruiting
Sterling Heights, Michigan, United States, 48312
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Premier Hematology Oncology Care Recruiting
Sterling Heights, Michigan, United States, 48312
Contact: Site Public Contact    248-551-7695      
Principal Investigator: Dana Zakalik         
Mitchell Folbe MD PC Suspended
Sterling Heights, Michigan, United States, 48314
Ascension Saint Joseph Hospital Recruiting
Tawas City, Michigan, United States, 48764
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Munson Medical Center Recruiting
Traverse City, Michigan, United States, 49684
Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Michigan Institute of Urology-Town Center Recruiting
Troy, Michigan, United States, 48084
Contact: Site Public Contact    248-551-7695      
Principal Investigator: Dana Zakalik         
Claudia BR Herke MD PC Suspended
Troy, Michigan, United States, 48085
William Beaumont Hospital - Troy Recruiting
Troy, Michigan, United States, 48085
Contact: Site Public Contact    248-551-7695      
Principal Investigator: Dana Zakalik         
Hematology Oncology Consultants PC-Troy Recruiting
Troy, Michigan, United States, 48098
Contact: Site Public Contact    248-551-7695      
Principal Investigator: Dana Zakalik         
Advanced Breast Care Center PLLC Recruiting
Warren, Michigan, United States, 48088
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Great Lakes Cancer Management Specialists-Macomb Professional Building Recruiting
Warren, Michigan, United States, 48093
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Macomb Hematology Oncology PC Recruiting
Warren, Michigan, United States, 48093
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Michigan Breast Specialists-Warren Recruiting
Warren, Michigan, United States, 48093
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Saint John Macomb-Oakland Hospital Recruiting
Warren, Michigan, United States, 48093
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Henry Ford West Bloomfield Hospital Recruiting
West Bloomfield, Michigan, United States, 48322
Contact: Site Public Contact    313-916-3721    CTOResearch@hfhs.org   
Principal Investigator: Ding Wang         
Saint Mary's Oncology/Hematology Associates of West Branch Recruiting
West Branch, Michigan, United States, 48661
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Metro Health Hospital Recruiting
Wyoming, Michigan, United States, 49519
Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org   
Principal Investigator: Kathleen J. Yost         
Huron Gastroenterology PC Recruiting
Ypsilanti, Michigan, United States, 48106
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
IHA Hematology Oncology Consultants-Ann Arbor Recruiting
Ypsilanti, Michigan, United States, 48197
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
United States, Minnesota
Riverwood Healthcare Center Recruiting
Aitkin, Minnesota, United States, 56431
Contact: Site Public Contact    218-786-3308    CancerTrials@EssentiaHealth.org   
Principal Investigator: Bret E. Friday         
Sanford Joe Lueken Cancer Center Recruiting
Bemidji, Minnesota, United States, 56601
Contact: Site Public Contact    218-333-5000    OncologyClinicalTrialsFargo@sanfordhealth.org   
Principal Investigator: Preston D. Steen         
Essentia Health Saint Joseph's Medical Center Recruiting
Brainerd, Minnesota, United States, 56401
Contact: Site Public Contact    218-786-3308    CancerTrials@EssentiaHealth.org   
Principal Investigator: Bret E. Friday         
Fairview Ridges Hospital Recruiting
Burnsville, Minnesota, United States, 55337
Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Cambridge Medical Center Recruiting
Cambridge, Minnesota, United States, 55008
Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Mercy Hospital Recruiting
Coon Rapids, Minnesota, United States, 55433
Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Essentia Health - Deer River Clinic Recruiting
Deer River, Minnesota, United States, 56636
Contact: Site Public Contact    218-786-3308    CancerTrials@EssentiaHealth.org   
Principal Investigator: Bret E. Friday         
Essentia Health Saint Mary's - Detroit Lakes Clinic Recruiting
Detroit Lakes, Minnesota, United States, 56501
Contact: Site Public Contact    218-786-3308    CancerTrials@EssentiaHealth.org   
Principal Investigator: Bret E. Friday         
Essentia Health Cancer Center Recruiting
Duluth, Minnesota, United States, 55805
Contact: Site Public Contact    218-786-3308    CancerTrials@EssentiaHealth.org   
Principal Investigator: Bret E. Friday         
Essentia Health Saint Mary's Medical Center Recruiting
Duluth, Minnesota, United States, 55805
Contact: Site Public Contact    218-786-3308    CancerTrials@EssentiaHealth.org   
Principal Investigator: Bret E. Friday         
Miller-Dwan Hospital Recruiting
Duluth, Minnesota, United States, 55805
Contact: Site Public Contact    218-786-3308    CancerTrials@EssentiaHealth.org   
Principal Investigator: Bret E. Friday         
Fairview-Southdale Hospital Recruiting
Edina, Minnesota, United States, 55435
Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Lake Region Healthcare Corporation-Cancer Care Recruiting
Fergus Falls, Minnesota, United States, 56537
Contact: Site Public Contact    218-786-3308    CancerTrials@EssentiaHealth.org   
Principal Investigator: Bret E. Friday         
Essentia Health - Fosston Recruiting
Fosston, Minnesota, United States, 56542
Contact: Site Public Contact    218-786-3308    CancerTrials@EssentiaHealth.org   
Principal Investigator: Bret E. Friday         
Unity Hospital Recruiting
Fridley, Minnesota, United States, 55432
Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Essentia Health Hibbing Clinic Recruiting
Hibbing, Minnesota, United States, 55746
Contact: Site Public Contact    218-786-3308      
Principal Investigator: Bret E. Friday         
Fairview Maple Grove Medical Center Recruiting
Maple Grove, Minnesota, United States, 55369
Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Minnesota Oncology Hematology PA-Maplewood Recruiting
Maplewood, Minnesota, United States, 55109
Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Saint John's Hospital - Healtheast Recruiting
Maplewood, Minnesota, United States, 55109
Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Abbott-Northwestern Hospital Recruiting
Minneapolis, Minnesota, United States, 55407
Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Hennepin County Medical Center Recruiting
Minneapolis, Minnesota, United States, 55415
Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Health Partners Inc Recruiting
Minneapolis, Minnesota, United States, 55454
Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
University of Minnesota/Masonic Cancer Center Recruiting
Minneapolis, Minnesota, United States, 55455
Contact: Site Public Contact    612-624-2620      
Principal Investigator: Emil Lou         
Monticello Cancer Center Recruiting
Monticello, Minnesota, United States, 55362
Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
New Ulm Medical Center Recruiting
New Ulm, Minnesota, United States, 56073
Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Essentia Health - Park Rapids Recruiting
Park Rapids, Minnesota, United States, 56470
Contact: Site Public Contact    218-786-3308    CancerTrials@EssentiaHealth.org   
Principal Investigator: Bret E. Friday         
Fairview Northland Medical Center Recruiting
Princeton, Minnesota, United States, 55371
Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
North Memorial Medical Health Center Recruiting
Robbinsdale, Minnesota, United States, 55422
Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Mayo Clinic Recruiting
Rochester, Minnesota, United States, 55905
Contact: Site Public Contact    855-776-0015      
Principal Investigator: Alan H. Bryce         
Park Nicollet Clinic - Saint Louis Park Recruiting
Saint Louis Park, Minnesota, United States, 55416
Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Regions Hospital Recruiting
Saint Paul, Minnesota, United States, 55101
Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
United Hospital Recruiting
Saint Paul, Minnesota, United States, 55102
Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Essentia Health Sandstone Recruiting
Sandstone, Minnesota, United States, 55072
Contact: Site Public Contact    218-786-3308    CancerTrials@EssentiaHealth.org   
Principal Investigator: Bret E. Friday         
Saint Francis Regional Medical Center Recruiting
Shakopee, Minnesota, United States, 55379
Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Lakeview Hospital Recruiting
Stillwater, Minnesota, United States, 55082
Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Essentia Health Virginia Clinic Recruiting
Virginia, Minnesota, United States, 55792
Contact: Site Public Contact    218-786-3308    CancerTrials@EssentiaHealth.org   
Principal Investigator: Bret E. Friday         
Ridgeview Medical Center Recruiting
Waconia, Minnesota, United States, 55387
Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Rice Memorial Hospital Recruiting
Willmar, Minnesota, United States, 56201
Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Minnesota Oncology Hematology PA-Woodbury Recruiting
Woodbury, Minnesota, United States, 55125
Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
Sanford Cancer Center Worthington Recruiting
Worthington, Minnesota, United States, 56187
Contact: Site Public Contact    605-312-3320      
Principal Investigator: Preston D. Steen         
Fairview Lakes Medical Center Recruiting
Wyoming, Minnesota, United States, 55092
Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com   
Principal Investigator: David M. King         
United States, Mississippi
Baptist Memorial Hospital and Cancer Center-Golden Triangle Recruiting
Columbus, Mississippi, United States, 39705
Contact: Site Public Contact    901-226-1366    BCCclintrials@bmhcc.org   
Principal Investigator: Donald S. Gravenor         
Baptist Cancer Center-Grenada Recruiting
Grenada, Mississippi, United States, 38901
Contact: Site Public Contact    901-226-1366    BCCclintrials@bmhcc.org   
Principal Investigator: Donald S. Gravenor         
Hattiesburg Clinic - Hematology/Oncology Clinic Recruiting
Hattiesburg, Mississippi, United States, 39401
Contact: Site Public Contact    601-288-2495    tmcbeth@forrestgeneral.com   
Principal Investigator: Marc R. Matrana         
Forrest General Hospital / Cancer Center Recruiting
Hattiesburg, Mississippi, United States, 39404
Contact: Site Public Contact    601-288-2495    tmcbeth@forrestgeneral.com   
Principal Investigator: Marc R. Matrana         
University of Mississippi Medical Center Recruiting
Jackson, Mississippi, United States, 39216
Contact: Site Public Contact    601-815-6700      
Principal Investigator: John C. Henegan         
Baptist Memorial Hospital and Cancer Center-Union County Recruiting
New Albany, Mississippi, United States, 38652
Contact: Site Public Contact    901-226-1366    BCCclintrials@bmhcc.org   
Principal Investigator: Donald S. Gravenor         
Baptist Memorial Hospital and Cancer Center-Oxford Recruiting
Oxford, Mississippi, United States, 38655
Contact: Site Public Contact    901-226-1366    BCCclintrials@bmhcc.org   
Principal Investigator: Donald S. Gravenor         
Singing River Hospital Recruiting
Pascagoula, Mississippi, United States, 39581
Contact: Site Public Contact    228-809-5292      
Principal Investigator: James E. Clarkson         
Baptist Memorial Hospital and Cancer Center-Desoto Recruiting
Southhaven, Mississippi, United States, 38671
Contact: Site Public Contact    901-226-1366    BCCclintrials@bmhcc.org   
Principal Investigator: Donald S. Gravenor         
United States, Missouri
Central Care Cancer Center - Bolivar Active, not recruiting
Bolivar, Missouri, United States, 65613
Parkland Health Center-Bonne Terre Recruiting
Bonne Terre, Missouri, United States, 63628
Contact: Site Public Contact    314-996-5569      
Principal Investigator: Bryan A. Faller         
Cox Cancer Center Branson Recruiting
Branson, Missouri, United States, 65616
Contact: Site Public Contact    417-269-4520      
Principal Investigator: Jay W. Carlson         
Saint Francis Medical Center Recruiting
Cape Girardeau, Missouri, United States, 63703
Contact: Site Public Contact    573-334-2230    sfmc@sfmc.net   
Principal Investigator: Bryan A. Faller         
Southeast Cancer Center Recruiting
Cape Girardeau, Missouri, United States, 63703
Contact: Site Public Contact    573-651-5550      
Principal Investigator: Bryan A. Faller         
Saint Luke's Hospital Recruiting
Chesterfield, Missouri, United States, 63017
Contact: Site Public Contact    314-205-6936      
Principal Investigator: Donald F. Busiek         
University of Missouri - Ellis Fischel Recruiting
Columbia, Missouri, United States, 65212
Contact: Site Public Contact    573-882-7440      
Principal Investigator: Michael C. Trendle         
Siteman Cancer Center at West County Hospital Recruiting
Creve Coeur, Missouri, United States, 63141
Contact: Site Public Contact    800-600-3606    info@siteman.wustl.edu   
Principal Investigator: Benjamin R. Tan         
Parkland Health Center - Farmington Recruiting
Farmington, Missouri, United States, 63640
Contact: Site Public Contact    314-996-5569      
Principal Investigator: Bryan A. Faller         
Centerpoint Medical Center LLC Active, not recruiting
Independence, Missouri, United States, 64057
Capital Region Southwest Campus Recruiting
Jefferson City, Missouri, United States, 65109
Contact: Site Public Contact    573-632-4814    swooden@mail.crmc.org   
Principal Investigator: Bryan A. Faller         
Freeman Health System Recruiting
Joplin, Missouri, United States, 64804
Contact: Site Public Contact    417-347-4030    LJCrockett@freemanhealth.com   
Principal Investigator: Jay W. Carlson         
Mercy Hospital Joplin Recruiting
Joplin, Missouri, United States, 64804
Contact: Site Public Contact    417-556-3074    esmeralda.carrillo@mercy.net   
Principal Investigator: Jay W. Carlson         
Truman Medical Center Recruiting
Kansas City, Missouri, United States, 64108
Contact: Site Public Contact    816-404-4375      
Principal Investigator: Stephen K. Williamson         
Saint Luke's Hospital of Kansas City Recruiting
Kansas City, Missouri, United States, 64111
Contact: Site Public Contact    913-948-5588    aroland@kccop.org   
Principal Investigator: Timothy J. Pluard         
The University of Kansas Cancer Center-South Suspended
Kansas City, Missouri, United States, 64131
Research Medical Center Active, not recruiting
Kansas City, Missouri, United States, 64132
The University of Kansas Cancer Center-North Recruiting
Kansas City, Missouri, United States, 64154
Contact: Site Public Contact    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Stephen K. Williamson         
The University of Kansas Cancer Center-Lee's Summit Recruiting
Lee's Summit, Missouri, United States, 64064
Contact: Site Public Contact    913-945-7552    ctnursenav@kumc.edu   
Principal Investigator: Stephen K. Williamson         
Saint Luke's East - Lee's Summit Recruiting
Lee's Summit, Missouri, United States, 64086
Contact: Site Public Contact    913-948-5588    aroland@kccop.org   
Principal Investigator: Timothy J. Pluard         
Liberty Radiation Oncology Center Active, not recruiting
Liberty, Missouri, United States, 64068
Delbert Day Cancer Institute at PCRMC Recruiting
Rolla, Missouri, United States, 65401
Contact: Site Public Contact    573-458-7504    jrichards@research.pcrmc.com   
Principal Investigator: Jay W. Carlson         
Mercy Clinic-Rolla-Cancer and Hematology Suspended
Rolla, Missouri, United States, 65401
Heartland Regional Medical Center Recruiting
Saint Joseph, Missouri, United States, 64507
Contact: Site Public Contact    816-271-7937    linda.schumacher@mymlc.com   
Principal Investigator: Jay W. Carlson         
Saint Louis Cancer and Breast Institute-South City Recruiting
Saint Louis, Missouri, United States, 63109
Contact: Site Public Contact    314-353-1870      
Principal Investigator: Jay W. Carlson         
Washington University School of Medicine Recruiting
Saint Louis, Missouri, United States, 63110
Contact: Site Public Contact    800-600-3606    info@siteman.wustl.edu   
Principal Investigator: Benjamin R. Tan         
Mercy Hospital South Recruiting
Saint Louis, Missouri, United States, 63128
Contact: Site Public Contact       janet.lesko@mercy.net   
Principal Investigator: Jay W. Carlson         
Siteman Cancer Center-South County Recruiting
Saint Louis, Missouri, United States, 63129
Contact: Site Public Contact    800-600-3606    info@siteman.wustl.edu   
Principal Investigator: Benjamin R. Tan         
Missouri Baptist Medical Center Recruiting
Saint Louis, Missouri, United States, 63131
Contact: Site Public Contact    314-996-5569      
Principal Investigator: Bryan A. Faller         
Siteman Cancer Center at Christian Hospital Recruiting
Saint Louis, Missouri, United States, 63136
Contact: Site Public Contact    800-600-3606    info@siteman.wustl.edu   
Principal Investigator: Benjamin R. Tan         
Mercy Hospital Saint Louis Recruiting
Saint Louis, Missouri, United States, 63141
Contact: Site Public Contact    314-251-7066      
Principal Investigator: Jay W. Carlson         
Siteman Cancer Center at Saint Peters Hospital Recruiting
Saint Peters, Missouri, United States, 63376
Contact: Site Public Contact    800-600-3606    info@siteman.wustl.edu   
Principal Investigator: Benjamin R. Tan         
Sainte Genevieve County Memorial Hospital Recruiting
Sainte Genevieve, Missouri, United States, 63670
Contact: Site Public Contact    314-996-5569      
Principal Investigator: Bryan A. Faller         
Mercy Hospital Springfield Recruiting
Springfield, Missouri, United States, 65804
Contact: Site Public Contact    417-269-4520      
Principal Investigator: Jay W. Carlson         
CoxHealth South Hospital Recruiting
Springfield, Missouri, United States, 65807
Contact: Site Public Contact    417-269-4520      
Principal Investigator: Jay W. Carlson         
Missouri Baptist Sullivan Hospital Recruiting
Sullivan, Missouri, United States, 63080
Contact: Site Public Contact    314-996-5569      
Principal Investigator: Bryan A. Faller         
Missouri Baptist Outpatient Center-Sunset Hills Recruiting
Sunset Hills, Missouri, United States, 63127
Contact: Site Public Contact    314-996-5569      
Principal Investigator: Bryan A. Faller         
United States, Montana
Community Hospital of Anaconda Recruiting
Anaconda, Montana, United States, 59711
Contact: Site Public Contact    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: John M. Schallenkamp         
Billings Clinic Cancer Center Recruiting
Billings, Montana, United States, 59101
Contact: Site Public Contact    800-996-2663    research@billingsclinic.org   
Principal Investigator: John M. Schallenkamp         
Saint Vincent Healthcare Suspended
Billings, Montana, United States, 59101
Saint Vincent Frontier Cancer Center Suspended
Billings, Montana, United States, 59102
Bozeman Deaconess Hospital Recruiting
Bozeman, Montana, United States, 59715
Contact: Site Public Contact    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: John M. Schallenkamp         
Saint James Community Hospital and Cancer Treatment Center Recruiting
Butte, Montana, United States, 59701
Contact: Site Public Contact    406-723-2621      
Principal Investigator: Keren Sturtz         
Benefis Healthcare- Sletten Cancer Institute Recruiting
Great Falls, Montana, United States, 59405
Contact: Site Public Contact    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: John M. Schallenkamp         
Saint Peter's Community Hospital Suspended
Helena, Montana, United States, 59601
Kalispell Regional Medical Center Recruiting
Kalispell, Montana, United States, 59901
Contact: Site Public Contact    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: John M. Schallenkamp         
Saint Patrick Hospital - Community Hospital Recruiting
Missoula, Montana, United States, 59802
Contact: Site Public Contact    406-327-3118    amy.hanneman@providence.org   
Principal Investigator: Alison K. Conlin         
Community Medical Hospital Recruiting
Missoula, Montana, United States, 59804
Contact: Site Public Contact    406-969-6060    mccinfo@mtcancer.org   
Principal Investigator: John M. Schallenkamp         
United States, Nebraska
Nebraska Medicine-Bellevue Suspended
Bellevue, Nebraska, United States, 68123
CHI Health Saint Francis Recruiting
Grand Island, Nebraska, United States, 68803
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Heartland Hematology and Oncology Suspended
Kearney, Nebraska, United States, 68845
CHI Health Good Samaritan Recruiting
Kearney, Nebraska, United States, 68847
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Nebraska Hematology and Oncology Suspended
Lincoln, Nebraska, United States, 68506
Nebraska Cancer Research Center Suspended
Lincoln, Nebraska, United States, 68510
Saint Elizabeth Regional Medical Center Recruiting
Lincoln, Nebraska, United States, 68510
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Southeast Nebraska Cancer Center - 68th Street Place Suspended
Lincoln, Nebraska, United States, 68516
Faith Regional Health Services Carson Cancer Center Suspended
Norfolk, Nebraska, United States, 68701
Great Plains Health Callahan Cancer Center Suspended
North Platte, Nebraska, United States, 69101
Nebraska Medicine-Village Pointe Suspended
Omaha, Nebraska, United States, 68118
Alegent Health Immanuel Medical Center Recruiting
Omaha, Nebraska, United States, 68122
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Hematology and Oncology Consultants PC Suspended
Omaha, Nebraska, United States, 68122
Alegent Health Bergan Mercy Medical Center Recruiting
Omaha, Nebraska, United States, 68124
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Nebraska Cancer Specialists - Omaha Suspended
Omaha, Nebraska, United States, 68124
Alegent Health Lakeside Hospital Recruiting
Omaha, Nebraska, United States, 68130
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Oncology Hematology West PC Suspended
Omaha, Nebraska, United States, 68130
Creighton University Medical Center Recruiting
Omaha, Nebraska, United States, 68131
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
University of Nebraska Medical Center Active, not recruiting
Omaha, Nebraska, United States, 68198
Midlands Community Hospital Recruiting
Papillion, Nebraska, United States, 68046
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Regional West Medical Center Cancer Center Suspended
Scottsbluff, Nebraska, United States, 69361
United States, Nevada
Carson Tahoe Regional Medical Center Recruiting
Carson City, Nevada, United States, 89703
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Cancer and Blood Specialists-Henderson Recruiting
Henderson, Nevada, United States, 89052
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada - Henderson Recruiting
Henderson, Nevada, United States, 89052
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada-Horizon Ridge Recruiting
Henderson, Nevada, United States, 89052
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Las Vegas Cancer Center-Henderson Recruiting
Henderson, Nevada, United States, 89052
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
OptumCare Cancer Care at Seven Hills Recruiting
Henderson, Nevada, United States, 89052
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
21st Century Oncology-Henderson Recruiting
Henderson, Nevada, United States, 89074
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada-Southeast Henderson Recruiting
Henderson, Nevada, United States, 89074
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Las Vegas Urology - Green Valley Recruiting
Henderson, Nevada, United States, 89074
Contact: Site Public Contact       research@sncrf.org   
Principal Investigator: John A. Ellerton         
Las Vegas Urology - Pebble Recruiting
Henderson, Nevada, United States, 89074
Contact: Site Public Contact       research@sncrf.org   
Principal Investigator: John A. Ellerton         
Urology Specialists of Nevada - Green Valley Recruiting
Henderson, Nevada, United States, 89074
Contact: Site Public Contact       research@sncrf.org   
Principal Investigator: John A. Ellerton         
Las Vegas Urology - Pecos Recruiting
Las Vegas, Nevada, United States, 89074
Contact: Site Public Contact       research@sncrf.org   
Principal Investigator: John A. Ellerton         
Desert West Surgery Recruiting
Las Vegas, Nevada, United States, 89102
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
University Medical Center of Southern Nevada Recruiting
Las Vegas, Nevada, United States, 89102
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Cancer and Blood Specialists-Shadow Recruiting
Las Vegas, Nevada, United States, 89106
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
OptumCare Cancer Care at Oakey Recruiting
Las Vegas, Nevada, United States, 89106
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Radiation Oncology Centers of Nevada Central Recruiting
Las Vegas, Nevada, United States, 89106
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Urology Specialists of Nevada - Central Recruiting
Las Vegas, Nevada, United States, 89106
Contact: Site Public Contact       research@sncrf.org   
Principal Investigator: John A. Ellerton         
21st Century Oncology Recruiting
Las Vegas, Nevada, United States, 89109
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway Recruiting
Las Vegas, Nevada, United States, 89109
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Sunrise Hospital and Medical Center Recruiting
Las Vegas, Nevada, United States, 89109
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
HealthCare Partners Medical Group Oncology/Hematology-San Martin Recruiting
Las Vegas, Nevada, United States, 89113
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Las Vegas Prostate Cancer Center Recruiting
Las Vegas, Nevada, United States, 89113
Contact: Site Public Contact       research@sncrf.org   
Principal Investigator: John A. Ellerton         
Las Vegas Urology - Sunset Recruiting
Las Vegas, Nevada, United States, 89113
Contact: Site Public Contact       research@sncrf.org   
Principal Investigator: John A. Ellerton         
Radiation Oncology Centers of Nevada Southeast Recruiting
Las Vegas, Nevada, United States, 89119
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Cancer Therapy and Integrative Medicine Suspended
Las Vegas, Nevada, United States, 89121
21st Century Oncology-Vegas Tenaya Recruiting
Las Vegas, Nevada, United States, 89128
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Ann M Wierman MD LTD Recruiting
Las Vegas, Nevada, United States, 89128
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Cancer and Blood Specialists-Tenaya Recruiting
Las Vegas, Nevada, United States, 89128
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada - Northwest Recruiting
Las Vegas, Nevada, United States, 89128
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
HealthCare Partners Medical Group Oncology/Hematology-Tenaya Recruiting
Las Vegas, Nevada, United States, 89128
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Las Vegas Urology - Cathedral Rock Recruiting
Las Vegas, Nevada, United States, 89128
Contact: Site Public Contact       research@sncrf.org   
Principal Investigator: John A. Ellerton         
Las Vegas Urology - Smoke Ranch Recruiting
Las Vegas, Nevada, United States, 89128
Contact: Site Public Contact       research@smcrf.org   
Principal Investigator: John A. Ellerton         
OptumCare Cancer Care at MountainView Recruiting
Las Vegas, Nevada, United States, 89128
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Urology Specialists of Nevada - Northwest Recruiting
Las Vegas, Nevada, United States, 89128
Contact: Site Public Contact       research@sncrf.org   
Principal Investigator: John A. Ellerton         
Alliance for Childhood Diseases/Cure 4 the Kids Foundation Recruiting
Las Vegas, Nevada, United States, 89135
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada - Town Center Recruiting
Las Vegas, Nevada, United States, 89144
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada-Summerlin Recruiting
Las Vegas, Nevada, United States, 89144
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Summerlin Hospital Medical Center Recruiting
Las Vegas, Nevada, United States, 89144
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Las Vegas Cancer Center-Medical Center Recruiting
Las Vegas, Nevada, United States, 89148-2405
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
21st Century Oncology-Fort Apache Recruiting
Las Vegas, Nevada, United States, 89148
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada Recruiting
Las Vegas, Nevada, United States, 89148
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
OptumCare Cancer Care at Fort Apache Recruiting
Las Vegas, Nevada, United States, 89148
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Urology Specialists of Nevada - Southwest Recruiting
Las Vegas, Nevada, United States, 89148
Contact: Site Public Contact       research@sncrf.org   
Principal Investigator: John A. Ellerton         
HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills Recruiting
Las Vegas, Nevada, United States, 89149
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada - Central Valley Recruiting
Las Vegas, Nevada, United States, 89169
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Hope Cancer Care of Nevada-Pahrump Recruiting
Pahrump, Nevada, United States, 89048
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Center of Hope at Renown Medical Center Active, not recruiting
Reno, Nevada, United States, 89502
Renown Regional Medical Center Recruiting
Reno, Nevada, United States, 89502
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Saint Mary's Regional Medical Center Recruiting
Reno, Nevada, United States, 89503
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
Radiation Oncology Associates Recruiting
Reno, Nevada, United States, 89509
Contact: Site Public Contact    702-384-0013    research@sncrf.org   
Principal Investigator: John A. Ellerton         
United States, New Hampshire
New Hampshire Oncology Hematology PA-Concord Recruiting
Concord, New Hampshire, United States, 03301
Contact: Site Public Contact    603-224-2556      
Principal Investigator: Douglas J. Weckstein         
New Hampshire Oncology Hematology PA-Hooksett Recruiting
Hooksett, New Hampshire, United States, 03106
Contact: Site Public Contact    800-339-6484      
Principal Investigator: Douglas J. Weckstein         
Dartmouth Hitchcock Medical Center Recruiting
Lebanon, New Hampshire, United States, 03756
Contact: Site Public Contact    800-639-6918    cancer.research.nurse@dartmouth.edu   
Principal Investigator: Konstantin H. Dragnev         
Norris Cotton Cancer Center-Manchester Recruiting
Manchester, New Hampshire, United States, 03102
Contact: Site Public Contact    603-629-1828      
Principal Investigator: Konstantin H. Dragnev         
Norris Cotton Cancer Center-Nashua Recruiting
Nashua, New Hampshire, United States, 03063
Contact: Site Public Contact    603-577-4282    Laura.A.Menken@hitchcock.org   
Principal Investigator: Konstantin H. Dragnev         
United States, New Jersey
Ocean Medical Center Recruiting
Brick, New Jersey, United States, 08724
Contact: Site Public Contact    732-206-8384      
Principal Investigator: Denis B. Fitzgerald         
AtlantiCare Health Park-Cape May Court House Recruiting
Cape May Court House, New Jersey, United States, 08210
Contact: Site Public Contact    888-369-2427      
Principal Investigator: Joseph J. Vadakara         
AtlantiCare Surgery Center Recruiting
Egg Harbor Township, New Jersey, United States, 08234
Contact: Site Public Contact    609-748-7200      
Principal Investigator: Joseph J. Vadakara         
Trinitas Hospital and Comprehensive Cancer Center - Williamson Street Campus Recruiting
Elizabeth, New Jersey, United States, 07207
Contact: Site Public Contact    908-994-8000      
Principal Investigator: Russell J. Schilder         
Hunterdon Medical Center Recruiting
Flemington, New Jersey, United States, 08822
Contact: Site Public Contact    888-788-1260      
Principal Investigator: Kenneth B. Blankstein         
Hackensack University Medical Center Recruiting
Hackensack, New Jersey, United States, 07601
Contact: Site Public Contact    201-996-2879      
Principal Investigator: Donna M. McNamara         
Bayshore Community Hospital Recruiting
Holmdel, New Jersey, United States, 07733
Contact: Site Public Contact       ecog.rss@jimmy.harvard.edu   
Principal Investigator: Denis B. Fitzgerald         
Monmouth Medical Center Southern Campus Recruiting
Lakewood, New Jersey, United States, 08701
Contact: Site Public Contact    732-923-6564    Rita.McTighe@rwjbh.org   
Principal Investigator: Seth D. Cohen         
Saint Barnabas Medical Center Suspended
Livingston, New Jersey, United States, 07039
Monmouth Medical Center Recruiting
Long Branch, New Jersey, United States, 07740
Contact: Site Public Contact    732-923-7689      
Principal Investigator: Seth D. Cohen         
Southern Ocean County Medical Center Recruiting
Manahawkin, New Jersey, United States, 08050
Contact: Site Public Contact    609-978-3429      
Principal Investigator: Denis B. Fitzgerald         
Memorial Sloan Kettering Monmouth Recruiting
Middletown, New Jersey, United States, 07748
Contact: Site Public Contact    212-639-7592      
Principal Investigator: David M. Hyman         
Morristown Medical Center Recruiting
Morristown, New Jersey, United States, 07960
Contact: Site Public Contact    973-971-5900      
Principal Investigator: Paul B. Heller         
Jersey Shore Medical Center Recruiting
Neptune, New Jersey, United States, 07753
Contact: Site Public Contact    732-776-4240      
Principal Investigator: Denis B. Fitzgerald         
Rutgers Cancer Institute of New Jersey Recruiting
New Brunswick, New Jersey, United States, 08903
Contact: Site Public Contact    732-235-8675      
Principal Investigator: Shridar Ganesan         
Capital Health Medical Center-Hopewell Recruiting
Pennington, New Jersey, United States, 08534
Contact: Site Public Contact    800-255-3440      
Principal Investigator: David L. Schaebler         
Riverview Medical Center/Booker Cancer Center Recruiting
Red Bank, New Jersey, United States, 07701
Contact: Site Public Contact    732-530-2382      
Principal Investigator: Denis B. Fitzgerald         
Kennedy Health Systems-Cancer Center Recruiting
Sewell, New Jersey, United States, 08080
Contact: Site Public Contact    856-218-5790    t.carducci@kennedyhealth.org   
Principal Investigator: Russell J. Schilder         
Overlook Hospital Suspended
Summit, New Jersey, United States, 07902
Inspira Medical Center Vineland Active, not recruiting
Vineland, New Jersey, United States, 08360
Inspira Medical Center Woodbury Active, not recruiting
Woodbury, New Jersey, United States, 08096
United States, New Mexico
Lovelace Medical Center-Downtown Suspended
Albuquerque, New Mexico, United States, 87102
University of New Mexico Cancer Center Recruiting
Albuquerque, New Mexico, United States, 87102
Contact: Site Public Contact    505-925-0366    LByatt@nmcca.org   
Principal Investigator: Ursa A. Brown-Glaberman         
Southwest Gynecologic Oncology Associates Inc Recruiting
Albuquerque, New Mexico, United States, 87106
Contact: Site Public Contact    505-272-0530    RDraper@nmcca.org   
Principal Investigator: Ursa A. Brown-Glaberman         
New Mexico Oncology Hematology Consultants Recruiting
Albuquerque, New Mexico, United States, 87109
Contact: Site Public Contact    505-272-0530    CLee@nmcca.org   
Principal Investigator: Ursa A. Brown-Glaberman         
Presbyterian Kaseman Hospital Recruiting
Albuquerque, New Mexico, United States, 87110
Contact: Site Public Contact    505-559-6113    WBurman@phs.org   
Principal Investigator: Ursa A. Brown-Glaberman         
Memorial Medical Center - Las Cruces Recruiting
Las Cruces, New Mexico, United States, 88011
Contact: Site Public Contact    575-556-6545    Kim.Hoffman@lpnt.net   
Principal Investigator: Ursa A. Brown-Glaberman         
Christus Saint Vincent Regional Cancer Center Recruiting
Santa Fe, New Mexico, United States, 87505
Contact: Site Public Contact    505-913-8933    Olivia.Sloan@nmcancercare.com   
Principal Investigator: Ursa A. Brown-Glaberman         
United States, New York
Montefiore Medical Center-Einstein Campus Recruiting
Bronx, New York, United States, 10461
Contact: Site Public Contact    718-379-6866    aaraiza@montefiore.org   
Principal Investigator: Balazs Halmos         
Montefiore Medical Center-Weiler Hospital Recruiting
Bronx, New York, United States, 10461
Contact: Site Public Contact    718-379-6866    aaraiza@montefiore.org   
Principal Investigator: Balazs Halmos         
Children's Hospital at Montefiore Suspended
Bronx, New York, United States, 10467
Montefiore Medical Center - Moses Campus Recruiting
Bronx, New York, United States, 10467
Contact: Site Public Contact    718-379-6866    aaraiza@montefiore.org   
Principal Investigator: Balazs Halmos         
State University of New York Downstate Medical Center Suspended
Brooklyn, New York, United States, 11203
Roswell Park Cancer Institute Recruiting
Buffalo, New York, United States, 14263
Contact: Site Public Contact    800-767-9355    askroswell@roswellpark.org   
Principal Investigator: Ellis G. Levine         
Arnot Ogden Medical Center/Falck Cancer Center Active, not recruiting
Elmira, New York, United States, 14905
Glens Falls Hospital Recruiting
Glens Falls, New York, United States, 12801
Contact: Site Public Contact    518-926-6700      
Principal Investigator: Marc S. Greenblatt         
Memorial Sloan Kettering Westchester Recruiting
Harrison, New York, United States, 10604
Contact: Site Public Contact    212-639-7592      
Principal Investigator: David M. Hyman         
Northwell Health/Center for Advanced Medicine Recruiting
Lake Success, New York, United States, 11042
Contact: Site Public Contact    516-734-8896      
Principal Investigator: Xinhua Zhu         
North Shore University Hospital Recruiting
Manhasset, New York, United States, 11030
Contact: Site Public Contact    516-734-8896      
Principal Investigator: Xinhua Zhu         
Long Island Jewish Medical Center Recruiting
New Hyde Park, New York, United States, 11040
Contact: Site Public Contact    516-734-8896      
Principal Investigator: Xinhua Zhu         
Lenox Hill Hospital Recruiting
New York, New York, United States, 10021
Contact: Site Public Contact    516-734-8896      
Principal Investigator: Xinhua Zhu         
Mount Sinai Hospital Recruiting
New York, New York, United States, 10029
Contact: Site Public Contact    212-824-7309    CCTO@mssm.edu   
Principal Investigator: Charles L. Shapiro         
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center Recruiting
New York, New York, United States, 10032
Contact: Site Public Contact    212-305-6361    nr2616@cumc.columbia.edu   
Principal Investigator: Richard D. Carvajal         
Memorial Sloan Kettering Cancer Center Recruiting
New York, New York, United States, 10065
Contact: Site Public Contact    212-639-7592      
Principal Investigator: David M. Hyman         
NYP/Weill Cornell Medical Center Recruiting
New York, New York, United States, 10065
Contact: Site Public Contact    212-746-1848      
Principal Investigator: Ashish Saxena         
Rochester General Hospital Recruiting
Rochester, New York, United States, 14621
Contact: Site Public Contact    585-922-3536    tia.derosa@rochestergeneral.org   
Principal Investigator: Peter W. Bushunow         
University of Rochester Recruiting
Rochester, New York, United States, 14642
Contact: Site Public Contact    585-275-5830      
Principal Investigator: Paul M. Barr         
Stony Brook University Medical Center Active, not recruiting
Stony Brook, New York, United States, 11794
State University of New York Upstate Medical University Recruiting
Syracuse, New York, United States, 13210
Contact: Site Public Contact    315-464-5476      
Principal Investigator: Stephen L. Graziano         
SUNY Upstate Medical Center-Community Campus Recruiting
Syracuse, New York, United States, 13215
Contact: Site Public Contact    315-464-5476      
Principal Investigator: Stephen L. Graziano         
Dickstein Cancer Treatment Center Recruiting
White Plains, New York, United States, 10601
Contact: Site Public Contact    914-849-7582    mcortese@wphospital.org   
Principal Investigator: Julie A. Monroe         
United States, North Carolina
Cancer Care of Western North Carolina Recruiting
Asheville, North Carolina, United States, 28801
Contact: Site Public Contact    828-213-2539    Karen.Smith3@HCAHealthcare.com   
Principal Investigator: Christopher H. Chay         
Mission Hospital Recruiting
Asheville, North Carolina, United States, 28801
Contact: Site Public Contact    828-213-2539    Karen.Smith3@HCAHealthcare.com   
Principal Investigator: Christopher H. Chay         
AdventHealth Infusion Center Asheville Recruiting
Asheville, North Carolina, United States, 28803
Contact: Site Public Contact    828-650-8037    Heather.M.Duncan@AdventHealth.com   
Principal Investigator: Raymond Thertulien         
Hope Women's Cancer Centers-Asheville Recruiting
Asheville, North Carolina, United States, 28816
Contact: Site Public Contact    828-213-2539    Karen.Smith3@HCAHealthcare.com   
Principal Investigator: Christopher H. Chay         
Waverly Hematology Oncology Recruiting
Cary, North Carolina, United States, 27518
Contact: Site Public Contact    919-233-8585    gboyd@waverlyhemeonc.com   
Principal Investigator: Mark L. Graham         
UNC Lineberger Comprehensive Cancer Center Recruiting
Chapel Hill, North Carolina, United States, 27599
Contact: Site Public Contact    877-668-0683    cancerclinicaltrials@med.unc.edu   
Principal Investigator: Juneko E. Grilley-Olson         
Novant Health Presbyterian Medical Center Recruiting
Charlotte, North Carolina, United States, 28204
Contact: Site Public Contact    704-384-5369    nnechiporchik@novanthealth.org   
Principal Investigator: Nasfat Shehadeh         
Carolina Surgical Clinic of Charlotte PA Suspended
Charlotte, North Carolina, United States, 28207
Oncology Specialists of Charlotte Recruiting
Charlotte, North Carolina, United States, 28207
Contact: Site Public Contact    704-384-8920    nnechiporchik@novanthealth.org   
Principal Investigator: Nasfat Shehadeh         
Southern Oncology Specialists-Charlotte Recruiting
Charlotte, North Carolina, United States, 28262
Contact: Site Public Contact    704-384-8920    nnechiporchik@novanthealth.org   
Principal Investigator: Nasfat Shehadeh         
Southeastern Medical Oncology Center-Clinton Recruiting
Clinton, North Carolina, United States, 28328
Contact: Site Public Contact    919-587-9077    ecooke@cancersmoc.com   
Principal Investigator: Nagesh H. Jayaram         
AdventHealth Infusion Center Haywood Recruiting
Clyde, North Carolina, United States, 28721
Contact: Site Public Contact    828-650-8037    Heather.M.Duncan@AdventHealth.com   
Principal Investigator: Raymond Thertulien         
Durham VA Medical Center Active, not recruiting
Durham, North Carolina, United States, 27705
Duke University Medical Center Recruiting
Durham, North Carolina, United States, 27710
Contact: Site Public Contact    888-275-3853      
Principal Investigator: April K. Salama         
Southeastern Medical Oncology Center-Goldsboro Recruiting
Goldsboro, North Carolina, United States, 27534
Contact: Site Public Contact    919-587-9077    ecooke@cancersmoc.com   
Principal Investigator: Nagesh H. Jayaram         
Wayne Memorial Hospital Active, not recruiting
Goldsboro, North Carolina, United States, 27534
Hendersonville Hematology and Oncology at Pardee Recruiting
Hendersonville, North Carolina, United States, 28791
Contact: James E. Radford    828-696-4716      
Principal Investigator: James E. Radford         
Margaret R Pardee Memorial Hospital Recruiting
Hendersonville, North Carolina, United States, 28791
Contact: Site Public Contact    828-696-4716    karen.morris@unchealth.unc.edu   
Principal Investigator: James E. Radford         
AdventHealth Hendersonville Recruiting
Hendersonville, North Carolina, United States, 28792
Contact: Site Public Contact    828-650-8037    Heather.M.Duncan@AdventHealth.com   
Principal Investigator: Raymond Thertulien         
Lake Norman Hematology Oncology Specialists-Huntersville Recruiting
Huntersville, North Carolina, United States, 28078
Contact: Site Public Contact    704-384-8920    nnechiporchik@novanthealth.org   
Principal Investigator: Nasfat Shehadeh         
Novant Health Presbyterian Medical Center Huntersville Recruiting
Huntersville, North Carolina, United States, 28078
Contact: Site Public Contact    704-384-5369    nnechiporchik@novanthealth.org   
Principal Investigator: Nasfat Shehadeh         
Southern Oncology Specialists-Huntersville Recruiting
Huntersville, North Carolina, United States, 28078
Contact: Site Public Contact    704-384-8920    nnechiporchik@novanthealth.org   
Principal Investigator: Nasfat Shehadeh         
Onslow Memorial Hospital Active, not recruiting
Jacksonville, North Carolina, United States, 28546
Southeastern Medical Oncology Center-Jacksonville Recruiting
Jacksonville, North Carolina, United States, 28546
Contact: Site Public Contact    910-353-0824    ecooke@cancersmoc.com   
Principal Investigator: Nagesh H. Jayaram         
Novant Health Oncology Specialists-Kernersville Recruiting
Kernersville, North Carolina, United States, 27284
Contact: Site Public Contact    336-718-8335    asmarrs@novanthealth.org   
Principal Investigator: Judith O. Hopkins         
Matthews Radiation Oncology Center Recruiting
Matthews, North Carolina, United States, 28105
Contact: Site Public Contact    704-384-8920    nnechiporchik@novanthealth.org   
Principal Investigator: Nasfat Shehadeh         
Novant Health Cancer Specialists-Matthews Recruiting
Matthews, North Carolina, United States, 28105
Contact: Site Public Contact    704-384-8920    nnechiporchik@novanthealth.org   
Principal Investigator: Nasfat Shehadeh         
Lake Norman Hematology Oncology Specialists-Mooresville Recruiting
Mooresville, North Carolina, United States, 28117
Contact: Site Public Contact    704-384-8920    nnechiporchik@novanthealth.org   
Principal Investigator: Nasfat Shehadeh         
Lake Norman Radiation Oncology Center-Mooresville Recruiting
Mooresville, North Carolina, United States, 28117
Contact: Site Public Contact    704-384-8920    nnechiporchik@novanthealth.org   
Principal Investigator: Nasfat Shehadeh         
Novant Health Oncology Specialists-Mount Airy Recruiting
Mount Airy, North Carolina, United States, 27030
Contact: Site Public Contact    336-718-8335    asmarrs@novanthealth.org   
Principal Investigator: Judith O. Hopkins         
FirstHealth of the Carolinas-Moore Regional Hospital Recruiting
Pinehurst, North Carolina, United States, 28374
Contact: Site Public Contact    910-715-3500    jcwilliams@firsthealth.org   
Principal Investigator: Charles S. Kuzma         
Duke Raleigh Hospital Active, not recruiting
Raleigh, North Carolina, United States, 27609
Carolina Oncology Associates PA Recruiting
Salisbury, North Carolina, United States, 28144
Contact: Site Public Contact    704-636-5542    nnechiporchik@novanthealth.org   
Principal Investigator: Nasfat Shehadeh         
Rowan Regional Medical Center Recruiting
Salisbury, North Carolina, United States, 28144
Contact: Site Public Contact    704-210-5000    nnechiporchik@novanthealth.org   
Principal Investigator: Nasfat Shehadeh         
Novant Health Oncology Specialists-Statesville Recruiting
Statesville, North Carolina, United States, 28625
Contact: Site Public Contact    336-718-8335    asmarrs@novanthealth.org   
Principal Investigator: Judith O. Hopkins         
Novant Health Oncology Specialists-Davidson County Recruiting
Thomasville, North Carolina, United States, 27360
Contact: Site Public Contact    336-718-8335    asmarrs@novanthealth.org   
Principal Investigator: Judith O. Hopkins         
Marion L Shepard Cancer Center at Vidant Beaufort Hospital Active, not recruiting
Washington, North Carolina, United States, 27889
Novant Health Oncology Specialists-Wilkesboro Recruiting
Wilkesboro, North Carolina, United States, 28659
Contact: Site Public Contact    336-718-8335    asmarrs@novanthealth.org   
Principal Investigator: Judith O. Hopkins         
Novant Health Forsyth Medical Center Recruiting
Winston-Salem, North Carolina, United States, 27103
Contact: Site Public Contact    336-718-8335    asmarrs@novanthealth.org   
Principal Investigator: Judith O. Hopkins         
Novant Health Oncology Specialists Recruiting
Winston-Salem, North Carolina, United States, 27103
Contact: Site Public Contact    336-718-8335    asmarrs@novanthealth.org   
Principal Investigator: Judith O. Hopkins         
Winston-Salem Health Care Active, not recruiting
Winston-Salem, North Carolina, United States, 27103
Wake Forest University Health Sciences Recruiting
Winston-Salem, North Carolina, United States, 27157
Contact: Site Public Contact    336-713-6771      
Principal Investigator: Stefan C. Grant         
United States, North Dakota
Sanford Bismarck Medical Center Recruiting
Bismarck, North Dakota, United States, 58501
Contact: Site Public Contact    701-323-5760    OncologyClinicalTrialsFargo@sanfordhealth.org   
Principal Investigator: Preston D. Steen         
Essentia Health Cancer Center-South University Clinic Recruiting
Fargo, North Dakota, United States, 58103
Contact: Site Public Contact    218-786-3308    CancerTrials@EssentiaHealth.org   
Principal Investigator: Bret E. Friday         
Sanford South University Medical Center Recruiting
Fargo, North Dakota, United States, 58103
Contact: Site Public Contact    701-234-6161      
Principal Investigator: Preston D. Steen         
Sanford Broadway Medical Center Recruiting
Fargo, North Dakota, United States, 58122
Contact: Site Public Contact    701-323-5760    OncologyClinicalTrialsFargo@sanfordhealth.org   
Principal Investigator: Preston D. Steen         
Sanford Clinic North-Fargo Suspended
Fargo, North Dakota, United States, 58122
Sanford Roger Maris Cancer Center Recruiting
Fargo, North Dakota, United States, 58122
Contact: Site Public Contact    701-234-6161    OncologyClinicalTrialsFargo@sanfordhealth.org   
Principal Investigator: Preston D. Steen         
Essentia Health - Jamestown Clinic Recruiting
Jamestown, North Dakota, United States, 58401
Contact: Site Public Contact    218-786-3308    CancerTrials@EssentiaHealth.org   
Principal Investigator: Bret E. Friday         
Trinity Cancer Care Center Recruiting
Minot, North Dakota, United States, 58701
Contact: Site Public Contact    800-862-0005      
Principal Investigator: Patanit Watanaboonyakhet         
United States, Ohio
UHHS-Chagrin Highlands Medical Center Recruiting
Beachwood, Ohio, United States, 44122
Contact: Site Public Contact    800-641-2422    CTUReferral@UHhospitals.org   
Principal Investigator: Christopher J. Hoimes         
Indu and Raj Soin Medical Center Recruiting
Beavercreek, Ohio, United States, 45431
Contact: Site Public Contact    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Strecker Cancer Center-Belpre Recruiting
Belpre, Ohio, United States, 45714
Contact: Site Public Contact    800-523-3977    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Saint Elizabeth Boardman Hospital Recruiting
Boardman, Ohio, United States, 44512
Contact: Site Public Contact    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Mercy Medical Center Recruiting
Canton, Ohio, United States, 44708
Contact: Site Public Contact    888-293-4673      
Principal Investigator: Mitchell Haut         
Aultman Health Foundation Active, not recruiting
Canton, Ohio, United States, 44710
Dayton Physicians LLC-Miami Valley South Recruiting
Centerville, Ohio, United States, 45459
Contact: Site Public Contact    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Miami Valley Hospital South Recruiting
Centerville, Ohio, United States, 45459
Contact: Site Public Contact    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Geauga Hospital Recruiting
Chardon, Ohio, United States, 44024
Contact: Site Public Contact    800-641-2422    CTUReferral@UHhospitals.org   
Principal Investigator: Christopher J. Hoimes         
Adena Regional Medical Center Recruiting
Chillicothe, Ohio, United States, 45601
Contact: Site Public Contact    877-779-7585    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Oncology Hematology Care Inc-Eden Park Suspended
Cincinnati, Ohio, United States, 45202
Oncology Hematology Care Inc-Mercy West Suspended
Cincinnati, Ohio, United States, 45211
Good Samaritan Hospital - Cincinnati Recruiting
Cincinnati, Ohio, United States, 45220
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Cincinnati Children's Hospital Medical Center Recruiting
Cincinnati, Ohio, United States, 45229
Contact: Site Public Contact    513-636-2799    cancer@cchmc.org   
Principal Investigator: John P. Perentesis         
Oncology Hematology Care Inc - Anderson Suspended
Cincinnati, Ohio, United States, 45230
Oncology Hematology Care Inc-Kenwood Recruiting
Cincinnati, Ohio, United States, 45236
Contact: Site Public Contact    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Bethesda North Hospital Recruiting
Cincinnati, Ohio, United States, 45242
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Oncology Hematology Care Inc-Blue Ash Suspended
Cincinnati, Ohio, United States, 45242
TriHealth Cancer Institute-Westside Recruiting
Cincinnati, Ohio, United States, 45247
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
TriHealth Cancer Institute-Anderson Recruiting
Cincinnati, Ohio, United States, 45255
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Case Western Reserve University Recruiting
Cleveland, Ohio, United States, 44106
Contact: Site Public Contact    800-641-2422    CTUReferral@UHhospitals.org   
Principal Investigator: Christopher J. Hoimes         
MetroHealth Medical Center Recruiting
Cleveland, Ohio, United States, 44109
Contact: Site Public Contact    216-778-8526    dstrater@metrohealth.org   
Principal Investigator: Bruce J. Averbook         
Cleveland Clinic Foundation Recruiting
Cleveland, Ohio, United States, 44195
Contact: Site Public Contact    866-223-8100    CancerAnswer@ccf.org   
Principal Investigator: Dale R. Shepard         
Ohio State University Comprehensive Cancer Center Recruiting
Columbus, Ohio, United States, 43210
Contact: Site Public Contact    800-293-5066    Jamesline@osumc.edu   
Principal Investigator: John L. Hays         
Mount Carmel East Hospital Recruiting
Columbus, Ohio, United States, 43213
Contact: Site Public Contact    614-488-2118    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Columbus Oncology and Hematology Associates Inc Recruiting
Columbus, Ohio, United States, 43214
Contact: Site Public Contact    614-488-2118    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Riverside Methodist Hospital Recruiting
Columbus, Ohio, United States, 43214
Contact: Site Public Contact    614-566-4475    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Grant Medical Center Recruiting
Columbus, Ohio, United States, 43215
Contact: Site Public Contact    614-566-4475    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
The Mark H Zangmeister Center Recruiting
Columbus, Ohio, United States, 43219
Contact: Site Public Contact    614-488-2118    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Mount Carmel Health Center West Recruiting
Columbus, Ohio, United States, 43222
Contact: Site Public Contact    614-234-5433    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Doctors Hospital Recruiting
Columbus, Ohio, United States, 43228
Contact: Site Public Contact    614-566-3275    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Good Samaritan Hospital - Dayton Suspended
Dayton, Ohio, United States, 45406
Miami Valley Hospital Recruiting
Dayton, Ohio, United States, 45409
Contact: Site Public Contact    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Dayton Physician LLC-Miami Valley Hospital North Recruiting
Dayton, Ohio, United States, 45415
Contact: Site Public Contact    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Miami Valley Hospital North Suspended
Dayton, Ohio, United States, 45415
Delaware Health Center-Grady Cancer Center Recruiting
Delaware, Ohio, United States, 43015
Contact: Site Public Contact    740-615-0227    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Delaware Radiation Oncology Suspended
Delaware, Ohio, United States, 43015
Grady Memorial Hospital Recruiting
Delaware, Ohio, United States, 43015
Contact: Site Public Contact    740-615-2403    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Dublin Methodist Hospital Recruiting
Dublin, Ohio, United States, 43016
Contact: Site Public Contact    800-752-9119    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Hematology Oncology Center Incorporated Suspended
Elyria, Ohio, United States, 44035
Mercy Cancer Center-Elyria Recruiting
Elyria, Ohio, United States, 44035
Contact: Site Public Contact    800-641-2422    CTUReferral@UHhospitals.org   
Principal Investigator: Christopher J. Hoimes         
Oncology Hematology Care Inc-Healthplex Suspended
Fairfield, Ohio, United States, 45014
Armes Family Cancer Center Recruiting
Findlay, Ohio, United States, 45840
Contact: Site Public Contact    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Blanchard Valley Hospital Recruiting
Findlay, Ohio, United States, 45840
Contact: Site Public Contact    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Orion Cancer Care Recruiting
Findlay, Ohio, United States, 45840
Contact: Site Public Contact    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Atrium Medical Center-Middletown Regional Hospital Recruiting
Franklin, Ohio, United States, 45005-1066
Contact: Site Public Contact    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Dayton Physicians LLC-Atrium Recruiting
Franklin, Ohio, United States, 45005
Contact: Site Public Contact    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Dayton Physicians LLC-Wayne Recruiting
Greenville, Ohio, United States, 45331
Contact: Site Public Contact    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Wayne Hospital Recruiting
Greenville, Ohio, United States, 45331
Contact: Site Public Contact    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Greater Dayton Cancer Center Recruiting
Kettering, Ohio, United States, 45409
Contact: Site Public Contact    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
First Dayton Cancer Care Recruiting
Kettering, Ohio, United States, 45420
Contact: Site Public Contact    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Kettering Medical Center Recruiting
Kettering, Ohio, United States, 45429
Contact: Site Public Contact    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Fairfield Medical Center Recruiting
Lancaster, Ohio, United States, 43130
Contact: Site Public Contact    740-687-8863    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Marietta Memorial Hospital Recruiting
Marietta, Ohio, United States, 45750
Contact: Site Public Contact    800-523-3977    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
OhioHealth Marion General Hospital Recruiting
Marion, Ohio, United States, 43302
Contact: Site Public Contact    614-488-2118    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Toledo Clinic Cancer Centers-Maumee Active, not recruiting
Maumee, Ohio, United States, 43537
Toledo Radiation Oncology at Northwest Ohio Onocolgy Center Active, not recruiting
Maumee, Ohio, United States, 43537
UH Seidman Cancer Center at Landerbrook Health Center Recruiting
Mayfield Heights, Ohio, United States, 44124
Contact: Site Public Contact    800-641-2422    CTUReferral@UHhospitals.org   
Principal Investigator: Christopher J. Hoimes         
UH Seidman Cancer Center at Lake Health Mentor Campus Recruiting
Mentor, Ohio, United States, 44060
Contact: Site Public Contact    800-641-2422    CTUReferral@UHhospitals.org   
Principal Investigator: Christopher J. Hoimes         
UH Seidman Cancer Center at Southwest General Hospital Recruiting
Middleburg Heights, Ohio, United States, 44130
Contact: Site Public Contact    800-641-2422    CTUReferral@UHhospitals.org   
Principal Investigator: Christopher J. Hoimes         
Dayton Physicians LLC-Signal Point Active, not recruiting
Middletown, Ohio, United States, 45042
Knox Community Hospital Recruiting
Mount Vernon, Ohio, United States, 43050
Contact: Site Public Contact    740-393-9000    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Licking Memorial Hospital Recruiting
Newark, Ohio, United States, 43055
Contact: Site Public Contact    740-348-4000    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Newark Radiation Oncology Recruiting
Newark, Ohio, United States, 43055
Contact: Site Public Contact    614-488-2118    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
Saint Charles Hospital Active, not recruiting
Oregon, Ohio, United States, 43616
University Hospitals Parma Medical Center Recruiting
Parma, Ohio, United States, 44129
Contact: Site Public Contact    800-641-2422    CTUReferral@UHhospitals.org   
Principal Investigator: Christopher J. Hoimes         
Mercy Health Perrysburg Cancer Center Recruiting
Perrysburg, Ohio, United States, 43551
Contact: Site Public Contact    419-479-5605    pshoup@toledoclinic.com   
Principal Investigator: Rex B. Mowat         
Southern Ohio Medical Center Recruiting
Portsmouth, Ohio, United States, 45662
Contact: Site Public Contact    614-488-2118    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
UH Seidman Cancer Center at Firelands Regional Medical Center Recruiting
Sandusky, Ohio, United States, 44870
Contact: Site Public Contact    800-641-2422    CTUReferral@UHhospitals.org   
Principal Investigator: Christopher J. Hoimes         
Dayton Physicians LLC-Wilson Active, not recruiting
Sidney, Ohio, United States, 45365
Springfield Regional Cancer Center Recruiting
Springfield, Ohio, United States, 45504
Contact: Site Public Contact    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Springfield Regional Medical Center Recruiting
Springfield, Ohio, United States, 45505
Contact: Site Public Contact    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
ProMedica Flower Hospital Recruiting
Sylvania, Ohio, United States, 43560
Contact: Site Public Contact    419-824-1842      
Principal Investigator: Abhijit B. Saste         
The Toledo Hospital/Toledo Children's Hospital Recruiting
Toledo, Ohio, United States, 43606
Contact: Site Public Contact    419-824-1842      
Principal Investigator: Abhijit B. Saste         
University of Toledo Active, not recruiting
Toledo, Ohio, United States, 43614
Mercy Saint Anne Hospital Recruiting
Toledo, Ohio, United States, 43623
Contact: Site Public Contact    419-407-1160      
Principal Investigator: Rex B. Mowat         
Toledo Clinic Cancer Centers-Toledo Recruiting
Toledo, Ohio, United States, 43623
Contact: Site Public Contact    800-444-3561      
Principal Investigator: Rex B. Mowat         
Dayton Physicians LLC-Upper Valley Recruiting
Troy, Ohio, United States, 45373
Contact: Site Public Contact    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Upper Valley Medical Center Recruiting
Troy, Ohio, United States, 45373
Contact: Site Public Contact    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
University Hospitals Sharon Health Center Recruiting
Wadsworth, Ohio, United States, 44281
Contact: Site Public Contact    800-641-2422    CTUReferral@UHhospitals.org   
Principal Investigator: Christopher J. Hoimes         
Saint Joseph Warren Hospital Recruiting
Warren, Ohio, United States, 44484
Contact: Site Public Contact    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Saint Ann's Hospital Recruiting
Westerville, Ohio, United States, 43081
Contact: Site Public Contact    614-234-5433    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
UH Seidman Cancer Center at Saint John Medical Center Recruiting
Westlake, Ohio, United States, 44145
Contact: Site Public Contact    800-641-2422    CTUReferral@UHhospitals.org   
Principal Investigator: Christopher J. Hoimes         
UHHS-Westlake Medical Center Recruiting
Westlake, Ohio, United States, 44145
Contact: Site Public Contact    800-641-2422    CTUReferral@UHhospitals.org   
Principal Investigator: Christopher J. Hoimes         
Saint Elizabeth Youngstown Hospital Recruiting
Youngstown, Ohio, United States, 44501
Contact: Site Public Contact    937-775-1350    som_dcop@wright.edu   
Principal Investigator: Howard M. Gross         
Genesis Healthcare System Cancer Care Center Recruiting
Zanesville, Ohio, United States, 43701
Contact: Site Public Contact    740-454-5232    sheree@columbusccop.org   
Principal Investigator: Timothy D. Moore         
United States, Oklahoma
Cancer Centers of Southwest Oklahoma Research Recruiting
Lawton, Oklahoma, United States, 73505
Contact: Site Public Contact    877-231-4440      
Principal Investigator: Kathleen N. Moore         
University of Oklahoma Health Sciences Center Recruiting
Oklahoma City, Oklahoma, United States, 73104
Contact: Site Public Contact    405-271-8777    ou-clinical-trials@ouhsc.edu   
Principal Investigator: Kathleen N. Moore         
Integris Southwest Medical Center Recruiting
Oklahoma City, Oklahoma, United States, 73109
Contact: Site Public Contact    888-823-5923    ctsucontact@westat.com   
Principal Investigator: Kathleen N. Moore         
Mercy Hospital Oklahoma City Recruiting
Oklahoma City, Oklahoma, United States, 73120
Contact: Site Public Contact    405-752-3402      
Principal Investigator: Jay W. Carlson         
Integris Cancer Institute of Oklahoma Recruiting
Oklahoma City, Oklahoma, United States, 73142
Contact: Site Public Contact    405-773-6613      
Principal Investigator: Kathleen N. Moore         
Cancer Treatment Centers of America Recruiting
Tulsa, Oklahoma, United States, 74133
Contact: Site Public Contact    888-823-5923    ctsucontact@westat.com   
Principal Investigator: Theodore W. Pollock         
Oklahoma Cancer Specialists and Research Institute-Tulsa Recruiting
Tulsa, Oklahoma, United States, 74146
Contact: Site Public Contact    918-505-3200      
Principal Investigator: Kathleen N. Moore         
United States, Oregon
Saint Alphonsus Medical Center-Baker City Recruiting
Baker City, Oregon, United States, 97814
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: John M. Schallenkamp         
Saint Charles Health System Recruiting
Bend, Oregon, United States, 97701
Contact: Site Public Contact    541-706-2909    nosall@stcharleshealthcare.org   
Principal Investigator: Alison K. Conlin         
Clackamas Radiation Oncology Center Recruiting
Clackamas, Oregon, United States, 97015
Contact: Site Public Contact    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Providence Oncology and Hematology Care Southeast Recruiting
Clackamas, Oregon, United States, 97015
Contact: Site Public Contact    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Bay Area Hospital Recruiting
Coos Bay, Oregon, United States, 97420
Contact: Site Public Contact    541-269-8392    cherie.cox@bayareahospital.org   
Principal Investigator: Alison K. Conlin         
Good Samaritan Hospital Recruiting
Corvallis, Oregon, United States, 97330
Contact: Site Public Contact    541-768-4352    stmock@samhealth.org   
Principal Investigator: Wei Bai         
Legacy Mount Hood Medical Center Recruiting
Gresham, Oregon, United States, 97030
Contact: Site Public Contact    503-413-2150      
Principal Investigator: Jacqueline Vuky         
Providence Newberg Medical Center Recruiting
Newberg, Oregon, United States, 97132
Contact: Site Public Contact    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Saint Alphonsus Medical Center-Ontario Recruiting
Ontario, Oregon, United States, 97914
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: John M. Schallenkamp         
Providence Willamette Falls Medical Center Suspended
Oregon City, Oregon, United States, 97045
Legacy Good Samaritan Hospital and Medical Center Recruiting
Portland, Oregon, United States, 97210
Contact: Site Public Contact    800-220-4937    cancer@lhs.org   
Principal Investigator: Jacqueline Vuky         
Providence Portland Medical Center Recruiting
Portland, Oregon, United States, 97213
Contact: Site Public Contact    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Providence Saint Vincent Medical Center Recruiting
Portland, Oregon, United States, 97225
Contact: Site Public Contact    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Alison K. Conlin         
Kaiser Permanente Northwest Recruiting
Portland, Oregon, United States, 97227
Contact: Site Public Contact    503-335-2400    information@kpchr.org   
Principal Investigator: Abdul Hai Mansoor         
Oregon Health and Science University Recruiting
Portland, Oregon, United States, 97239
Contact: Site Public Contact    503-494-1080    trials@ohsu.edu   
Principal Investigator: Christopher W. Ryan         
Saint Charles Health System-Redmond Recruiting
Redmond, Oregon, United States, 97756
Contact: Site Public Contact    541-706-2909      
Principal Investigator: Alison K. Conlin         
Legacy Meridian Park Hospital Recruiting
Tualatin, Oregon, United States, 97062
Contact: Site Public Contact    503-413-1742      
Principal Investigator: Jacqueline Vuky         
United States, Pennsylvania
Abington Memorial Hospital Suspended
Abington, Pennsylvania, United States, 19001
Lehigh Valley Hospital-Cedar Crest Recruiting
Allentown, Pennsylvania, United States, 18103
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Lehigh Valley Hospital - Muhlenberg Recruiting
Bethlehem, Pennsylvania, United States, 18017
Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org   
Principal Investigator: Philip J. Stella         
Bryn Mawr Hospital Recruiting
Bryn Mawr, Pennsylvania, United States, 19010
Contact: Site Public Contact    484-476-2649    turzoe@mlhs.org   
Principal Investigator: Albert S. DeNittis         
Christiana Care Health System-Concord Health Center Recruiting
Chadds Ford, Pennsylvania, United States, 19317
Contact: Site Public Contact    302-623-4450    KDempsey@christianacare.org   
Principal Investigator: Gregory A. Masters         
Chambersburg Hospital Recruiting
Chambersburg, Pennsylvania, United States, 17201
Contact: Site Public Contact    888-823-5923    ctsucontact@westat.com   
Principal Investigator: Amir Tabatabai         
Main Line Health Center-Collegeville Recruiting
Collegeville, Pennsylvania, United States, 19426
Contact: Site Public Contact    484-476-2649    turzoe@mlhs.org   
Principal Investigator: Albert S. DeNittis         
Geisinger Medical Center Recruiting
Danville, Pennsylvania, United States, 17822
Contact: Site Public Contact    570-271-5251    HemonCCTrials@geisinger.edu   
Principal Investigator: Joseph J. Vadakara         
Doylestown Hospital Active, not recruiting
Doylestown, Pennsylvania, United States, 18901
Pocono Medical Center Recruiting
East Stroudsburg, Pennsylvania, United States, 18301
Contact: Site Public Contact    570-422-1700    ann.foster@lvhn.org   
Principal Investigator: Philip J. Stella         
Easton Hospital Active, not recruiting
Easton, Pennsylvania, United States, 18042
Ephrata Cancer Center Recruiting
Ephrata, Pennsylvania, United States, 17522
Contact: Site Public Contact    717-721-4840      
Principal Investigator: Amir Tabatabai         
Ephrata Community Hospital Recruiting
Ephrata, Pennsylvania, United States, 17522
Contact: Site Public Contact    888-823-5923    ctsucontact@westat.com   
Principal Investigator: Amir Tabatabai         
The Regional Cancer Center Suspended
Erie, Pennsylvania, United States, 16505
Main Line Health Center-Exton Recruiting
Exton, Pennsylvania, United States, 19341
Contact: Site Public Contact    484-476-2649    turzoe@mlhs.org   
Principal Investigator: Albert S. DeNittis         
Adams Cancer Center Recruiting
Gettysburg, Pennsylvania, United States, 17325
Contact: Site Public Contact    877-441-7957      
Principal Investigator: Amir Tabatabai         
Cherry Tree Cancer Center Recruiting
Hanover, Pennsylvania, United States, 17331
Contact: Site Public Contact    877-441-7957      
Principal Investigator: Amir Tabatabai         
UPMC Pinnacle Cancer Center/Community Osteopathic Campus Recruiting
Harrisburg, Pennsylvania, United States, 17109
Contact: Site Public Contact    717-724-6765    klitchfield@PINNACLEHEALTH.org   
Principal Investigator: Adam M. Brufsky         
Geisinger Medical Center-Cancer Center Hazleton Recruiting
Hazleton, Pennsylvania, United States, 18201
Contact: Site Public Contact    570-459-2901    HemonCCTrials@geisinger.edu   
Principal Investigator: Joseph J. Vadakara         
Lehigh Valley Hospital-Hazleton Recruiting
Hazleton, Pennsylvania, United States, 18201
Contact: Site Public Contact    570-501-1242      
Principal Investigator: Philip J. Stella         
Penn State Milton S Hershey Medical Center Active, not recruiting
Hershey, Pennsylvania, United States, 17033-0850
Armstrong Center for Medicine and Health Recruiting
Kittanning, Pennsylvania, United States, 16201
Contact: Site Public Contact    724-543-8682      
Principal Investigator: Gene G. Finley         
Lancaster General Hospital Recruiting
Lancaster, Pennsylvania, United States, 17604
Contact: Site Public Contact    717-544-5511      
Principal Investigator: Shyam S. Balepur         
Sechler Family Cancer Center Recruiting
Lebanon, Pennsylvania, United States, 17042
Contact: Site Public Contact    717-741-8303    doxenberg@wellspan.org   
Principal Investigator: Amir Tabatabai         
Geisinger Medical Oncology-Lewisburg Recruiting
Lewisburg, Pennsylvania, United States, 17837
Contact: Site Public Contact    570-374-8555    HemonCCTrials@geisinger.edu   
Principal Investigator: Joseph J. Vadakara         
Lewistown Hospital Recruiting
Lewistown, Pennsylvania, United States, 17044
Contact: Site Public Contact    717-242-7703    HemonCCTrials@geisinger.edu   
Principal Investigator: Joseph J. Vadakara         
Holy Redeemer Hospital and Medical Center Recruiting
Meadowbrook, Pennsylvania, United States, 19046
Contact: Site Public Contact    215-938-3551      
Principal Investigator: Michael J. Seidman         
Riddle Memorial Hospital Recruiting
Media, Pennsylvania, United States, 19063
Contact: Site Public Contact    484-476-2649    turzoe@mlhs.org   
Principal Investigator: Albert S. DeNittis         
Forbes Hospital Recruiting
Monroeville, Pennsylvania, United States, 15146
Contact: Site Public Contact    412-858-7746      
Principal Investigator: Gene G. Finley         
Allegheny Valley Hospital Recruiting
Natrona Heights, Pennsylvania, United States, 15065
Contact: Site Public Contact    724-226-7380      
Principal Investigator: Gene G. Finley         
Suburban Community Hospital and Cancer Center Active, not recruiting
Norristown, Pennsylvania, United States, 19401
Paoli Memorial Hospital Recruiting
Paoli, Pennsylvania, United States, 19301
Contact: Site Public Contact    484-476-2649    turzoe@mlhs.org   
Principal Investigator: Albert S. DeNittis         
Drexel University School of Medicine Active, not recruiting
Philadelphia, Pennsylvania, United States, 19102
Thomas Jefferson University Hospital Recruiting
Philadelphia, Pennsylvania, United States, 19107
Contact: Site Public Contact    215-955-6084      
Principal Investigator: Russell J. Schilder         
Fox Chase Cancer Center Recruiting
Philadelphia, Pennsylvania, United States, 19111
Contact: Site Public Contact    215-728-4790      
Principal Investigator: Lori J. Goldstein         
Aria Health-Torresdale Campus Recruiting
Philadelphia, Pennsylvania, United States, 19114
Contact: Site Public Contact    215-612-5296      
Principal Investigator: Russell J. Schilder         
Eastern Regional Medical Center Recruiting
Philadelphia, Pennsylvania, United States, 19124
Contact: Site Public Contact    888-823-5923    ctsucontact@westat.com   
Principal Investigator: Arturo Loaiza-Bonilla         
Nazareth Hospital Recruiting
Philadelphia, Pennsylvania, United States, 19152
Contact: Site Public Contact    888-823-5923    ctsucontact@westat.com   
Principal Investigator: Russell J. Schilder         
Phoenixville Hospital Active, not recruiting
Phoenixville, Pennsylvania, United States, 19460
Allegheny General Hospital Recruiting
Pittsburgh, Pennsylvania, United States, 15212
Contact: Site Public Contact    877-284-2000      
Principal Investigator: Gene G. Finley         
West Penn Hospital Recruiting
Pittsburgh, Pennsylvania, United States, 15224
Contact: Site Public Contact    412-578-5000      
Principal Investigator: Gene G. Finley         
University of Pittsburgh Cancer Institute (UPCI) Recruiting
Pittsburgh, Pennsylvania, United States, 15232
Contact: Site Public Contact    412-647-8073      
Principal Investigator: Adam M. Brufsky         
Geisinger Cancer Services-Pottsville Recruiting
Pottsville, Pennsylvania, United States, 17901
Contact: Site Public Contact    800-275-6401    HemonCCTrials@geisinger.edu   
Principal Investigator: Joseph J. Vadakara         
Penn State Health Saint Joseph Medical Center Active, not recruiting
Reading, Pennsylvania, United States, 19605
Guthrie Medical Group PC-Robert Packer Hospital Recruiting
Sayre, Pennsylvania, United States, 18840
Contact: Site Public Contact    800-836-0388      
Principal Investigator: Philip A. Lowry         
Hematology and Oncology Associates of North East Pennsylvania Recruiting
Scranton, Pennsylvania, United States, 18508
Contact: Site Public Contact    570-342-3675 ext 218      
Principal Investigator: Russell J. Schilder         
Community Medical Center Recruiting
Scranton, Pennsylvania, United States, 18510
Contact: Site Public Contact    570-703-4768    HemonCCTrials@geisinger.edu   
Principal Investigator: Joseph J. Vadakara         
Geisinger Medical Oncology-Selinsgrove Recruiting
Selinsgrove, Pennsylvania, United States, 17870
Contact: Site Public Contact    570-374-8555    HemonCCTrials@geisinger.edu   
Principal Investigator: Joseph J. Vadakara         
Geisinger Medical Group Suspended
State College, Pennsylvania, United States, 16801
Mount Nittany Medical Center Active, not recruiting
State College, Pennsylvania, United States, 16803
Chester County Hospital Recruiting
West Chester, Pennsylvania, United States, 19380
Contact: Site Public Contact    610-431-5297      
Principal Investigator: William E. Luginbuhl         
Reading Hospital Recruiting
West Reading, Pennsylvania, United States, 19611
Contact: Site Public Contact    610-988-9323      
Principal Investigator: Terrence P. Cescon         
Geisinger Wyoming Valley/Henry Cancer Center Recruiting
Wilkes-Barre, Pennsylvania, United States, 18711
Contact: Site Public Contact    570-271-5251    HemonCCTrials@geisinger.edu   
Principal Investigator: Joseph J. Vadakara         
UPMC Susquehanna Recruiting
Williamsport, Pennsylvania, United States, 17701
Contact: Site Public Contact    800-598-4282      
Principal Investigator: Adam M. Brufsky         
Abington Memorial Hospital-Asplundh Cancer Pavilion Recruiting
Willow Grove, Pennsylvania, United States, 19090
Contact: Site Public Contact    215-481-2402      
Principal Investigator: Mark S. Shahin         
Lankenau Medical Center Recruiting
Wynnewood, Pennsylvania, United States, 19096
Contact: Site Public Contact    484-476-2649    turzoe@mlhs.org   
Principal Investigator: Albert S. DeNittis         
WellSpan Health-York Cancer Center Recruiting
York, Pennsylvania, United States, 17403
Contact: Site Public Contact    877-441-7957      
Principal Investigator: Amir Tabatabai         
WellSpan Health-York Hospital Recruiting
York, Pennsylvania, United States, 17403
Contact: Site Public Contact    877-441-7957      
Principal Investigator: Amir Tabatabai         
United States, Rhode Island
Newport Hospital Suspended
Newport, Rhode Island, United States, 02840
Rhode Island Hospital Recruiting
Providence, Rhode Island, United States, 02903
Contact: Site Public Contact    401-444-1488      
Principal Investigator: John L. Reagan         
Women and Infants Hospital Active, not recruiting
Providence, Rhode Island, United States, 02905
Miriam Hospital Suspended
Providence, Rhode Island, United States, 02906
United States, South Carolina
AnMed Health Cancer Center Recruiting
Anderson, South Carolina, United States, 29621
Contact: Site Public Contact    864-512-4651    rhonda.ballew@anmedhealth.org   
Principal Investigator: David Griffin         
Beaufort Memorial Hospital Active, not recruiting
Beaufort, South Carolina, United States, 29902
Roper Hospital Active, not recruiting
Charleston, South Carolina, United States, 29401
Charleston Oncology - Roper Active, not recruiting
Charleston, South Carolina, United States, 29403
Lowcountry Hematology Oncology PA-North Charleston Active, not recruiting
Charleston, South Carolina, United States, 29406
Bon Secours Saint Francis Hospital Active, not recruiting
Charleston, South Carolina, United States, 29414
Charleston Oncology - Saint Francis Active, not recruiting
Charleston, South Carolina, United States, 29414
Lowcountry Hematology Oncology PA-West Ashley Active, not recruiting
Charleston, South Carolina, United States, 29414
Medical University of South Carolina Recruiting
Charleston, South Carolina, United States, 29425
Contact: Site Public Contact    843-792-9321    hcc-clinical-trials@musc.edu   
Principal Investigator: Antonio Giordano         
Prisma Health Cancer Institute - Easley Recruiting
Easley, South Carolina, United States, 29640
Contact: Site Public Contact    864-522-2066    kim.williams3@prismahealth.org   
Principal Investigator: Jeffrey K. Giguere         
McLeod Regional Medical Center Recruiting
Florence, South Carolina, United States, 29506
Contact: Site Public Contact    843-777-0770    dorie.sturgill@mcleodhealth.org   
Principal Investigator: Rajesh Bajaj         
Gibbs Cancer Center-Gaffney Recruiting
Gaffney, South Carolina, United States, 29341
Contact: Site Public Contact    864-560-6104    kmertz-rivera@gibbscc.org   
Principal Investigator: James D. Bearden         
Tidelands Georgetown Memorial Hospital Active, not recruiting
Georgetown, South Carolina, United States, 29440
Greenville Health System Cancer Institute-Andrews Active, not recruiting
Greenville, South Carolina, United States, 29601
Saint Francis Hospital Recruiting
Greenville, South Carolina, United States, 29601
Contact: Site Public Contact    864-603-6213    meissa_beckman@bshsi.org   
Principal Investigator: Robert D. Siegel         
Prisma Health Cancer Institute - Butternut Recruiting
Greenville, South Carolina, United States, 29605
Contact: Site Public Contact    864-522-2066    kim.williams3@prismahealth.org   
Principal Investigator: Jeffrey K. Giguere         
Prisma Health Cancer Institute - Faris Recruiting
Greenville, South Carolina, United States, 29605
Contact: Site Public Contact    864-522-2066    kim.williams3@prismahealth.org   
Principal Investigator: Jeffrey K. Giguere         
Prisma Health Greenville Memorial Hospital Recruiting
Greenville, South Carolina, United States, 29605
Contact: Site Public Contact    864-522-2066    kim.williams3@prismahealth.org   
Principal Investigator: Jeffrey K. Giguere         
Saint Francis Cancer Center Recruiting
Greenville, South Carolina, United States, 29607
Contact: Site Public Contact    864-603-6213    meissa_beckman@bshsi.org   
Principal Investigator: Robert D. Siegel         
Prisma Health Cancer Institute - Eastside Recruiting
Greenville, South Carolina, United States, 29615
Contact: Site Public Contact    864-522-2066    kim.williams3@prismahealth.org   
Principal Investigator: Jeffrey K. Giguere         
Self Regional Healthcare Active, not recruiting
Greenwood, South Carolina, United States, 29646
Prisma Health Cancer Institute - Greer Recruiting
Greer, South Carolina, United States, 29650
Contact: Site Public Contact    864-522-2066    kim.williams3@prismahealth.org   
Principal Investigator: Jeffrey K. Giguere         
Gibbs Cancer Center-Pelham Recruiting
Greer, South Carolina, United States, 29651
Contact: Site Public Contact    864-560-6104    kmertz-rivera@gibbscc.org   
Principal Investigator: James D. Bearden         
South Carolina Cancer Specialists PC Recruiting
Hilton Head Island, South Carolina, United States, 29926-3827
Contact: Site Public Contact    912-819-5704    underberga@sjchs.org   
Principal Investigator: Howard A. Zaren         
The Radiation Oncology Center-Hilton Head/Bluffton Recruiting
Hilton Head Island, South Carolina, United States, 29926
Contact: Site Public Contact    912-819-5704    underberga@sjchs.org   
Principal Investigator: Howard A. Zaren         
Lowcountry Hematology Oncology PA-Mount Pleasant Active, not recruiting
Mount Pleasant, South Carolina, United States, 29464
Prisma Health Cancer Institute - Seneca Recruiting
Seneca, South Carolina, United States, 29672
Contact: Site Public Contact    864-522-2066    kim.williams3@prismahealth.org   
Principal Investigator: Jeffrey K. Giguere         
Spartanburg Medical Center Recruiting
Spartanburg, South Carolina, United States, 29303
Contact: Site Public Contact    864-560-6104    kmertz-rivera@gibbscc.org   
Principal Investigator: James D. Bearden         
Prisma Health Cancer Institute - Spartanburg Recruiting
Spartanburg, South Carolina, United States, 29307
Contact: Site Public Contact    864-522-2066    kim.williams3@prismahealth.org   
Principal Investigator: Jeffrey K. Giguere         
MGC Hematology Oncology-Union Recruiting
Union, South Carolina, United States, 29379
Contact: Site Public Contact    864-560-6104    kmertz-rivera@gibbscc.org   
Principal Investigator: James D. Bearden         
United States, South Dakota
Avera Cancer Institute-Aberdeen Active, not recruiting
Aberdeen, South Dakota, United States, 57401
Rapid City Regional Hospital Active, not recruiting
Rapid City, South Dakota, United States, 57701
Sanford Cancer Center Oncology Clinic Recruiting
Sioux Falls, South Dakota, United States, 57104
Contact: Site Public Contact    605-312-3320    OncologyClinicTrialsSF@sanfordhealth.org   
Principal Investigator: Preston D. Steen         
Avera Cancer Institute Active, not recruiting
Sioux Falls, South Dakota, United States, 57105
Sanford USD Medical Center - Sioux Falls Recruiting
Sioux Falls, South Dakota, United States, 57117-5134
Contact: Site Public Contact    605-312-3320    OncologyClinicalTrialsSF@SanfordHealth.org   
Principal Investigator: Preston D. Steen         
United States, Tennessee
Memorial Hospital Suspended
Chattanooga, Tennessee, United States, 37404
Integrity Oncology PLLC-Collierville Suspended
Collierville, Tennessee, United States, 38017
Cookeville Regional Medical Center Recruiting
Cookeville, Tennessee, United States, 38501
Contact: Site Public Contact    931-783-2714      
Principal Investigator: Venumadhav R. Kotla         
Vanderbilt-Ingram Cancer Center Cool Springs Recruiting
Franklin, Tennessee, United States, 37067
Contact: Site Public Contact    800-811-8480      
Principal Investigator: Douglas B. Johnson         
Pulmonary Medicine Center of Chattanooga-Hixson Suspended
Hixson, Tennessee, United States, 37343
Tennessee Cancer Specialists-Dowell Springs Recruiting
Knoxville, Tennessee, United States, 37909
Contact: Site Public Contact    865-244-3209      
Principal Investigator: Tracy W. Dobbs         
Thompson Cancer Survival Center Recruiting
Knoxville, Tennessee, United States, 37916
Contact: Site Public Contact    865-331-1812      
Principal Investigator: Brook A. Saunders         
Thompson Cancer Survival Center - West Recruiting
Knoxville, Tennessee, United States, 37932
Contact: Site Public Contact    865-331-1812      
Principal Investigator: Brook A. Saunders         
Thompson Oncology Group-Maryville Suspended
Maryville, Tennessee, United States, 37804
Baptist Memorial Hospital and Cancer Center-Memphis Recruiting
Memphis, Tennessee, United States, 38120
Contact: Site Public Contact    901-226-1366    BCCclintrials@bmhcc.org   
Principal Investigator: Donald S. Gravenor         
Family Cancer Center-Memphis Suspended
Memphis, Tennessee, United States, 38120
Vanderbilt Breast Center at One Hundred Oaks Recruiting
Nashville, Tennessee, United States, 37204
Contact: Site Public Contact    800-811-8480      
Principal Investigator: Douglas B. Johnson         
Meharry Medical College Recruiting
Nashville, Tennessee, United States, 37208
Contact: Site Public Contact       Nancy.McCullough@NashvilleHA.org   
Principal Investigator: Philip E. Lammers         
Vanderbilt University/Ingram Cancer Center Recruiting
Nashville, Tennessee, United States, 37232
Contact: Site Public Contact    800-811-8480      
Principal Investigator: Douglas B. Johnson         
Thompson Oncology Group-Oak Ridge Recruiting
Oak Ridge, Tennessee, United States, 37830
Contact: Site Public Contact    865-331-1812      
Principal Investigator: Brook A. Saunders         
Memorial GYN Plus Suspended
Ooltewah, Tennessee, United States, 37363
United States, Texas
Dell Seton Medical Center at The University of Texas Active, not recruiting
Austin, Texas, United States, 78701
Saint Joseph Regional Cancer Center Recruiting
Bryan, Texas, United States, 77802
Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org   
Principal Investigator: Richard L. Deming         
Parkland Memorial Hospital Recruiting
Dallas, Texas, United States, 75235
Contact: Site Public Contact    214-590-5582    canceranswerline@UTSouthwestern.edu   
Principal Investigator: Saad A. Khan         
Baylor University Medical Center Suspended
Dallas, Texas, United States, 75246
UT Southwestern/Simmons Cancer Center-Dallas Recruiting
Dallas, Texas, United States, 75390
Contact: Site Public Contact    214-648-7097    canceranswerline@UTSouthwestern.edu   
Principal Investigator: Saad A. Khan         
UT Southwestern/Simmons Cancer Center-Fort Worth Recruiting
Fort Worth, Texas, United States, 76104
Contact: Site Public Contact    214-648-7097    canceranswerline@UTSouthwestern.edu   
Principal Investigator: Saad A. Khan         
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center Recruiting
Houston, Texas, United States, 77030
Contact: Site Public Contact    713-798-1354    burton@bcm.edu   
Principal Investigator: Charles K. Osborne         
M D Anderson Cancer Center Recruiting
Houston, Texas, United States, 77030
Contact: Site Public Contact    877-632-6789    askmdanderson@mdanderson.org   
Principal Investigator: Funda Meric-Bernstam         
The Methodist Hospital System Active, not recruiting
Houston, Texas, United States, 77030
MD Anderson in Katy Recruiting
Houston, Texas, United States, 77094
Contact: Site Public Contact    877-632-6789    askmdanderson@mdanderson.org   
Principal Investigator: Funda Meric-Bernstam         
Covenant Medical Center-Lakeside Recruiting
Lubbock, Texas, United States, 79410
Contact: Site Public Contact    806-725-8000    jaccresearch@covhs.org   
Principal Investigator: Isaac Tafur         
MD Anderson League City Recruiting
Nassau Bay, Texas, United States, 77058
Contact: Site Public Contact    877-632-6789    askmdanderson@mdanderson.org   
Principal Investigator: Funda Meric-Bernstam         
UT Southwestern Clinical Center at Richardson/Plano Recruiting
Richardson, Texas, United States, 75080
Contact: Site Public Contact    972-669-7044    Suzanne.cole@utsouthwestern.edu   
Principal Investigator: Saad A. Khan         
Cancer Therapy and Research Center at The UT Health Science Center at San Antonio Active, not recruiting
San Antonio, Texas, United States, 78229
Methodist Children's Hospital of South Texas Recruiting
San Antonio, Texas, United States, 78229
Contact: Site Public Contact    210-575-6240    Vinod.GidvaniDiaz@hcahealthcare.com   
Principal Investigator: Vinod K. Gidvani-Diaz         
University Hospital Active, not recruiting
San Antonio, Texas, United States, 78229
University of Texas Health Science Center at San Antonio Recruiting
San Antonio, Texas, United States, 78229
Contact: Site Public Contact    210-450-3800    phoresearchoffice@uthscsa.edu   
Principal Investigator: Virginia G. Kaklamani         
MD Anderson in Sugar Land